"","record_id","outdesc","out","outprimary","outtype","outanalysis___1","outanalysis___2","outanalysis___3","outanalysis___4","outanalysisdesc","outhowgconfound___1","outhowgconfound___2","outhowgconfound___3","outhowgconfound___4","outhowgconfound___5","outhowgconfound___6","outhowgconfound___7","outhowgconfound___8","outhowconfounddesc","outconfdomains___1","outconfdomains___2","outconfdomains___3","outconfdomains___4","outconfdomains___5","outconfdomains___6","outconfdomains___7","outconfdomains___8","outconfdomains___9","outconfdomains___10","outconfdomains___11","outconfdomains___12","outconfdomains___13","outconfdomains___14","outconfdomains___15","outconfdomains___16","outconfdomains___17","outmingenetics","outmincoinfect","outminatopic","outminneonatal","outminchildsex","outminantibiotic","outminses","outminsibling","outminsmoking","outminnutrition","outminallergens","outminpollution","outminageexp","outminageout","expdesc","expmeth___1","expmeth___2","expmeth___3","expmeth___4","expmeth___5","exptype","exptime___1","exptime___2","exptime___3","exptimedesc","compdesc","type","time2needed","time3needed","expdesc.1","time","estype","esdesc","esmethod","es","es.se.report","es.se","n","expevent","expnonevent","compevent","compnonevent","outage","id","comparison"
"10",2,"Authors just state: ""All patients who presented with LRI and wheezing were followed up for two years in order to determine recurrent episodes of wheezing""",2,1,1,1,0,0,0,"Authors only state: ""Descriptive statistics were used in the analysis with SPSS software.""",0,0,0,0,0,0,0,1,"No attempt to reduce confounding was made",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV/LRTI positive",1,0,0,0,0,1,0,0,1,"Birth to five years","RSV/LRTI negative",2,2,1,NA,1,10,"can't calculate an effect size because some cells of the 2x2 table could not be filled in",2,NA,2,NA,121,11,26,NA,NA,"wheezing in past two years (ages 0-7-->had to be <5 years of age at start of study)",2,1
"13",2,"Authors just state: ""All patients who presented with LRI and wheezing were followed up for two years in order to determine recurrent episodes of wheezing""",2,1,1,1,0,0,0,"Authors only state: ""Descriptive statistics were used in the analysis with SPSS software.""",0,0,0,0,0,0,0,1,"No attempt to reduce confounding was made",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV/LRTI positive",1,0,0,0,0,1,0,0,1,"Birth to five years","RSV/LRTI negative",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",2,1
"14",2,"Authors just state: ""All patients who presented with LRI and wheezing were followed up for two years in order to determine recurrent episodes of wheezing""",2,1,1,1,0,0,0,"Authors only state: ""Descriptive statistics were used in the analysis with SPSS software.""",0,0,0,0,0,0,0,1,"No attempt to reduce confounding was made",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV/LRTI positive",1,0,0,0,0,1,0,0,1,"Birth to five years","RSV/LRTI negative",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",2,1
"1147",3,"Asthma:  Parents completed a respiratory health-related questionnaire when their infant was 2 years of age regarding whether their infant had been diagnosed by a doctor as having asthma.  - The primary outcome of this study was healthcare utilization and health-related cost of care in the first 2 years after birth in infants who developed an RSV LRTI, another viral LRTI or no LRTI in infancy.  The authors also assessed wheezing and asthma in the second year of life.    ",1,2,1,1,0,0,0,"Baseline factors were compared across the three groups using the Kruskal-Wallis test with post hoc tests adjusted for multiple comparisons.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants who had at least one RSV LRTI in the first year after birth.  In the second year, they could have had no LRTI, an RSV or another viral LRTI ('RSV Group').",1,0,0,0,0,0,1,0,0,"","The second group I coded for was infants who had at least one LRTI with viruses other than RSV detected from the NPA in the first year and no RSV LRTI in the second year (other viral group)`  - Two comparator groups:  1) Infants who did not have a symptomatic LRTI in the first 2 years  2) Infants who had at least one LRTI with viruses other than RSV detected from nasopharyngeal aspirate in the first year and no RSV LRTI in the second year  ",2,2,1,NA,1,1,"Groups were compared using the Kruskal-Wallis test, which just provides an overall p-value (i.e., is there a difference between any of the three groups for the outcome?)  -I hand calculated the OR based on stats given in Table 4    OR 9.35 (95% CI 0.41-211.63)",2,9.35,1,1.59,34,2,11,0,21,"ever asthma diagnosis by age 2 (ages 0-2)",3,2
"1148",3,"Asthma:  Parents completed a respiratory health-related questionnaire when their infant was 2 years of age regarding whether their infant had been diagnosed by a doctor as having asthma.  - The primary outcome of this study was healthcare utilization and health-related cost of care in the first 2 years after birth in infants who developed an RSV LRTI, another viral LRTI or no LRTI in infancy.  The authors also assessed wheezing and asthma in the second year of life.    ",1,2,1,1,0,0,0,"Baseline factors were compared across the three groups using the Kruskal-Wallis test with post hoc tests adjusted for multiple comparisons.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants who had at least one RSV LRTI in the first year after birth.  In the second year, they could have had no LRTI, an RSV or another viral LRTI ('RSV Group').",1,0,0,0,0,0,1,0,0,"","The second group I coded for was infants who had at least one LRTI with viruses other than RSV detected from the NPA in the first year and no RSV LRTI in the second year (other viral group)`  - Two comparator groups:  1) Infants who did not have a symptomatic LRTI in the first 2 years  2) Infants who had at least one LRTI with viruses other than RSV detected from nasopharyngeal aspirate in the first year and no RSV LRTI in the second year  ",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,2
"1149",3,"Asthma:  Parents completed a respiratory health-related questionnaire when their infant was 2 years of age regarding whether their infant had been diagnosed by a doctor as having asthma.  - The primary outcome of this study was healthcare utilization and health-related cost of care in the first 2 years after birth in infants who developed an RSV LRTI, another viral LRTI or no LRTI in infancy.  The authors also assessed wheezing and asthma in the second year of life.    ",1,2,1,1,0,0,0,"Baseline factors were compared across the three groups using the Kruskal-Wallis test with post hoc tests adjusted for multiple comparisons.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants who had at least one RSV LRTI in the first year after birth.  In the second year, they could have had no LRTI, an RSV or another viral LRTI ('RSV Group').",1,0,0,0,0,0,1,0,0,"","The second group I coded for was infants who had at least one LRTI with viruses other than RSV detected from the NPA in the first year and no RSV LRTI in the second year (other viral group)`  - Two comparator groups:  1) Infants who did not have a symptomatic LRTI in the first 2 years  2) Infants who had at least one LRTI with viruses other than RSV detected from nasopharyngeal aspirate in the first year and no RSV LRTI in the second year  ",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,2
"22",3,"Wheeze:  Parents completed a respiratory health-related questionnaire when their infant was 2 years of age regarding whether their infant had cough and/or wheeze in their second year after birth.  ""Wheeze"" was explained to the parents.  - The primary outcome of this study was healthcare utilization and health-related cost of care in the first 2 years after birth in infants who developed an RSV LRTI, another viral LRTI or no LRTI in infancy.  The authors also assessed wheezing and asthma in the second year of life.    ",2,2,1,1,0,0,0,"Baseline factors were compared across the three groups using the Kruskal-Wallis test with post hoc tests adjusted for multiple comparisons.",0,0,0,0,0,0,0,1,"No attempt was made to control for confounders",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants who had at least one RSV LRTI in the first year after birth.  In the second year, they could have had no LRTI, an RSV or another viral LRTI ('RSV Group').",1,0,0,0,0,0,1,0,0,"","RSV(-) LRTI but infected with a different virus (""other viral group"")  -Two comparator groups:  1) Infants who did not have a symptomatic LRTI in the first 2 years  2) Infants who had at least one LRTI with viruses other than RSV detected from nasopharyngeal aspirate in the first year and no RSV LRTI in the second year  The second group I coded for was infants who had at least one LRTI with viruses other than RSV detected from the NPA in the first year and no RSV LRTI in the second year (other viral group)",2,2,1,NA,1,1,"Groups were compared using the Kruskal-Wallis test, which just provides an overall p-value (i.e., is there a difference between any of the three groups for the outcome?)  -I hand calculated the OR based on stats given in Table 4    OR 5.14 (95% CI 1.00-26.46)",2,5.14,1,0.84,34,6,7,3,18,"wheezing in the second year (ages 1-2)",3,2
"23",3,"Wheeze:  Parents completed a respiratory health-related questionnaire when their infant was 2 years of age regarding whether their infant had cough and/or wheeze in their second year after birth.  ""Wheeze"" was explained to the parents.  - The primary outcome of this study was healthcare utilization and health-related cost of care in the first 2 years after birth in infants who developed an RSV LRTI, another viral LRTI or no LRTI in infancy.  The authors also assessed wheezing and asthma in the second year of life.    ",2,2,1,1,0,0,0,"Baseline factors were compared across the three groups using the Kruskal-Wallis test with post hoc tests adjusted for multiple comparisons.",0,0,0,0,0,0,0,1,"No attempt was made to control for confounders",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants who had at least one RSV LRTI in the first year after birth.  In the second year, they could have had no LRTI, an RSV or another viral LRTI ('RSV Group').",1,0,0,0,0,0,1,0,0,"","RSV(-) LRTI but infected with a different virus (""other viral group"")  -Two comparator groups:  1) Infants who did not have a symptomatic LRTI in the first 2 years  2) Infants who had at least one LRTI with viruses other than RSV detected from nasopharyngeal aspirate in the first year and no RSV LRTI in the second year  The second group I coded for was infants who had at least one LRTI with viruses other than RSV detected from the NPA in the first year and no RSV LRTI in the second year (other viral group)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",3,2
"24",3,"Wheeze:  Parents completed a respiratory health-related questionnaire when their infant was 2 years of age regarding whether their infant had cough and/or wheeze in their second year after birth.  ""Wheeze"" was explained to the parents.  - The primary outcome of this study was healthcare utilization and health-related cost of care in the first 2 years after birth in infants who developed an RSV LRTI, another viral LRTI or no LRTI in infancy.  The authors also assessed wheezing and asthma in the second year of life.    ",2,2,1,1,0,0,0,"Baseline factors were compared across the three groups using the Kruskal-Wallis test with post hoc tests adjusted for multiple comparisons.",0,0,0,0,0,0,0,1,"No attempt was made to control for confounders",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants who had at least one RSV LRTI in the first year after birth.  In the second year, they could have had no LRTI, an RSV or another viral LRTI ('RSV Group').",1,0,0,0,0,0,1,0,0,"","RSV(-) LRTI but infected with a different virus (""other viral group"")  -Two comparator groups:  1) Infants who did not have a symptomatic LRTI in the first 2 years  2) Infants who had at least one LRTI with viruses other than RSV detected from nasopharyngeal aspirate in the first year and no RSV LRTI in the second year  The second group I coded for was infants who had at least one LRTI with viruses other than RSV detected from the NPA in the first year and no RSV LRTI in the second year (other viral group)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",3,2
"31",4,"Current asthma was defined as having a doctor's diagnosis of asthma and symptoms of wheezing or asthma and/or the use of anti-asthmatic treatment (beta-agonists or inhaled corticosteroids) during the preceding 12 months.  A doctor's diagnosis was either reported in the questionnaire or confirmed during a test procedure at the clinic.",1,1,1,0,1,0,0,"Multivariate logistic regression was used to assess the association between early and current risk factors and adult asthma.  Adjustments were made for gender, current allergy, active smoking, maternal smoking during pregnancy, family history of asthma, RSV infection at first admission, furry pets at home in infancy, start of wheezing before the age of six months, and intense obstructive disease as a young child.",0,1,1,0,0,0,0,0,"The authors performed multivariate logistic regression.  Additionally, they performed separate logistic regression analyses stratified for gender and current allergic status.",1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,1,NA,NA,NA,2,NA,NA,NA,1,NA,1,NA,NA,NA,"hospitalized for LRTI and RSV-positive ",1,0,0,0,0,2,0,1,0,"","hospitalized for LRTI and no RSV infection",2,2,1,NA,1,1,"Table 2:  OR 1.6 (95% CI 0.4-5.9)    n(%) given in Table 1",1,1.6,1,0.69,79,10,13,20,36,"asthma diagnosis in the past year (ages 25-28)",4,1
"28",4,"Current asthma was defined as having a doctor's diagnosis of asthma and symptoms of wheezing or asthma and/or the use of anti-asthmatic treatment (beta-agonists or inhaled corticosteroids) during the preceding 12 months.  A doctor's diagnosis was either reported in the questionnaire or confirmed during a test procedure at the clinic.",1,1,1,0,1,0,0,"Multivariate logistic regression was used to assess the association between early and current risk factors and adult asthma.  Adjustments were made for gender, current allergy, active smoking, maternal smoking during pregnancy, family history of asthma, RSV infection at first admission, furry pets at home in infancy, start of wheezing before the age of six months, and intense obstructive disease as a young child.",0,1,1,0,0,0,0,0,"The authors performed multivariate logistic regression.  Additionally, they performed separate logistic regression analyses stratified for gender and current allergic status.",1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,1,NA,NA,NA,2,NA,NA,NA,1,NA,1,NA,NA,NA,"hospitalized for LRTI and RSV-positive ",1,0,0,0,0,2,0,1,0,"","hospitalized for LRTI and no RSV infection",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",4,1
"36",4,"Current asthma was defined as having a doctor's diagnosis of asthma and symptoms of wheezing or asthma and/or the use of anti-asthmatic treatment (beta-agonists or inhaled corticosteroids) during the preceding 12 months.  A doctor's diagnosis was either reported in the questionnaire or confirmed during a test procedure at the clinic.",1,1,1,0,1,0,0,"Multivariate logistic regression was used to assess the association between early and current risk factors and adult asthma.  Adjustments were made for gender, current allergy, active smoking, maternal smoking during pregnancy, family history of asthma, RSV infection at first admission, furry pets at home in infancy, start of wheezing before the age of six months, and intense obstructive disease as a young child.",0,1,1,0,0,0,0,0,"The authors performed multivariate logistic regression.  Additionally, they performed separate logistic regression analyses stratified for gender and current allergic status.",1,0,0,0,1,0,0,0,1,0,1,0,0,0,0,1,0,1,NA,NA,NA,2,NA,NA,NA,1,NA,1,NA,NA,NA,"hospitalized for LRTI and RSV-positive ",1,0,0,0,0,2,0,1,0,"","hospitalized for LRTI and no RSV infection",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",4,1
"38",5,"Any subsequent wheeze  - ""Frequency of wheezing episodes was recorded during the follow-up period following acute bronchiolitis."" (no mention of how long after bronchiolitis was diagnosed that infants could have a recorded wheezing episode)  ",2,1,1,0,0,0,1,"Kruskal Wallis test was used for comparison of the groups with recurrent wheezing episodes (just gave an overall p-value- no effect size)",0,0,0,0,0,0,0,1,"No adjustment was made for confounders",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI and RSV-positive (PCR confirmed)",1,0,0,0,0,1,0,0,1,"birth to 36 months","LRTI but no RSV",2,2,1,NA,1,1,"the authors only report a p-value so I calculated the odds ratio and SE for the first comparison- recurrence of <3 wheezing episodes during follow up (table 3)    OR 1.00 (95% CI 0.36-2.81)",2,0.47,1,0.49,70,14,26,16,14,"~ ages 0-6: exposure at ages 0-3 and follow-up from 1-3 years",5,1
"1163",5," RECURRENT WHEEZE (3+ EPISODES): ",2,3,1,0,0,0,0,"Kruskal Wallis test was used for comparison of the groups with recurrent wheezing episodes (just gave an overall p-value- no effect size)",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI bronchiolitis",1,0,0,0,0,1,0,0,1,"birth to 36 months","RSV(-) bronchiolitis",2,2,1,NA,1,1,"unadjusted OR based on Table 3 stats",2,0.17,1,0.84,70,2,38,7,23,"approx ages 0-6: exposure at ages 0-3 and follow-up from 1-3 years",5,1
"43",5,"Any subsequent wheeze  - ""Frequency of wheezing episodes was recorded during the follow-up period following acute bronchiolitis."" (no mention of how long after bronchiolitis was diagnosed that infants could have a recorded wheezing episode)  ",2,1,1,0,0,0,1,"Kruskal Wallis test was used for comparison of the groups with recurrent wheezing episodes (just gave an overall p-value- no effect size)",0,0,0,0,0,0,0,1,"No adjustment was made for confounders",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI and RSV-positive (PCR confirmed)",1,0,0,0,0,1,0,0,1,"birth to 36 months","LRTI but no RSV",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",5,1
"1168",5," RECURRENT WHEEZE (3+ EPISODES): ",2,3,1,0,0,0,0,"Kruskal Wallis test was used for comparison of the groups with recurrent wheezing episodes (just gave an overall p-value- no effect size)",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI bronchiolitis",1,0,0,0,0,1,0,0,1,"birth to 36 months","RSV(-) bronchiolitis",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",5,1
"44",5,"Any subsequent wheeze  - ""Frequency of wheezing episodes was recorded during the follow-up period following acute bronchiolitis."" (no mention of how long after bronchiolitis was diagnosed that infants could have a recorded wheezing episode)  ",2,1,1,0,0,0,1,"Kruskal Wallis test was used for comparison of the groups with recurrent wheezing episodes (just gave an overall p-value- no effect size)",0,0,0,0,0,0,0,1,"No adjustment was made for confounders",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI and RSV-positive (PCR confirmed)",1,0,0,0,0,1,0,0,1,"birth to 36 months","LRTI but no RSV",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",5,1
"1169",5," RECURRENT WHEEZE (3+ EPISODES): ",2,3,1,0,0,0,0,"Kruskal Wallis test was used for comparison of the groups with recurrent wheezing episodes (just gave an overall p-value- no effect size)",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI bronchiolitis",1,0,0,0,0,1,0,0,1,"birth to 36 months","RSV(-) bronchiolitis",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",5,1
"46",6,"RECURRENT WHEEZE: The primary outcome was time to recurrent wheezing ever. It was defined as the earliest date during the 7-yr follow-up period when a child fulfilled one or more of the following  criteria: three physician-confirmed episodes of wheezing within the past 12 months; continuous lower respiratory symptoms (cough, wheezing) lasting >4 wk and relieved by recurrent use of bronchodilators; or moderate-to-severe wheezing episodes necessitating systemic corticosteroid use within 6 months",2,1,1,0,0,1,0,"Cox hazard ratio (HR) indicated the risk of recurrent wheezing. Interactions between treatment grouping (prednisolone vs. placebo) and pre-specified risk factors (eczema status and HRV, RSV or HRV-/RSV-negative aetiology) were studied with Cox regression. Multivariable model was repeated with significant interactions. Each study subject was censored from the analysis after the initiation of the daily controller therapy with inhaled corticosteroid treatment.  -RSV was not found to be significantly associated with risk of recurrent wheezing in the univariate model.  Therefore, it wasn't included in the multivariate model (no adjusted HR is listed so I coded it as not adjusting for confounders).",0,1,0,0,0,0,0,0,"I am just reporting on the univariate results for the association between RSV and recurrent wheezing.  As it wasn't significant, the authors didn't include it in the multivariate model.  The authors showed that there were no differences between the two groups with respect to the following characteristics: sex, blood eosinophil count, parental asthma, parental smoking, and day care.  The authors found significant differences between the children with and without recurrent wheezing for the following variables (which were included in the multivariate model): viral etiology (HRV), allergen sensitization, age <1 year, and eczema at study entry.",1,1,1,0,1,0,0,0,1,0,0,0,1,0,0,1,0,1,2,2,NA,2,NA,NA,NA,1,NA,NA,NA,2,NA," -[Steve: RSV(+) LRTI]  - Children included in the RSV group could have either an RSV monoinfection or co-infection excluding HRV",1,0,0,0,0,2,0,0,1,"Birth to 3 years"," - [Steve: HRV(+) LRTI]",2,2,1,NA,1,4,"[Steve: based on multivariable Cox regression; ""In the final model of backward stepwise multivariable analysis, the risk factors for recurrent wheezing were HRV (HR 3.54, 95% CI 1.51-8.30)."" I took the inverse so that HRV was the comaparator]  - [Steve: doesn't say explicitly the RSV was the comparison group, but based on Table 1, all kids were classified into HRV or RSV groups and this was the comparison used in this study in a previous paper (Lehtinen 2007)]",2,0.28,1,0.43,78,12,32,39,28,"~ wheezing between ages 1-7",6,1
"50",6,"RECURRENT WHEEZE: The primary outcome was time to recurrent wheezing ever. It was defined as the earliest date during the 7-yr follow-up period when a child fulfilled one or more of the following  criteria: three physician-confirmed episodes of wheezing within the past 12 months; continuous lower respiratory symptoms (cough, wheezing) lasting >4 wk and relieved by recurrent use of bronchodilators; or moderate-to-severe wheezing episodes necessitating systemic corticosteroid use within 6 months",2,1,1,0,0,1,0,"Cox hazard ratio (HR) indicated the risk of recurrent wheezing. Interactions between treatment grouping (prednisolone vs. placebo) and pre-specified risk factors (eczema status and HRV, RSV or HRV-/RSV-negative aetiology) were studied with Cox regression. Multivariable model was repeated with significant interactions. Each study subject was censored from the analysis after the initiation of the daily controller therapy with inhaled corticosteroid treatment.  -RSV was not found to be significantly associated with risk of recurrent wheezing in the univariate model.  Therefore, it wasn't included in the multivariate model (no adjusted HR is listed so I coded it as not adjusting for confounders).",0,1,0,0,0,0,0,0,"I am just reporting on the univariate results for the association between RSV and recurrent wheezing.  As it wasn't significant, the authors didn't include it in the multivariate model.  The authors showed that there were no differences between the two groups with respect to the following characteristics: sex, blood eosinophil count, parental asthma, parental smoking, and day care.  The authors found significant differences between the children with and without recurrent wheezing for the following variables (which were included in the multivariate model): viral etiology (HRV), allergen sensitization, age <1 year, and eczema at study entry.",1,1,1,0,1,0,0,0,1,0,0,0,1,0,0,1,0,1,2,2,NA,2,NA,NA,NA,1,NA,NA,NA,2,NA," -[Steve: RSV(+) LRTI]  - Children included in the RSV group could have either an RSV monoinfection or co-infection excluding HRV",1,0,0,0,0,2,0,0,1,"Birth to 3 years"," - [Steve: HRV(+) LRTI]",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",6,1
"51",6,"RECURRENT WHEEZE: The primary outcome was time to recurrent wheezing ever. It was defined as the earliest date during the 7-yr follow-up period when a child fulfilled one or more of the following  criteria: three physician-confirmed episodes of wheezing within the past 12 months; continuous lower respiratory symptoms (cough, wheezing) lasting >4 wk and relieved by recurrent use of bronchodilators; or moderate-to-severe wheezing episodes necessitating systemic corticosteroid use within 6 months",2,1,1,0,0,1,0,"Cox hazard ratio (HR) indicated the risk of recurrent wheezing. Interactions between treatment grouping (prednisolone vs. placebo) and pre-specified risk factors (eczema status and HRV, RSV or HRV-/RSV-negative aetiology) were studied with Cox regression. Multivariable model was repeated with significant interactions. Each study subject was censored from the analysis after the initiation of the daily controller therapy with inhaled corticosteroid treatment.  -RSV was not found to be significantly associated with risk of recurrent wheezing in the univariate model.  Therefore, it wasn't included in the multivariate model (no adjusted HR is listed so I coded it as not adjusting for confounders).",0,1,0,0,0,0,0,0,"I am just reporting on the univariate results for the association between RSV and recurrent wheezing.  As it wasn't significant, the authors didn't include it in the multivariate model.  The authors showed that there were no differences between the two groups with respect to the following characteristics: sex, blood eosinophil count, parental asthma, parental smoking, and day care.  The authors found significant differences between the children with and without recurrent wheezing for the following variables (which were included in the multivariate model): viral etiology (HRV), allergen sensitization, age <1 year, and eczema at study entry.",1,1,1,0,1,0,0,0,1,0,0,0,1,0,0,1,0,1,2,2,NA,2,NA,NA,NA,1,NA,NA,NA,2,NA," -[Steve: RSV(+) LRTI]  - Children included in the RSV group could have either an RSV monoinfection or co-infection excluding HRV",1,0,0,0,0,2,0,0,1,"Birth to 3 years"," - [Steve: HRV(+) LRTI]",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",6,1
"89",10,"At 12-24-36 months after infant's discharge parents were asked to answer a structured questionnaire during a telephone interview seeking information on recurrent wheezing. Recurrent wheezing was defined as two or more physician-diagnosed wheezing episodes per year.",2,2,1,1,0,0,0,"A chi-squared test was run to compare proportions of recurrent wheezing among infants with RSV only and those with co-infections.",0,0,0,0,0,0,0,1,"authors only performed univariate comparisons",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV + during hospitalization for bronchiolitis",1,0,0,0,0,2,1,0,0,"","HRV+ during hospitalization for bronchiolitis (Table 4)- no co-infection between RSV and HRV (single viruses)",2,2,2,2,1,1,"[Steve: I think we cannot use the total n provided at the top of the columns of Table 4 because there was attrition at the follow-ups. Rather, I calculated the total n for each column based on the numbers and percentages provided in each cell. When doing this you can see that there was attrition and the total n in the header row do not actually apply. I adjusted the effect size estimates accordingly.]    The authors only report the p-value from a chi-squared test, so I HAND CALCULATED the unadjusted odds ratio and SE for recurrent wheezing at 12 months (Table 4)  OR 0.61 (95% CI 0.35-1.06)",2,0.52,1,0.32,313,131,133,32,17,"recurrent wheezing in past 12 months at age 2 (ages 1-2)",10,2
"87",10,"At 12-24-36 months after infant's discharge parents were asked to answer a structured questionnaire during a telephone interview seeking information on recurrent wheezing. Recurrent wheezing was defined as two or more physician-diagnosed wheezing episodes per year.",2,2,1,1,0,0,0,"A chi-squared test was run to compare proportions of recurrent wheezing among infants with RSV only and those with co-infections.",0,0,0,0,0,0,0,1,"authors only performed univariate comparisons",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV + during hospitalization for bronchiolitis",1,0,0,0,0,2,1,0,0,"","HRV+ during hospitalization for bronchiolitis (Table 4)- no co-infection between RSV and HRV (single viruses)",2,2,2,2,2,1,"[Steve: See my notes above. I recalculated the OR and SE with a new total n for each cell that accounts for attrition.]    The authors only report the p-value from a chi-squared test, so I HAND CALCULATED the unadjusted odds ratio and SE for recurrent wheezing at 24 months (Table 4)  OR 0.54 (95% CI 0.31-0.95)",2,0.52,1,0.33,263,89,130,25,19,"recurrent wheezing in past 12 months at age 3 (ages2-3)",10,2
"90",10,"At 12-24-36 months after infant's discharge parents were asked to answer a structured questionnaire during a telephone interview seeking information on recurrent wheezing. Recurrent wheezing was defined as two or more physician-diagnosed wheezing episodes per year.",2,2,1,1,0,0,0,"A chi-squared test was run to compare proportions of recurrent wheezing among infants with RSV only and those with co-infections.",0,0,0,0,0,0,0,1,"authors only performed univariate comparisons",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV + during hospitalization for bronchiolitis",1,0,0,0,0,2,1,0,0,"","HRV+ during hospitalization for bronchiolitis (Table 4)- no co-infection between RSV and HRV (single viruses)",2,2,2,2,3,1,"The authors only report the p-value from a chi-squared test, so I HAND CALCULATED the unadjusted odds ratio and SE for recurrent wheezing at 36 months (Table 4)  OR 0.71 (95% CI 0.38-1.35)",2,0.88,1,0.36,218,66,112,16,24,"recurrent wheezing in past 12 months at age 4 (ages 3-4)",10,2
"93",11,"Current asthma at up to 20 years follow-up  - Infants were followed up to 20 years.  For current asthma, previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication with inhaled corticosteroids, during the last 12 months, were required.  In addition, study subjects were regarded as having asthma if they presented an abnormal result in the home peak expiratory flow monitoring, and also reported asthma-presumptive symptoms or repeated use of bronchodilators.  - ""Repeated wheezing episodes (more than 2 episodes during the last 12 months), chronic night cough, and prolonged cough for more than 4 weeks apart from infection were regarded as asthma-presumptive  symptoms.""",1,1,1,0,1,0,0,"Multivariate logistic regression was used to compare the cases (early childhood wheezing episode) with population-based controls.  As the wheezing episode didn't necessarily have to be caused by RSV, I left this analysis out of the coding for this study and focused on the post-hoc analysis.  -Study subjects with early-childhood  wheezing were divided into three groups positive for RV, RSV, and other viruses. Those 40 study subjects with PCR tests performed during the initial wheezing episode were included in the post hoc analysis to compare these viral wheezing groups. In post hoc analyses, all groups were compared to the control group, and viral wheezing groups were also compared to each other in paired comparisons (Table 2)",1,1,0,0,0,0,0,0,"adjusted for age, sex, current daily smoking, and current allergy    [Steve: adjusted for current smoking at ages 17-20, but not for prenatal or early postnatal smoke exposure]    controls matched for sex and age ",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"[Steve: RSV(+) wheezing hospitalization at ages 0-2]",1,0,0,0,0,2,0,1,0,"","[Steve: RV(+) wheeze hospitalization in the first two years of life]",2,2,1,NA,1,1,"[Steve: unadjusted OR based on data provided in Table 2; not adjusted OR provided] ",2,0.42,1,0.78,28,6,8,9,5,"current wheeze at ages ~ 17-20; previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication during the last 12 months (17-19 years)",11,2
"97",11,"Current asthma at up to 20 years follow-up  - Infants were followed up to 20 years.  For current asthma, previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication with inhaled corticosteroids, during the last 12 months, were required.  In addition, study subjects were regarded as having asthma if they presented an abnormal result in the home peak expiratory flow monitoring, and also reported asthma-presumptive symptoms or repeated use of bronchodilators.  - ""Repeated wheezing episodes (more than 2 episodes during the last 12 months), chronic night cough, and prolonged cough for more than 4 weeks apart from infection were regarded as asthma-presumptive  symptoms.""",1,1,1,0,1,0,0,"Multivariate logistic regression was used to compare the cases (early childhood wheezing episode) with population-based controls.  As the wheezing episode didn't necessarily have to be caused by RSV, I left this analysis out of the coding for this study and focused on the post-hoc analysis.  -Study subjects with early-childhood  wheezing were divided into three groups positive for RV, RSV, and other viruses. Those 40 study subjects with PCR tests performed during the initial wheezing episode were included in the post hoc analysis to compare these viral wheezing groups. In post hoc analyses, all groups were compared to the control group, and viral wheezing groups were also compared to each other in paired comparisons (Table 2)",1,1,0,0,0,0,0,0,"adjusted for age, sex, current daily smoking, and current allergy    [Steve: adjusted for current smoking at ages 17-20, but not for prenatal or early postnatal smoke exposure]    controls matched for sex and age ",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"[Steve: RSV(+) wheezing hospitalization at ages 0-2]",1,0,0,0,0,2,0,1,0,"","[Steve: RV(+) wheeze hospitalization in the first two years of life]",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",11,2
"98",11,"Current asthma at up to 20 years follow-up  - Infants were followed up to 20 years.  For current asthma, previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication with inhaled corticosteroids, during the last 12 months, were required.  In addition, study subjects were regarded as having asthma if they presented an abnormal result in the home peak expiratory flow monitoring, and also reported asthma-presumptive symptoms or repeated use of bronchodilators.  - ""Repeated wheezing episodes (more than 2 episodes during the last 12 months), chronic night cough, and prolonged cough for more than 4 weeks apart from infection were regarded as asthma-presumptive  symptoms.""",1,1,1,0,1,0,0,"Multivariate logistic regression was used to compare the cases (early childhood wheezing episode) with population-based controls.  As the wheezing episode didn't necessarily have to be caused by RSV, I left this analysis out of the coding for this study and focused on the post-hoc analysis.  -Study subjects with early-childhood  wheezing were divided into three groups positive for RV, RSV, and other viruses. Those 40 study subjects with PCR tests performed during the initial wheezing episode were included in the post hoc analysis to compare these viral wheezing groups. In post hoc analyses, all groups were compared to the control group, and viral wheezing groups were also compared to each other in paired comparisons (Table 2)",1,1,0,0,0,0,0,0,"adjusted for age, sex, current daily smoking, and current allergy    [Steve: adjusted for current smoking at ages 17-20, but not for prenatal or early postnatal smoke exposure]    controls matched for sex and age ",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"[Steve: RSV(+) wheezing hospitalization at ages 0-2]",1,0,0,0,0,2,0,1,0,"","[Steve: RV(+) wheeze hospitalization in the first two years of life]",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",11,2
"92",11,"Current asthma at up to 20 years follow-up  - Infants were followed up to 20 years.  For current asthma, previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication with inhaled corticosteroids, during the last 12 months, were required.  In addition, study subjects were regarded as having asthma if they presented an abnormal result in the home peak expiratory flow monitoring, and also reported asthma-presumptive symptoms or repeated use of bronchodilators.  - ""Repeated wheezing episodes (more than 2 episodes during the last 12 months), chronic night cough, and prolonged cough for more than 4 weeks apart from infection were regarded as asthma-presumptive  symptoms.""",1,1,1,0,1,0,0,"Multivariate logistic regression was used to compare the cases (early childhood wheezing episode) with population-based controls.  As the wheezing episode didn't necessarily have to be caused by RSV, I left this analysis out of the coding for this study and focused on the post-hoc analysis.  -Study subjects with early-childhood  wheezing were divided into three groups positive for RV, RSV, and other viruses. Those 40 study subjects with PCR tests performed during the initial wheezing episode were included in the post hoc analysis to compare these viral wheezing groups. In post hoc analyses, all groups were compared to the control group, and viral wheezing groups were also compared to each other in paired comparisons (Table 2)",1,1,0,0,0,0,0,0,"adjusted for age, sex, current daily smoking, and current allergy    [Steve: adjusted for current smoking at ages 17-20, but not for prenatal or early postnatal smoke exposure]    controls matched for sex and age ",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"[Steve: RSV(+) wheezing hospitalization at ages 0-2]",1,0,0,0,0,2,0,1,0,"","[Steve: Non-RSV and Non-RV induced wheeze hospitalization in the first two years of life]",2,2,1,NA,1,1,"[Steve: unadjusted OR based on data provided in Table 2; not adjusted OR provided] ",2,0.54,1,0.8,26,6,8,7,5,"current wheeze at ages ~ 17-20; previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication during the last 12 months (17-19 years)",11,3
"99",11,"Current asthma at up to 20 years follow-up  - Infants were followed up to 20 years.  For current asthma, previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication with inhaled corticosteroids, during the last 12 months, were required.  In addition, study subjects were regarded as having asthma if they presented an abnormal result in the home peak expiratory flow monitoring, and also reported asthma-presumptive symptoms or repeated use of bronchodilators.  - ""Repeated wheezing episodes (more than 2 episodes during the last 12 months), chronic night cough, and prolonged cough for more than 4 weeks apart from infection were regarded as asthma-presumptive  symptoms.""",1,1,1,0,1,0,0,"Multivariate logistic regression was used to compare the cases (early childhood wheezing episode) with population-based controls.  As the wheezing episode didn't necessarily have to be caused by RSV, I left this analysis out of the coding for this study and focused on the post-hoc analysis.  -Study subjects with early-childhood  wheezing were divided into three groups positive for RV, RSV, and other viruses. Those 40 study subjects with PCR tests performed during the initial wheezing episode were included in the post hoc analysis to compare these viral wheezing groups. In post hoc analyses, all groups were compared to the control group, and viral wheezing groups were also compared to each other in paired comparisons (Table 2)",1,1,0,0,0,0,0,0,"adjusted for age, sex, current daily smoking, and current allergy    [Steve: adjusted for current smoking at ages 17-20, but not for prenatal or early postnatal smoke exposure]    controls matched for sex and age ",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"[Steve: RSV(+) wheezing hospitalization at ages 0-2]",1,0,0,0,0,2,0,1,0,"","[Steve: Non-RSV and Non-RV induced wheeze hospitalization in the first two years of life]",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",11,3
"96",11,"Current asthma at up to 20 years follow-up  - Infants were followed up to 20 years.  For current asthma, previously diagnosed asthma combined with asthma symptoms or ongoing regular maintenance medication with inhaled corticosteroids, during the last 12 months, were required.  In addition, study subjects were regarded as having asthma if they presented an abnormal result in the home peak expiratory flow monitoring, and also reported asthma-presumptive symptoms or repeated use of bronchodilators.  - ""Repeated wheezing episodes (more than 2 episodes during the last 12 months), chronic night cough, and prolonged cough for more than 4 weeks apart from infection were regarded as asthma-presumptive  symptoms.""",1,1,1,0,1,0,0,"Multivariate logistic regression was used to compare the cases (early childhood wheezing episode) with population-based controls.  As the wheezing episode didn't necessarily have to be caused by RSV, I left this analysis out of the coding for this study and focused on the post-hoc analysis.  -Study subjects with early-childhood  wheezing were divided into three groups positive for RV, RSV, and other viruses. Those 40 study subjects with PCR tests performed during the initial wheezing episode were included in the post hoc analysis to compare these viral wheezing groups. In post hoc analyses, all groups were compared to the control group, and viral wheezing groups were also compared to each other in paired comparisons (Table 2)",1,1,0,0,0,0,0,0,"adjusted for age, sex, current daily smoking, and current allergy    [Steve: adjusted for current smoking at ages 17-20, but not for prenatal or early postnatal smoke exposure]    controls matched for sex and age ",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"[Steve: RSV(+) wheezing hospitalization at ages 0-2]",1,0,0,0,0,2,0,1,0,"","[Steve: Non-RSV and Non-RV induced wheeze hospitalization in the first two years of life]",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",11,3
"131",15,"Asthma at age 28-31  - A previous doctor-settled asthma diagnosis combined with ongoing regular maintenance medication with inhaled corticosteroids, or with asthma-presumptive symptoms, or with repeated use of bronchodilators during the preceding 12 months, was required for the diagnosis of self-reported asthma.  In addition, study subjects with asthma-presumptive symptoms and/or repeated use of bronchodilators during the preceding 12 months, combined with a pathological result in the home peak expiratory flow monitoring were included.  Asthma was reported at the age of 28-31 years.",1,1,1,0,1,0,0,"Logistic regression was used to assess the association between RSV and asthma at age of 28-31",0,1,0,0,0,0,0,0,"Adjustments were made for current daily smoking.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI hospitalization and RSV +",1,0,0,0,0,2,0,1,0,"","LRTI hospitalization and non-RSV etiology",2,2,1,NA,1,1,"Logistic regression was used, adjusting for current daily smoking  -aOR 1.43 (0.39-5.22)",1,1.43,1,0.66,47,6,8,11,22,"[Steve: The asthma dx required symptoms or medication management in prior 12 months, so I think this covers ages 27-30]; ever asthma diagnosis by age 28-31 (ages 0-31)",15,1
"128",15,"Asthma at age 28-31  - A previous doctor-settled asthma diagnosis combined with ongoing regular maintenance medication with inhaled corticosteroids, or with asthma-presumptive symptoms, or with repeated use of bronchodilators during the preceding 12 months, was required for the diagnosis of self-reported asthma.  In addition, study subjects with asthma-presumptive symptoms and/or repeated use of bronchodilators during the preceding 12 months, combined with a pathological result in the home peak expiratory flow monitoring were included.  Asthma was reported at the age of 28-31 years.",1,1,1,0,1,0,0,"Logistic regression was used to assess the association between RSV and asthma at age of 28-31",0,1,0,0,0,0,0,0,"Adjustments were made for current daily smoking.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI hospitalization and RSV +",1,0,0,0,0,2,0,1,0,"","LRTI hospitalization and non-RSV etiology",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",15,1
"129",15,"Asthma at age 28-31  - A previous doctor-settled asthma diagnosis combined with ongoing regular maintenance medication with inhaled corticosteroids, or with asthma-presumptive symptoms, or with repeated use of bronchodilators during the preceding 12 months, was required for the diagnosis of self-reported asthma.  In addition, study subjects with asthma-presumptive symptoms and/or repeated use of bronchodilators during the preceding 12 months, combined with a pathological result in the home peak expiratory flow monitoring were included.  Asthma was reported at the age of 28-31 years.",1,1,1,0,1,0,0,"Logistic regression was used to assess the association between RSV and asthma at age of 28-31",0,1,0,0,0,0,0,0,"Adjustments were made for current daily smoking.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI hospitalization and RSV +",1,0,0,0,0,2,0,1,0,"","LRTI hospitalization and non-RSV etiology",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",15,1
"138",16,"Wheezing subsequent to bronchiolitis and/pneumonia hospitalization was the primary outcome. At the first control visit 4 weeks after hospital treatment the children were examined and the parents were interviewed. The history of previous wheezing, the number of the wheezing attacks if present were recorded.   In the course of the follow-up study, the children were examined and the parents were interviewed by the same author twice at I.5 to 2 years of age and again at 2.5 to 3 years of age. At all visits, the numbers of wheezing attacks and the age during each attack were registered. Throughout the follow-up, the data were collected by using standardized questionnaires; only the attacks diagnosed and treated by a physician were included. ",2,1,1,1,0,0,0,"The authors only state that, ""a chi-square test with a correction devised by Yates was applied.""",0,0,0,0,0,1,0,0,"[Steve: Table 1 shows that the percent of children breast feeding for 3+ months was equal across the groups, so the potential confounding effect was somewhat reduced]",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,"children who sought medical treatment for wheezing (wheezing group) and were found to be RSV +",1,0,0,0,0,1,0,1,0,"","Table 4- the RSV group was compared to children without RSV (within the wheezing group)",2,2,1,NA,1,1,"odds ratio was not significant-no confidence intervals provided by authors so I HAND CALCULATED the OR (only gave one decimal place in table 4), CIs and SE  -Look at Table 3 to see how many infants had viruses other than RSV  ",2,0.67,1,0.48,76,15,14,29,18,"wheezing after acute bronchiolitis or pneumonia (ages 0-3)",16,1
"139",16,"Wheezing subsequent to bronchiolitis and/pneumonia hospitalization was the primary outcome. At the first control visit 4 weeks after hospital treatment the children were examined and the parents were interviewed. The history of previous wheezing, the number of the wheezing attacks if present were recorded.   In the course of the follow-up study, the children were examined and the parents were interviewed by the same author twice at I.5 to 2 years of age and again at 2.5 to 3 years of age. At all visits, the numbers of wheezing attacks and the age during each attack were registered. Throughout the follow-up, the data were collected by using standardized questionnaires; only the attacks diagnosed and treated by a physician were included. ",2,1,1,1,0,0,0,"The authors only state that, ""a chi-square test with a correction devised by Yates was applied.""",0,0,0,0,0,1,0,0,"[Steve: Table 1 shows that the percent of children breast feeding for 3+ months was equal across the groups, so the potential confounding effect was somewhat reduced]",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,"children who sought medical treatment for wheezing (wheezing group) and were found to be RSV +",1,0,0,0,0,1,0,1,0,"","Table 4- the RSV group was compared to children without RSV (within the wheezing group)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",16,1
"136",16,"Wheezing subsequent to bronchiolitis and/pneumonia hospitalization was the primary outcome. At the first control visit 4 weeks after hospital treatment the children were examined and the parents were interviewed. The history of previous wheezing, the number of the wheezing attacks if present were recorded.   In the course of the follow-up study, the children were examined and the parents were interviewed by the same author twice at I.5 to 2 years of age and again at 2.5 to 3 years of age. At all visits, the numbers of wheezing attacks and the age during each attack were registered. Throughout the follow-up, the data were collected by using standardized questionnaires; only the attacks diagnosed and treated by a physician were included. ",2,1,1,1,0,0,0,"The authors only state that, ""a chi-square test with a correction devised by Yates was applied.""",0,0,0,0,0,1,0,0,"[Steve: Table 1 shows that the percent of children breast feeding for 3+ months was equal across the groups, so the potential confounding effect was somewhat reduced]",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,"children who sought medical treatment for wheezing (wheezing group) and were found to be RSV +",1,0,0,0,0,1,0,1,0,"","Table 4- the RSV group was compared to children without RSV (within the wheezing group)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",16,1
"143",16,"Wheezing subsequent to bronchiolitis and/pneumonia hospitalization was the primary outcome. At the first control visit 4 weeks after hospital treatment the children were examined and the parents were interviewed. The history of previous wheezing, the number of the wheezing attacks if present were recorded.   In the course of the follow-up study, the children were examined and the parents were interviewed by the same author twice at I.5 to 2 years of age and again at 2.5 to 3 years of age. At all visits, the numbers of wheezing attacks and the age during each attack were registered. Throughout the follow-up, the data were collected by using standardized questionnaires; only the attacks diagnosed and treated by a physician were included. ",2,1,1,1,0,0,0,"The authors only state that, ""a chi-square test with a correction devised by Yates was applied.""",0,0,0,0,0,1,0,0,"[Steve: Table 1 shows that the percent of children breast feeding for 3+ months was equal across the groups, so the potential confounding effect was somewhat reduced]",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,"[Steve: RSV(+) LRTI (in either group) --Table 3]",1,0,0,0,0,1,0,1,0,"","[Steve: RSV(-) LRTI (in either group) --Table 3]",2,2,1,NA,1,1,"[Steve: These were complex calculations based on Table 3, especially since there were some co-infections (see Steve's excel sheet) Ultimately, the cells in Table 3 do not add up to the total sample size listed in the table title, but this may be because some kids did not have had a confirmed viral or bacterial cause?]     I HAND CALCULATED the odds ratio based on information provided in table 3 (the authors just state in a footnote that the comparison is non-significant)  OR 0.16 (95% CI 0.03-0.82)",2,0.52,1,0.47,77,17,26,19,15,"wheezing after acute bronchiolitis or pneumonia (ages 0-3)",16,2
"140",16,"Wheezing subsequent to bronchiolitis and/pneumonia hospitalization was the primary outcome. At the first control visit 4 weeks after hospital treatment the children were examined and the parents were interviewed. The history of previous wheezing, the number of the wheezing attacks if present were recorded.   In the course of the follow-up study, the children were examined and the parents were interviewed by the same author twice at I.5 to 2 years of age and again at 2.5 to 3 years of age. At all visits, the numbers of wheezing attacks and the age during each attack were registered. Throughout the follow-up, the data were collected by using standardized questionnaires; only the attacks diagnosed and treated by a physician were included. ",2,1,1,1,0,0,0,"The authors only state that, ""a chi-square test with a correction devised by Yates was applied.""",0,0,0,0,0,1,0,0,"[Steve: Table 1 shows that the percent of children breast feeding for 3+ months was equal across the groups, so the potential confounding effect was somewhat reduced]",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,"[Steve: RSV(+) LRTI (in either group) --Table 3]",1,0,0,0,0,1,0,1,0,"","[Steve: RSV(-) LRTI (in either group) --Table 3]",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",16,2
"137",16,"Wheezing subsequent to bronchiolitis and/pneumonia hospitalization was the primary outcome. At the first control visit 4 weeks after hospital treatment the children were examined and the parents were interviewed. The history of previous wheezing, the number of the wheezing attacks if present were recorded.   In the course of the follow-up study, the children were examined and the parents were interviewed by the same author twice at I.5 to 2 years of age and again at 2.5 to 3 years of age. At all visits, the numbers of wheezing attacks and the age during each attack were registered. Throughout the follow-up, the data were collected by using standardized questionnaires; only the attacks diagnosed and treated by a physician were included. ",2,1,1,1,0,0,0,"The authors only state that, ""a chi-square test with a correction devised by Yates was applied.""",0,0,0,0,0,1,0,0,"[Steve: Table 1 shows that the percent of children breast feeding for 3+ months was equal across the groups, so the potential confounding effect was somewhat reduced]",0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,"[Steve: RSV(+) LRTI (in either group) --Table 3]",1,0,0,0,0,1,0,1,0,"","[Steve: RSV(-) LRTI (in either group) --Table 3]",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",16,2
"145",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"Birth to 6 months","hospitalized for acute bronchiolitis in first 6 months of life and pathogens other than RSV or no pathogen ('Group 3 and Group 4 combined')",2,2,1,NA,1,1,"I HAND CALCULATED the odds ratio based on the descriptive statistics given in Table 5    [Steve: OR=1.19, SE=0.48  OR 0.78 (95% CI 0.37-0.64)",2,1.19,1,0.48,102,47,33,12,10,"wheezing between six months and 3 years",17,1
"153",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"Birth to 6 months","hospitalized for acute bronchiolitis in first 6 months of life and pathogens other than RSV or no pathogen ('Group 3 and Group 4 combined')",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",17,1
"150",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"Birth to 6 months","hospitalized for acute bronchiolitis in first 6 months of life and pathogens other than RSV or no pathogen ('Group 3 and Group 4 combined')",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",17,1
"146",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"birth to six months","hospitalized for acute bronchiolitis in first 6 months of life and pathogens other than RSV ('Group 3')",2,2,1,NA,1,1,"I HAND CALCULATED the odds ratio based on the descriptive statistics given in Table 5    OR 0.95 (95% CI 0.31-2.92)",2,0.95,1,0.57,95,47,33,9,6,"wheezing between six months and 3 years",17,2
"147",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"birth to six months","hospitalized for acute bronchiolitis in first 6 months of life and pathogens other than RSV ('Group 3')",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",17,2
"148",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"birth to six months","hospitalized for acute bronchiolitis in first 6 months of life and pathogens other than RSV ('Group 3')",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",17,2
"151",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"birth to six months","hospitalized for acute bronchiolitis in first 6 months of life and no pathogen identified ('Group 4')",2,2,1,NA,1,1,"I HAND CALCULATED the odds ratio based on the descriptive statistics given in Table 5    [Steve: OR=1.90, SE=0.80]  OR 1.90 (95% CI 0.40-9.05)",1,1.9,1,0.8,87,47,33,3,4,"wheezing between six months and 3 years",17,3
"152",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"birth to six months","hospitalized for acute bronchiolitis in first 6 months of life and no pathogen identified ('Group 4')",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",17,3
"149",17,"The primary outcome was recurrent wheezing episode, defined as 2 or more episodes of wheezing between 6 months and 3 years of age.  Data were collected from ambulatory children's records.",2,1,1,0,1,0,0,"chi-squared test was performed to assess the difference in recurrent wheezing between 4 groups: 1) RSV plus one or more pathogens, 2) RSV alone, 3) pathogens other than RSV, and 4) no pathogen. A  multivariate logistic regression model was also used to examine possible risk factors affecting the outcome.  ",0,0,0,0,0,0,0,1,"[Steve: Matched study and control groups on several factors and ran multivariable logistic regression, but calculation of relevant effect sizes (comparing RSV-LRTI vs. non-RSV-LRTI)  was based on descriptive (naive) data. So no effort to reduce confounding in these comparisons.]",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"hospitalized for acute bronchiolitis in first 6 months of life and only RSV positive (labeled as 'Group 2' in table 5)",1,0,0,0,0,2,0,0,1,"birth to six months","hospitalized for acute bronchiolitis in first 6 months of life and no pathogen identified ('Group 4')",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",17,3
"198",22,"The primary outcome was report of physician diagnosed asthma.",1,1,1,0,1,0,0,"logistic regression was performed to estimate the association of asthma with early-infection (RSV or LRI) history,  ",0,1,0,0,0,0,0,0,"The analysis controlled for age, sex, ethnicity, ancestry, socioeconomic factors, environmental factors (history of farm animal exposure, received antibiotics during first year), family history of asthma, and recruitment site.",1,0,0,0,1,1,1,0,0,0,0,0,0,1,0,1,0,1,NA,NA,NA,2,1,1,NA,NA,NA,NA,NA,NA,2,"Symptomatic bronchiolitis / RSV episodes requiring medical attention within the first 2 years  of life was ascertained by the following question: ""Was <CHILD> diagnosed with bronchiolitis  or RSV before age 2 yrs.""",0,0,0,1,0,1,0,1,0,"","Symptomatic lower respiratory tract illnesses (LRI) requiring medical attention within the first  2 years of life was ascertained by the following question: ""Was <CHILD> seen by a doctor for  chest illness before age 2 yrs."" (we don't know if the child was assessed for RSV or not)",2,10,1,NA,1,1,"there was a significant increase in the likelihood of asthma in subjects with a history of  early life infection such as RSV bronchiolitis   aOR 9.92 (95% CI 4.88-20.16)",1,9.92,1,0.36,3483,161,16,952,174,"ever asthma diagnosis by age 8-21 (ages 0-21)",22,1
"195",22,"The primary outcome was report of physician diagnosed asthma.",1,1,1,0,1,0,0,"logistic regression was performed to estimate the association of asthma with early-infection (RSV or LRI) history,  ",0,1,0,0,0,0,0,0,"The analysis controlled for age, sex, ethnicity, ancestry, socioeconomic factors, environmental factors (history of farm animal exposure, received antibiotics during first year), family history of asthma, and recruitment site.",1,0,0,0,1,1,1,0,0,0,0,0,0,1,0,1,0,1,NA,NA,NA,2,1,1,NA,NA,NA,NA,NA,NA,2,"Symptomatic bronchiolitis / RSV episodes requiring medical attention within the first 2 years  of life was ascertained by the following question: ""Was <CHILD> diagnosed with bronchiolitis  or RSV before age 2 yrs.""",0,0,0,1,0,1,0,1,0,"","Symptomatic lower respiratory tract illnesses (LRI) requiring medical attention within the first  2 years of life was ascertained by the following question: ""Was <CHILD> seen by a doctor for  chest illness before age 2 yrs."" (we don't know if the child was assessed for RSV or not)",2,10,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",22,1
"196",22,"The primary outcome was report of physician diagnosed asthma.",1,1,1,0,1,0,0,"logistic regression was performed to estimate the association of asthma with early-infection (RSV or LRI) history,  ",0,1,0,0,0,0,0,0,"The analysis controlled for age, sex, ethnicity, ancestry, socioeconomic factors, environmental factors (history of farm animal exposure, received antibiotics during first year), family history of asthma, and recruitment site.",1,0,0,0,1,1,1,0,0,0,0,0,0,1,0,1,0,1,NA,NA,NA,2,1,1,NA,NA,NA,NA,NA,NA,2,"Symptomatic bronchiolitis / RSV episodes requiring medical attention within the first 2 years  of life was ascertained by the following question: ""Was <CHILD> diagnosed with bronchiolitis  or RSV before age 2 yrs.""",0,0,0,1,0,1,0,1,0,"","Symptomatic lower respiratory tract illnesses (LRI) requiring medical attention within the first  2 years of life was ascertained by the following question: ""Was <CHILD> seen by a doctor for  chest illness before age 2 yrs."" (we don't know if the child was assessed for RSV or not)",2,10,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",22,1
"208",24,"ASTHMA by mean age 6: 'Asthma was defined as at least three episodes of bronchial obstruction confirmed by a pediatrician.  Current asthma was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,1,1,0,0,0,1,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,1,"None",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI with HBoV (Table 2)",2,2,1,NA,1,1,"[Steve: I inverted the odds ratio so that HBoV is the reference group.]    OR 1.29 (95% CI 0.99-1.66)  HAND CALCULATED the SE",2,0.78,1,0.13,80,49,21,10,0,"ever asthma diagnosis by age 6 (ages 0-6)",24,1
"1333",24,"CURRENT ASTHMA: was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,3,1,0,1,0,0,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI with HBoV (Table 2)",2,2,1,NA,1,1,"[Steve: I inverted the OR so that HBoV is the reference group.]    OR 2.188 (95% CI 1.029-4652) (Table 1)  HAND CALCULATED the SE",2,0.46,1,0.38,80,16,54,5,5,"RW withages 3-6",24,1
"209",24,"ASTHMA by mean age 6: 'Asthma was defined as at least three episodes of bronchial obstruction confirmed by a pediatrician.  Current asthma was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,1,1,0,0,0,1,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,1,"None",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI with HBoV (Table 2)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",24,1
"1334",24,"CURRENT ASTHMA: was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,3,1,0,1,0,0,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI with HBoV (Table 2)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",24,1
"214",24,"ASTHMA by mean age 6: 'Asthma was defined as at least three episodes of bronchial obstruction confirmed by a pediatrician.  Current asthma was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,1,1,0,0,0,1,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,1,"None",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI with HBoV (Table 2)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",24,1
"1339",24,"CURRENT ASTHMA: was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,3,1,0,1,0,0,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI with HBoV (Table 2)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",24,1
"212",24,"ASTHMA by mean age 6: 'Asthma was defined as at least three episodes of bronchial obstruction confirmed by a pediatrician.  Current asthma was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,1,1,0,0,0,1,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,1,"None",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: Unclear to me what the comparator group is.]     LRTI without RSV (any viral type)- (Table 3)",2,2,1,NA,1,1,"OR 14.40 (95% CI 6.88-30.14)  ",2,14.4,1,0.38,80,49,21,NA,NA,"ever asthma diagnosis by age ~6",24,2
"1337",24,"CURRENT ASTHMA: was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,3,1,0,1,0,0,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI without RSV (any viral type)- (Table 3)",2,2,1,NA,1,1,"OR 4.70 (95% CI 2.02-10.90) (Table 3)",2,4.7,1,0.43,80,16,54,NA,NA,"ever asthma diagnosis by age 4 (ages 0-4)",24,2
"213",24,"ASTHMA by mean age 6: 'Asthma was defined as at least three episodes of bronchial obstruction confirmed by a pediatrician.  Current asthma was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,1,1,0,0,0,1,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,1,"None",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: Unclear to me what the comparator group is.]     LRTI without RSV (any viral type)- (Table 3)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",24,2
"1338",24,"CURRENT ASTHMA: was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,3,1,0,1,0,0,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI without RSV (any viral type)- (Table 3)",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,2
"216",24,"ASTHMA by mean age 6: 'Asthma was defined as at least three episodes of bronchial obstruction confirmed by a pediatrician.  Current asthma was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,1,1,0,0,0,1,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,1,"None",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: Unclear to me what the comparator group is.]     LRTI without RSV (any viral type)- (Table 3)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",24,2
"1341",24,"CURRENT ASTHMA: was defined as recurrent wheezing with at least one episode occurring in the year prior to the follow-up visit.' (so technically 'current asthma' is recurrent wheezing)",1,3,1,0,1,0,0,"Clinical characteristics and laboratory variables were compared using the Student t test, the Mann---Whitney U test, the chi-squared test, and Fisher's exact test, where appropriate.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"LRTI- RSV positive",1,0,0,0,0,2,0,1,0,"","LRTI without RSV (any viral type)- (Table 3)",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,2
"1344",25,"ASTHMA: Asthma diagnosis was made on the basis of one of the following: 1) the GINA guideline in children with recurrent wheezing with predictive factors; 2) a doctor's diagnosis and the child's being prescribed inhaled corticosteroid for control.",1,3,1,0,0,1,0,"Cox regression analysis was used to estimate the hazard ratio of the risk factors of subsequent development of wheezing and asthma.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"[Steve: RSV(+) LRTI]    URTI-RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) LRTI]    URTI without RSV  ""The RNA and DNA were extracted from the nasopharyngeal secretion to detect for four RNA viruses (viz., RSV, hMPV, influenza A and influenza B) and atypical bacterial pathogens (M. pneumoniae, C. pneumoniae and C. trachomatis).""",2,2,1,NA,1,4,"Table 6-  HR 0.94 (95% CI 0.36-2.43)  -To figure out how many children contributed to this analysis, I had to go to the second paragraph under ""Subsequent wheezing and asthma"" in the results.  ""At the end of the 3rd and 5th years, we were able to contact 152 (89%) and 91 (60%) of the parents/children for medical information, respectively.""",1,0.94,1,0.49,91,27,NA,NA,NA,"asthma after initial hospitalization (ages 0-5 years)",25,1
"1342",25,"ASTHMA: Asthma diagnosis was made on the basis of one of the following: 1) the GINA guideline in children with recurrent wheezing with predictive factors; 2) a doctor's diagnosis and the child's being prescribed inhaled corticosteroid for control.",1,3,1,0,0,1,0,"Cox regression analysis was used to estimate the hazard ratio of the risk factors of subsequent development of wheezing and asthma.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"[Steve: RSV(+) LRTI]    URTI-RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) LRTI]    URTI without RSV  ""The RNA and DNA were extracted from the nasopharyngeal secretion to detect for four RNA viruses (viz., RSV, hMPV, influenza A and influenza B) and atypical bacterial pathogens (M. pneumoniae, C. pneumoniae and C. trachomatis).""",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",25,1
"1343",25,"ASTHMA: Asthma diagnosis was made on the basis of one of the following: 1) the GINA guideline in children with recurrent wheezing with predictive factors; 2) a doctor's diagnosis and the child's being prescribed inhaled corticosteroid for control.",1,3,1,0,0,1,0,"Cox regression analysis was used to estimate the hazard ratio of the risk factors of subsequent development of wheezing and asthma.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"[Steve: RSV(+) LRTI]    URTI-RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) LRTI]    URTI without RSV  ""The RNA and DNA were extracted from the nasopharyngeal secretion to detect for four RNA viruses (viz., RSV, hMPV, influenza A and influenza B) and atypical bacterial pathogens (M. pneumoniae, C. pneumoniae and C. trachomatis).""",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",25,1
"219",25,"WHEEZING: Recurrent wheezing was defined as children  with a history of healthcare visits with wheezing or  having received beta 2 agonist nebulization to relieve respiratory symptoms.",2,3,1,0,0,1,0,"Cox regression analysis was used to estimate the hazard ratio of the risk factors of subsequent development of wheezing and asthma.",0,0,0,0,0,0,0,1,"The study did not attempt to reduce the influence of confounders in any way.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"[Steve: participants had acute bronchiolitis so I think we would count this as RSV(+) LRTI]     URTI-RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) LRTI]    URTI without RSV  ""The RNA and DNA were extracted from the nasopharyngeal secretion to detect for four RNA viruses (viz., RSV, hMPV, influenza A and influenza B) and atypical bacterial pathogens (M. pneumoniae, C. pneumoniae and C. trachomatis).""",2,2,1,NA,1,4,"Table 5-  HR 1.04 (95% CI 0.55-1.97)  -To figure out how many children contributed to this analysis, I had to go to the second paragraph under ""Subsequent wheezing and asthma"" in the results.  ""At the end of the 3rd and 5th years, we were able to contact 152 (89%) and 91 (60%) of the parents/children for medical information, respectively. In the first three years, recurrent wheezing was reported for 94 (61.8%) of the children.""",1,1.04,1,0.33,152,62,NA,NA,NA,"wheezing after initial hospitalization (ages 0-3 years)",25,1
"217",25,"WHEEZING: Recurrent wheezing was defined as children  with a history of healthcare visits with wheezing or  having received beta 2 agonist nebulization to relieve respiratory symptoms.",2,3,1,0,0,1,0,"Cox regression analysis was used to estimate the hazard ratio of the risk factors of subsequent development of wheezing and asthma.",0,0,0,0,0,0,0,1,"The study did not attempt to reduce the influence of confounders in any way.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"[Steve: participants had acute bronchiolitis so I think we would count this as RSV(+) LRTI]     URTI-RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) LRTI]    URTI without RSV  ""The RNA and DNA were extracted from the nasopharyngeal secretion to detect for four RNA viruses (viz., RSV, hMPV, influenza A and influenza B) and atypical bacterial pathogens (M. pneumoniae, C. pneumoniae and C. trachomatis).""",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",25,1
"218",25,"WHEEZING: Recurrent wheezing was defined as children  with a history of healthcare visits with wheezing or  having received beta 2 agonist nebulization to relieve respiratory symptoms.",2,3,1,0,0,1,0,"Cox regression analysis was used to estimate the hazard ratio of the risk factors of subsequent development of wheezing and asthma.",0,0,0,0,0,0,0,1,"The study did not attempt to reduce the influence of confounders in any way.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"[Steve: participants had acute bronchiolitis so I think we would count this as RSV(+) LRTI]     URTI-RSV positive",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) LRTI]    URTI without RSV  ""The RNA and DNA were extracted from the nasopharyngeal secretion to detect for four RNA viruses (viz., RSV, hMPV, influenza A and influenza B) and atypical bacterial pathogens (M. pneumoniae, C. pneumoniae and C. trachomatis).""",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",25,1
"278",31,"Current asthma at 11 years of age was defined as a positive answer to the ISAAC question regarding ''asthma ever'' and a positive answer to at least one of the two questions: (1) wheezing or whistling in the chest or chest tightness during the preceding 12 months or (2) use of asthma medication during the preceding 12 months.",1,1,1,0,1,0,0,"Unadjusted logistic regression analyses were used to assess relations between potential risk factors present at 2 years of age and asthma at 11 years of age. A multiple logistic regression model was constructed, including variables with a P-value <0.1 in unadjusted analyses. Analysis of interaction terms was used to assess if the explanatory variables influenced children hospitalized for RSV positive or RSV negative bronchiolitis differently with respect to the outcome variable, and to test for interaction effects between significant explanatory variables in the final model",0,1,0,0,0,0,0,0,"Unadjusted logistic regression analyses were used to assess relations between potential risk factors present at 2 years of age and asthma at 11 years of age. A multiple logistic regression model was constructed, including variables with a P-value <0.1 in unadjusted analyses. Analysis of interaction terms was used to assess if the explanatory variables influenced children  hospitalized for RSV positive or RSV negative bronchiolitis differently with respect to the outcome variable, and to test for interaction effects between significant explanatory variables in the final model.   - Table 1 shows exposure and comparator groups essentially equivalent on age at follow-up assessment",1,0,1,0,1,0,0,0,0,0,0,0,1,1,0,0,0,1,NA,1,NA,2,NA,NA,NA,NA,NA,NA,NA,2,2,"RSV+ LRTI requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV- LRTI requiring hospitalization",2,2,2,1,1,1,"Adjusted odds ratio based on Table 2. To get the aOR for RSV+ bronchiolitis, I applied the natural log transformation to the aOR provided in the table, calculated the inverse, then exponentiated again.",1,0.71,1,0.68,93,10,52,11,20,"~ages 10-11",31,1
"279",31,"Current asthma at 11 years of age was defined as a positive answer to the ISAAC question regarding ''asthma ever'' and a positive answer to at least one of the two questions: (1) wheezing or whistling in the chest or chest tightness during the preceding 12 months or (2) use of asthma medication during the preceding 12 months.",1,1,1,0,1,0,0,"Unadjusted logistic regression analyses were used to assess relations between potential risk factors present at 2 years of age and asthma at 11 years of age. A multiple logistic regression model was constructed, including variables with a P-value <0.1 in unadjusted analyses. Analysis of interaction terms was used to assess if the explanatory variables influenced children hospitalized for RSV positive or RSV negative bronchiolitis differently with respect to the outcome variable, and to test for interaction effects between significant explanatory variables in the final model",0,1,0,0,0,0,0,0,"Unadjusted logistic regression analyses were used to assess relations between potential risk factors present at 2 years of age and asthma at 11 years of age. A multiple logistic regression model was constructed, including variables with a P-value <0.1 in unadjusted analyses. Analysis of interaction terms was used to assess if the explanatory variables influenced children  hospitalized for RSV positive or RSV negative bronchiolitis differently with respect to the outcome variable, and to test for interaction effects between significant explanatory variables in the final model.   - Table 1 shows exposure and comparator groups essentially equivalent on age at follow-up assessment",1,0,1,0,1,0,0,0,0,0,0,0,1,1,0,0,0,1,NA,1,NA,2,NA,NA,NA,NA,NA,NA,NA,2,2,"RSV+ LRTI requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV- LRTI requiring hospitalization",2,2,2,1,2,1,"Based on descriptive stats (unadjusted) because the main analysis controlled for recurrent wheeze which may be on the causal pathway.",2,0.35,1,0.51,93,10,52,11,20,"~ ages 10-11",31,1
"276",31,"Current asthma at 11 years of age was defined as a positive answer to the ISAAC question regarding ''asthma ever'' and a positive answer to at least one of the two questions: (1) wheezing or whistling in the chest or chest tightness during the preceding 12 months or (2) use of asthma medication during the preceding 12 months.",1,1,1,0,1,0,0,"Unadjusted logistic regression analyses were used to assess relations between potential risk factors present at 2 years of age and asthma at 11 years of age. A multiple logistic regression model was constructed, including variables with a P-value <0.1 in unadjusted analyses. Analysis of interaction terms was used to assess if the explanatory variables influenced children hospitalized for RSV positive or RSV negative bronchiolitis differently with respect to the outcome variable, and to test for interaction effects between significant explanatory variables in the final model",0,1,0,0,0,0,0,0,"Unadjusted logistic regression analyses were used to assess relations between potential risk factors present at 2 years of age and asthma at 11 years of age. A multiple logistic regression model was constructed, including variables with a P-value <0.1 in unadjusted analyses. Analysis of interaction terms was used to assess if the explanatory variables influenced children  hospitalized for RSV positive or RSV negative bronchiolitis differently with respect to the outcome variable, and to test for interaction effects between significant explanatory variables in the final model.   - Table 1 shows exposure and comparator groups essentially equivalent on age at follow-up assessment",1,0,1,0,1,0,0,0,0,0,0,0,1,1,0,0,0,1,NA,1,NA,2,NA,NA,NA,NA,NA,NA,NA,2,2,"RSV+ LRTI requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV- LRTI requiring hospitalization",2,2,2,1,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",31,1
"303",34,"Asthma at mean age 6.5  - Current asthma was considered to be present if the child was on continuous maintenance medication for asthma, or if the child had suffered from doctor-diagnosed wheezing or prolonged (>4 weeks) cough or night cough, apart from infection, during the preceding 12 months, and BHR was documented in ECT.",1,3,1,0,1,0,0,"Logistic regression was used to analyse the associations between risk factors and asthma, first by univariate  analyses and then by multivariate analyses adjusted for age on admission (,3 versus .3 months), sex and characteristics which were significant in univariate analyses. Odds ratios with 95%  confidence intervals are reported from both univariate (OR) and multivariate adjusted (aOR) analyses.",0,1,0,0,0,0,0,0,"adjusted for age on admission (<3 versus >3 months), sex and characteristics which were significant in univariate analyses.",1,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,1,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+)-LRTI bronchiolitis hospitalization in first 6 months of life",1,0,0,0,0,2,0,0,1,"Birth to 6mos","RSV(-)-LRTI bronchiolitis hospitalization in first 6 months of life",2,2,1,NA,1,1,"Inverse of the adjusted odds ratio presented in Table 2",1,0.27,1,0.55,166,9,108,12,37,"approx. ages 4-7",34,1
"298",34,"Asthma at mean age 6.5  - Current asthma was considered to be present if the child was on continuous maintenance medication for asthma, or if the child had suffered from doctor-diagnosed wheezing or prolonged (>4 weeks) cough or night cough, apart from infection, during the preceding 12 months, and BHR was documented in ECT.",1,3,1,0,1,0,0,"Logistic regression was used to analyse the associations between risk factors and asthma, first by univariate  analyses and then by multivariate analyses adjusted for age on admission (,3 versus .3 months), sex and characteristics which were significant in univariate analyses. Odds ratios with 95%  confidence intervals are reported from both univariate (OR) and multivariate adjusted (aOR) analyses.",0,1,0,0,0,0,0,0,"adjusted for age on admission (<3 versus >3 months), sex and characteristics which were significant in univariate analyses.",1,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,1,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+)-LRTI bronchiolitis hospitalization in first 6 months of life",1,0,0,0,0,2,0,0,1,"Birth to 6mos","RSV(-)-LRTI bronchiolitis hospitalization in first 6 months of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",34,1
"299",34,"Asthma at mean age 6.5  - Current asthma was considered to be present if the child was on continuous maintenance medication for asthma, or if the child had suffered from doctor-diagnosed wheezing or prolonged (>4 weeks) cough or night cough, apart from infection, during the preceding 12 months, and BHR was documented in ECT.",1,3,1,0,1,0,0,"Logistic regression was used to analyse the associations between risk factors and asthma, first by univariate  analyses and then by multivariate analyses adjusted for age on admission (,3 versus .3 months), sex and characteristics which were significant in univariate analyses. Odds ratios with 95%  confidence intervals are reported from both univariate (OR) and multivariate adjusted (aOR) analyses.",0,1,0,0,0,0,0,0,"adjusted for age on admission (<3 versus >3 months), sex and characteristics which were significant in univariate analyses.",1,0,1,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,1,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+)-LRTI bronchiolitis hospitalization in first 6 months of life",1,0,0,0,0,2,0,0,1,"Birth to 6mos","RSV(-)-LRTI bronchiolitis hospitalization in first 6 months of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",34,1
"315",35,"Past history of asthma by self-reported physician dx",1,1,1,0,0,0,1,"Fisher's exact test;  - estimated the values for the relative  risk (RR) of developing asthma, wheezing",0,0,0,0,0,1,0,0,"showed that weeks gestation at birth was equal to the 10th decimal place across groups;  - showed that roughly an equivalent percentage of fathers and mothers had hx of atopic dermatitis across the two groups  - no adjustment in statistical analysis ",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI requiring hospitalization    Britt: RSV + was defined as ""either positive for viral antigen or they showed seroconversion or a fourfold increase in the antibody titer""",1,0,0,0,0,2,0,0,1,"Birth to age 36 months","RSV- LRTI requiring hospitalization",2,2,1,NA,1,1,"based on Table 2; they provide risk ratios but they are unadjusted so I calculated unadjusted odds ratios to be consistent with other studies    Britt: RR given in Table 2: 1.12 (95% CI 0.43-2.96)",2,1.14,1,0.57,133,5,31,12,85,"~ exposure to age 7 years",35,1
"1440",35,"Current treatment for asthma at age 7",1,3,1,0,0,0,1,"Fisher's test",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI hospitalization",1,0,0,0,0,2,0,0,1,"Birth - 36 mos","RSV- LRTI hospitalization",2,2,1,NA,1,1,"based on data in Table 2    Britt: RR given in Table 2: 1.80 (95% CI 0.54-6.00)",2,1.9,1,0.68,133,4,32,6,91,"Age 7 (current)",35,1
"310",35,"Past history of asthma by self-reported physician dx",1,1,1,0,0,0,1,"Fisher's exact test;  - estimated the values for the relative  risk (RR) of developing asthma, wheezing",0,0,0,0,0,1,0,0,"showed that weeks gestation at birth was equal to the 10th decimal place across groups;  - showed that roughly an equivalent percentage of fathers and mothers had hx of atopic dermatitis across the two groups  - no adjustment in statistical analysis ",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI requiring hospitalization    Britt: RSV + was defined as ""either positive for viral antigen or they showed seroconversion or a fourfold increase in the antibody titer""",1,0,0,0,0,2,0,0,1,"Birth to age 36 months","RSV- LRTI requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",35,1
"1435",35,"Current treatment for asthma at age 7",1,3,1,0,0,0,1,"Fisher's test",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI hospitalization",1,0,0,0,0,2,0,0,1,"Birth - 36 mos","RSV- LRTI hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",35,1
"314",35,"Past history of asthma by self-reported physician dx",1,1,1,0,0,0,1,"Fisher's exact test;  - estimated the values for the relative  risk (RR) of developing asthma, wheezing",0,0,0,0,0,1,0,0,"showed that weeks gestation at birth was equal to the 10th decimal place across groups;  - showed that roughly an equivalent percentage of fathers and mothers had hx of atopic dermatitis across the two groups  - no adjustment in statistical analysis ",0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI requiring hospitalization    Britt: RSV + was defined as ""either positive for viral antigen or they showed seroconversion or a fourfold increase in the antibody titer""",1,0,0,0,0,2,0,0,1,"Birth to age 36 months","RSV- LRTI requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",35,1
"1439",35,"Current treatment for asthma at age 7",1,3,1,0,0,0,1,"Fisher's test",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI hospitalization",1,0,0,0,0,2,0,0,1,"Birth - 36 mos","RSV- LRTI hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",35,1
"2565",35,"Recurrent wheeze: Wheezing detected by a physician >=3 times",2,3,1,0,0,0,1,"Fisher's test",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI hospitalization",1,0,0,0,0,2,0,0,1,"Birth - 36 mos","RSV(-) LRTI hospitalization",2,2,1,NA,1,1,"based on data in Table 2    Britt: RR based on Table 2: 0.95 (95% CI 0.33-2.88)",2,0.94,1,0.52,133,6,30,17,80,"exposure to age 7",35,1
"2560",35,"Recurrent wheeze: Wheezing detected by a physician >=3 times",2,3,1,0,0,0,1,"Fisher's test",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI hospitalization",1,0,0,0,0,2,0,0,1,"Birth - 36 mos","RSV(-) LRTI hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",35,1
"2564",35,"Recurrent wheeze: Wheezing detected by a physician >=3 times",2,3,1,0,0,0,1,"Fisher's test",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI hospitalization",1,0,0,0,0,2,0,0,1,"Birth - 36 mos","RSV(-) LRTI hospitalization",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35,1
"372",42,"asthma dx: Bronchial asthma was defined by two different ways reflecting  the degree of certainty of the diagnosis. (1) Current doctor-  diagnosed asthma: either asthma diagnosed by a doctor during the preceding 24 months, or the use of maintenance medication for asthma during the preceding 12 months",1,1,1,0,1,0,0,"When the former bronchiolitis  group was compared with selected controls from nonatopic families, chi-square test, Fisher's exact test and logistic regression analysis were applied. When the former bronchiolitis  group was compared with nonselected, population-based  controls, logistic regression analysis, adjusted first for age  and gender and further also for current smoking and allergic  rhinitis, was applied. The chi square and Fisher's exact tests were not used, as the subjects were age- and gender-matched. When the subjects with current self-reported asthma or current doctor-diagnosed asthma were compared with the controls, chi-square test and logistic regression were applied.",1,0,0,0,0,0,0,0,"Britt: Statistical adjusting was only applied when the former bronchiolitis group was compared with non-selected, population-based controls (this comparison was not coded for)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing hospitalization at <24 months",1,0,0,0,0,2,0,1,0,"","non-RSV hospitalization for wheezing at <24 months",2,2,1,NA,1,1,"unadjusted; determined based on information provided in Table 5 (see accompanying Excel file)",2,0.29,1,0.73,59,3,25,9,22,"approx. ages 25-27",42,1
"1497",42,"Asthma by self report  Britt: current self-reported asthma definition: either a weekly use of on-demand bronchodilating drugs or asthma diagnosed by a doctor previously and the presence of wheezing symptoms, prolonged cough or repeated night cough during the preceding 12 months (current doctor diagnosed asthma included by both asthma criteria)",1,3,1,0,0,0,1,"Based on descriptive stats (Table 5)",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ bronchiolitis requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV- bronchiolitis requiring hospitalization",2,2,1,NA,1,1,"Based on Table 5",2,0.51,1,0.54,59,9,19,15,16,"~ Ages 26-27",42,1
"373",42,"asthma dx: Bronchial asthma was defined by two different ways reflecting  the degree of certainty of the diagnosis. (1) Current doctor-  diagnosed asthma: either asthma diagnosed by a doctor during the preceding 24 months, or the use of maintenance medication for asthma during the preceding 12 months",1,1,1,0,1,0,0,"When the former bronchiolitis  group was compared with selected controls from nonatopic families, chi-square test, Fisher's exact test and logistic regression analysis were applied. When the former bronchiolitis  group was compared with nonselected, population-based  controls, logistic regression analysis, adjusted first for age  and gender and further also for current smoking and allergic  rhinitis, was applied. The chi square and Fisher's exact tests were not used, as the subjects were age- and gender-matched. When the subjects with current self-reported asthma or current doctor-diagnosed asthma were compared with the controls, chi-square test and logistic regression were applied.",1,0,0,0,0,0,0,0,"Britt: Statistical adjusting was only applied when the former bronchiolitis group was compared with non-selected, population-based controls (this comparison was not coded for)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing hospitalization at <24 months",1,0,0,0,0,2,0,1,0,"","non-RSV hospitalization for wheezing at <24 months",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",42,1
"1498",42,"Asthma by self report  Britt: current self-reported asthma definition: either a weekly use of on-demand bronchodilating drugs or asthma diagnosed by a doctor previously and the presence of wheezing symptoms, prolonged cough or repeated night cough during the preceding 12 months (current doctor diagnosed asthma included by both asthma criteria)",1,3,1,0,0,0,1,"Based on descriptive stats (Table 5)",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ bronchiolitis requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV- bronchiolitis requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",42,1
"370",42,"asthma dx: Bronchial asthma was defined by two different ways reflecting  the degree of certainty of the diagnosis. (1) Current doctor-  diagnosed asthma: either asthma diagnosed by a doctor during the preceding 24 months, or the use of maintenance medication for asthma during the preceding 12 months",1,1,1,0,1,0,0,"When the former bronchiolitis  group was compared with selected controls from nonatopic families, chi-square test, Fisher's exact test and logistic regression analysis were applied. When the former bronchiolitis  group was compared with nonselected, population-based  controls, logistic regression analysis, adjusted first for age  and gender and further also for current smoking and allergic  rhinitis, was applied. The chi square and Fisher's exact tests were not used, as the subjects were age- and gender-matched. When the subjects with current self-reported asthma or current doctor-diagnosed asthma were compared with the controls, chi-square test and logistic regression were applied.",1,0,0,0,0,0,0,0,"Britt: Statistical adjusting was only applied when the former bronchiolitis group was compared with non-selected, population-based controls (this comparison was not coded for)",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing hospitalization at <24 months",1,0,0,0,0,2,0,1,0,"","non-RSV hospitalization for wheezing at <24 months",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",42,1
"1495",42,"Asthma by self report  Britt: current self-reported asthma definition: either a weekly use of on-demand bronchodilating drugs or asthma diagnosed by a doctor previously and the presence of wheezing symptoms, prolonged cough or repeated night cough during the preceding 12 months (current doctor diagnosed asthma included by both asthma criteria)",1,3,1,0,0,0,1,"Based on descriptive stats (Table 5)",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ bronchiolitis requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV- bronchiolitis requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",42,1
"379",43,"[Steve: Recurrent wheeze at through age 3.]    The primary outcome of the study was development of recurrent wheezing requiring long-term asthma medication that was reimbursed by the Social Insurance Institution.  This outcome was analyzed separately for the first 1, 2, and 3 years after the child's hospitalization for bronchiolitis.    Data on asthma medications of the children were derived from the Social Insurance Institution that is the sole authority in Finland to keep a register of all sales and reimbursements of prescription medications on an individual level. The Social Insurance Institution supplies reimbursement for asthma medications if certain diagnostic criteria are fulfilled.  An essential requirement for granting reimbursement for asthma medications to a child was a medical certificate issued by a physician verifying the presence of recurrent wheezing (>=3 medically attended wheezing episodes) or the diagnosis of asthma.  A further  requirement was a long-term need for asthma controllers (e.g. corticosteroids); temporary 'as-needed' use of bronchodilators alone was not sufficient for granting reimbursement. For the  purposes of this study, a child was considered to have recurrent wheezing if reimbursement for asthma medications was granted by the Social Insurance Institution.    -The first outcome I coded for was recurrent wheezing at 1 year post bronchiolitis",2,1,1,0,1,0,0,"[Steve: the relative risk (RR) for the development of recurrent  wheezing between the RSV and non-RSV groups was calculated  using Poisson regression]    Comparison of proportions between the groups was performed by using the chi-square test.  Unadjusted relative risks and p-values were reported.    -Several subanalyses were performed to adjust for age and seasonal factors.  The results of these analyses were similar to the primary study findings.",1,0,0,0,0,0,1,0,"[Steve: matching based on age (maximum age difference 7 days in 77% and 20 days in 100% of pairs) and gender]",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"[Steve: RSV(+) bronchiolitis infants requiring hospitalization in first 2 years of life.]    Children who were negative for RSV, had a confirmed infection by some other virus than RSV, and those from whom a viral specimen had not been obtained and who were hospitalized in an even-numbered year (when RSV didn't circulate)",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) bronchiolitis infants requiring hospitalization in first 2 years of life -- matched by age and gender to exposed group.]      lab-confirmed RSV infection (the authors used this as the comparator group for the analysis--usually it is used as the exposure group)",2,2,1,NA,1,1,"[Steve: matched pair analyses described in last paragraph on p. 1362 -- matched on sex and age at exposure. Calculated OR]    Table 1 (year 1 post-RSV bronchiolitis):    RR 6.6 (95% CI 2.6-16.5)",1,0.25,1,0.41,228,9,105,29,85,"recurrent wheeze within a year after hospitalization (ages 1-3)",43,1
"380",43,"[Steve: Recurrent wheeze at through age 3.]    The primary outcome of the study was development of recurrent wheezing requiring long-term asthma medication that was reimbursed by the Social Insurance Institution.  This outcome was analyzed separately for the first 1, 2, and 3 years after the child's hospitalization for bronchiolitis.    Data on asthma medications of the children were derived from the Social Insurance Institution that is the sole authority in Finland to keep a register of all sales and reimbursements of prescription medications on an individual level. The Social Insurance Institution supplies reimbursement for asthma medications if certain diagnostic criteria are fulfilled.  An essential requirement for granting reimbursement for asthma medications to a child was a medical certificate issued by a physician verifying the presence of recurrent wheezing (>=3 medically attended wheezing episodes) or the diagnosis of asthma.  A further  requirement was a long-term need for asthma controllers (e.g. corticosteroids); temporary 'as-needed' use of bronchodilators alone was not sufficient for granting reimbursement. For the  purposes of this study, a child was considered to have recurrent wheezing if reimbursement for asthma medications was granted by the Social Insurance Institution.    -The first outcome I coded for was recurrent wheezing at 1 year post bronchiolitis",2,1,1,0,1,0,0,"[Steve: the relative risk (RR) for the development of recurrent  wheezing between the RSV and non-RSV groups was calculated  using Poisson regression]    Comparison of proportions between the groups was performed by using the chi-square test.  Unadjusted relative risks and p-values were reported.    -Several subanalyses were performed to adjust for age and seasonal factors.  The results of these analyses were similar to the primary study findings.",1,0,0,0,0,0,1,0,"[Steve: matching based on age (maximum age difference 7 days in 77% and 20 days in 100% of pairs) and gender]",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"[Steve: RSV(+) bronchiolitis infants requiring hospitalization in first 2 years of life.]    Children who were negative for RSV, had a confirmed infection by some other virus than RSV, and those from whom a viral specimen had not been obtained and who were hospitalized in an even-numbered year (when RSV didn't circulate)",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) bronchiolitis infants requiring hospitalization in first 2 years of life -- matched by age and gender to exposed group.]      lab-confirmed RSV infection (the authors used this as the comparator group for the analysis--usually it is used as the exposure group)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",43,1
"381",43,"[Steve: Recurrent wheeze at through age 3.]    The primary outcome of the study was development of recurrent wheezing requiring long-term asthma medication that was reimbursed by the Social Insurance Institution.  This outcome was analyzed separately for the first 1, 2, and 3 years after the child's hospitalization for bronchiolitis.    Data on asthma medications of the children were derived from the Social Insurance Institution that is the sole authority in Finland to keep a register of all sales and reimbursements of prescription medications on an individual level. The Social Insurance Institution supplies reimbursement for asthma medications if certain diagnostic criteria are fulfilled.  An essential requirement for granting reimbursement for asthma medications to a child was a medical certificate issued by a physician verifying the presence of recurrent wheezing (>=3 medically attended wheezing episodes) or the diagnosis of asthma.  A further  requirement was a long-term need for asthma controllers (e.g. corticosteroids); temporary 'as-needed' use of bronchodilators alone was not sufficient for granting reimbursement. For the  purposes of this study, a child was considered to have recurrent wheezing if reimbursement for asthma medications was granted by the Social Insurance Institution.    -The first outcome I coded for was recurrent wheezing at 1 year post bronchiolitis",2,1,1,0,1,0,0,"[Steve: the relative risk (RR) for the development of recurrent  wheezing between the RSV and non-RSV groups was calculated  using Poisson regression]    Comparison of proportions between the groups was performed by using the chi-square test.  Unadjusted relative risks and p-values were reported.    -Several subanalyses were performed to adjust for age and seasonal factors.  The results of these analyses were similar to the primary study findings.",1,0,0,0,0,0,1,0,"[Steve: matching based on age (maximum age difference 7 days in 77% and 20 days in 100% of pairs) and gender]",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"[Steve: RSV(+) bronchiolitis infants requiring hospitalization in first 2 years of life.]    Children who were negative for RSV, had a confirmed infection by some other virus than RSV, and those from whom a viral specimen had not been obtained and who were hospitalized in an even-numbered year (when RSV didn't circulate)",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) bronchiolitis infants requiring hospitalization in first 2 years of life -- matched by age and gender to exposed group.]      lab-confirmed RSV infection (the authors used this as the comparator group for the analysis--usually it is used as the exposure group)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",43,1
"385",43,"[Steve: Recurrent wheeze at through age 3.]    The primary outcome of the study was development of recurrent wheezing requiring long-term asthma medication that was reimbursed by the Social Insurance Institution.  This outcome was analyzed separately for the first 1, 2, and 3 years after the child's hospitalization for bronchiolitis.    Data on asthma medications of the children were derived from the Social Insurance Institution that is the sole authority in Finland to keep a register of all sales and reimbursements of prescription medications on an individual level. The Social Insurance Institution supplies reimbursement for asthma medications if certain diagnostic criteria are fulfilled.  An essential requirement for granting reimbursement for asthma medications to a child was a medical certificate issued by a physician verifying the presence of recurrent wheezing (>=3 medically attended wheezing episodes) or the diagnosis of asthma.  A further  requirement was a long-term need for asthma controllers (e.g. corticosteroids); temporary 'as-needed' use of bronchodilators alone was not sufficient for granting reimbursement. For the  purposes of this study, a child was considered to have recurrent wheezing if reimbursement for asthma medications was granted by the Social Insurance Institution.    -The first outcome I coded for was recurrent wheezing at 1 year post bronchiolitis",2,1,1,0,1,0,0,"[Steve: the relative risk (RR) for the development of recurrent  wheezing between the RSV and non-RSV groups was calculated  using Poisson regression]    Comparison of proportions between the groups was performed by using the chi-square test.  Unadjusted relative risks and p-values were reported.    -Several subanalyses were performed to adjust for age and seasonal factors.  The results of these analyses were similar to the primary study findings.",1,0,0,0,0,0,1,0,"[Steve: matching based on age (maximum age difference 7 days in 77% and 20 days in 100% of pairs) and gender]",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"[Steve: RSV(+) bronchiolitis infants requiring hospitalization in first 2 years of life.]  ",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) bronchiolitis infants requiring hospitalization in first 2 years of life -- matched by age and gender to exposed group.]",2,2,1,NA,1,1,"Based on matched case-control analyses (p. 1363, 2nd paragraph)",1,0.15,1,0.53,148,16,38,58,36,"ages 0-5",43,2
"382",43,"[Steve: Recurrent wheeze at through age 3.]    The primary outcome of the study was development of recurrent wheezing requiring long-term asthma medication that was reimbursed by the Social Insurance Institution.  This outcome was analyzed separately for the first 1, 2, and 3 years after the child's hospitalization for bronchiolitis.    Data on asthma medications of the children were derived from the Social Insurance Institution that is the sole authority in Finland to keep a register of all sales and reimbursements of prescription medications on an individual level. The Social Insurance Institution supplies reimbursement for asthma medications if certain diagnostic criteria are fulfilled.  An essential requirement for granting reimbursement for asthma medications to a child was a medical certificate issued by a physician verifying the presence of recurrent wheezing (>=3 medically attended wheezing episodes) or the diagnosis of asthma.  A further  requirement was a long-term need for asthma controllers (e.g. corticosteroids); temporary 'as-needed' use of bronchodilators alone was not sufficient for granting reimbursement. For the  purposes of this study, a child was considered to have recurrent wheezing if reimbursement for asthma medications was granted by the Social Insurance Institution.    -The first outcome I coded for was recurrent wheezing at 1 year post bronchiolitis",2,1,1,0,1,0,0,"[Steve: the relative risk (RR) for the development of recurrent  wheezing between the RSV and non-RSV groups was calculated  using Poisson regression]    Comparison of proportions between the groups was performed by using the chi-square test.  Unadjusted relative risks and p-values were reported.    -Several subanalyses were performed to adjust for age and seasonal factors.  The results of these analyses were similar to the primary study findings.",1,0,0,0,0,0,1,0,"[Steve: matching based on age (maximum age difference 7 days in 77% and 20 days in 100% of pairs) and gender]",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"[Steve: RSV(+) bronchiolitis infants requiring hospitalization in first 2 years of life.]  ",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) bronchiolitis infants requiring hospitalization in first 2 years of life -- matched by age and gender to exposed group.]",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",43,2
"383",43,"[Steve: Recurrent wheeze at through age 3.]    The primary outcome of the study was development of recurrent wheezing requiring long-term asthma medication that was reimbursed by the Social Insurance Institution.  This outcome was analyzed separately for the first 1, 2, and 3 years after the child's hospitalization for bronchiolitis.    Data on asthma medications of the children were derived from the Social Insurance Institution that is the sole authority in Finland to keep a register of all sales and reimbursements of prescription medications on an individual level. The Social Insurance Institution supplies reimbursement for asthma medications if certain diagnostic criteria are fulfilled.  An essential requirement for granting reimbursement for asthma medications to a child was a medical certificate issued by a physician verifying the presence of recurrent wheezing (>=3 medically attended wheezing episodes) or the diagnosis of asthma.  A further  requirement was a long-term need for asthma controllers (e.g. corticosteroids); temporary 'as-needed' use of bronchodilators alone was not sufficient for granting reimbursement. For the  purposes of this study, a child was considered to have recurrent wheezing if reimbursement for asthma medications was granted by the Social Insurance Institution.    -The first outcome I coded for was recurrent wheezing at 1 year post bronchiolitis",2,1,1,0,1,0,0,"[Steve: the relative risk (RR) for the development of recurrent  wheezing between the RSV and non-RSV groups was calculated  using Poisson regression]    Comparison of proportions between the groups was performed by using the chi-square test.  Unadjusted relative risks and p-values were reported.    -Several subanalyses were performed to adjust for age and seasonal factors.  The results of these analyses were similar to the primary study findings.",1,0,0,0,0,0,1,0,"[Steve: matching based on age (maximum age difference 7 days in 77% and 20 days in 100% of pairs) and gender]",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"[Steve: RSV(+) bronchiolitis infants requiring hospitalization in first 2 years of life.]  ",1,0,0,0,0,2,0,1,0,"","[Steve: RSV(-) bronchiolitis infants requiring hospitalization in first 2 years of life -- matched by age and gender to exposed group.]",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",43,2
"388",44,"recurrent wheezing defined as 2+ episodes measured one year after enrollment",2,3,1,0,0,0,1,"The data were analyzed using the Mann - Whitney U -test or Fisher's exact test, except for changes in white blood cell and eosinophil counts, which were analyzed with the Wilcoxon test. The criterion for statistical significance was the 0.05 level.",0,0,0,0,0,1,0,0,"from what I can tell, all analyses were unadjusted  - Table 1 shows groups had nearly identical rates of family hx of allergy but there were missing data for the RSV(+) group, so hard to know if they were truly balanced",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life and no prior wheezing",1,0,0,0,0,2,0,1,0,"","RSV(-) but hospitalized for wheezing in the first two years of life with their first wheezing episode",2,2,1,NA,1,1,"unadjusted, based on descriptive stats (p. 501, 2nd to last paragraph)    Britt: Information given in table 2- HAND CALCULATED the OR, 95% CI, and SE   OR 1.29 (95% CI 0.26-6.27)",2,1.29,1,0.81,26,9,7,5,5,"~ ages 0-3",44,1
"392",44,"recurrent wheezing defined as 2+ episodes measured one year after enrollment",2,3,1,0,0,0,1,"The data were analyzed using the Mann - Whitney U -test or Fisher's exact test, except for changes in white blood cell and eosinophil counts, which were analyzed with the Wilcoxon test. The criterion for statistical significance was the 0.05 level.",0,0,0,0,0,1,0,0,"from what I can tell, all analyses were unadjusted  - Table 1 shows groups had nearly identical rates of family hx of allergy but there were missing data for the RSV(+) group, so hard to know if they were truly balanced",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life and no prior wheezing",1,0,0,0,0,2,0,1,0,"","RSV(-) but hospitalized for wheezing in the first two years of life with their first wheezing episode",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",44,1
"396",44,"recurrent wheezing defined as 2+ episodes measured one year after enrollment",2,3,1,0,0,0,1,"The data were analyzed using the Mann - Whitney U -test or Fisher's exact test, except for changes in white blood cell and eosinophil counts, which were analyzed with the Wilcoxon test. The criterion for statistical significance was the 0.05 level.",0,0,0,0,0,1,0,0,"from what I can tell, all analyses were unadjusted  - Table 1 shows groups had nearly identical rates of family hx of allergy but there were missing data for the RSV(+) group, so hard to know if they were truly balanced",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life and no prior wheezing",1,0,0,0,0,2,0,1,0,"","RSV(-) but hospitalized for wheezing in the first two years of life with their first wheezing episode",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",44,1
"408",46,"At least one recurrence of wheeze in the 6 months following first wheezing illness (exposure)",2,2,1,0,0,0,1,"based on descriptive stats in Table 3",0,0,0,0,0,0,0,1,"no attempt  - ""There were no differences in the demographic characteristics of the two age groups"" but no supporting data provided",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing episode requiring hospitalization ib the first year of life",1,0,0,0,0,2,1,0,0,"","hospitalization for wheezing illness in the first year of life without RSV detection",2,2,1,NA,1,1,"unadjusted OR based on Table 3, aggregating across the <3 months and 3-12 months subgroups",2,30.12,1,1.48,61,32,20,0,9,"exposure (0-12 months) to 6-18 months",46,1
"413",46,"At least one recurrence of wheeze in the 6 months following first wheezing illness (exposure)",2,2,1,0,0,0,1,"based on descriptive stats in Table 3",0,0,0,0,0,0,0,1,"no attempt  - ""There were no differences in the demographic characteristics of the two age groups"" but no supporting data provided",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing episode requiring hospitalization ib the first year of life",1,0,0,0,0,2,1,0,0,"","hospitalization for wheezing illness in the first year of life without RSV detection",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",46,1
"410",46,"At least one recurrence of wheeze in the 6 months following first wheezing illness (exposure)",2,2,1,0,0,0,1,"based on descriptive stats in Table 3",0,0,0,0,0,0,0,1,"no attempt  - ""There were no differences in the demographic characteristics of the two age groups"" but no supporting data provided",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing episode requiring hospitalization ib the first year of life",1,0,0,0,0,2,1,0,0,"","hospitalization for wheezing illness in the first year of life without RSV detection",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",46,1
"451",51,"Strict asthma diagnosis: Bronchial asthma was defined in two different ways, reflecting the certainty of the diagnosis. The strict definition (asthma 1) was: the child had needed treatment for acute wheezing either at a healthcare centre or in hospital in 1994-1995, or the child had been on continuous anti-inflammatory medication for asthma during the same years. The less strict asthma definition (asthma 2) was: the child had needed bronchodilators for wheezing episodes at home, asthma 1 included.  - The questionnaire consisted of questions on the symptoms suggestive for asthma, such as wheezing, and on asthma medication, including the use of on-demand bronchodilators and the use of continuous anti-inflammatory drugs. In addition, the subjects were asked to answer if they had needed medication for acute wheezing at home, in the healthcare centre, or in the outpatient or inpatient clinic of a hospital.  - For all the questions, the  subjects had to answer separately for the 2 y (1994 and 1995) preceding the study.",1,1,1,0,1,0,0,"logistic regression, the risk for asthma (separately by both definitions) was estimated as odds ratios (ORs) and related 95% confidence intervals (CIs), adjusted for age, sex and the original presentation (bronchiolitis or pneumonia).",0,1,0,0,0,0,0,0,"""In the logistic regression, the risk for asthma (separately by both definitions) was estimated as odds ratios (ORs) and related 95% confidence intervals (CIs), adjusted for age, sex and the original presentation (bronchiolitis or pneumonia).""",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV+ LRTI hospitalization in first 2 years of life",1,0,0,0,0,2,0,1,0,"","NonRSV infection",2,2,1,NA,1,1,"based on data in Table 1; adjusted OR",1,0.48,1,0.73,98,3,33,10,52,"approx. 12.5 - 16 years old",51,1
"1576",51,"asthma 2 by less strict criteria:  - ""the child had needed bronchodilators for wheezing episodes at home, asthma 1 included""",1,3,1,0,1,0,0,"Logistic regression",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV- LRTI requiring hospitalization",2,2,1,NA,1,1," - see Table 1; adjusted OR",1,0.79,1,0.58,98,6,30,14,48,"approx. 12.5 - 16 years old",51,1
"452",51,"Strict asthma diagnosis: Bronchial asthma was defined in two different ways, reflecting the certainty of the diagnosis. The strict definition (asthma 1) was: the child had needed treatment for acute wheezing either at a healthcare centre or in hospital in 1994-1995, or the child had been on continuous anti-inflammatory medication for asthma during the same years. The less strict asthma definition (asthma 2) was: the child had needed bronchodilators for wheezing episodes at home, asthma 1 included.  - The questionnaire consisted of questions on the symptoms suggestive for asthma, such as wheezing, and on asthma medication, including the use of on-demand bronchodilators and the use of continuous anti-inflammatory drugs. In addition, the subjects were asked to answer if they had needed medication for acute wheezing at home, in the healthcare centre, or in the outpatient or inpatient clinic of a hospital.  - For all the questions, the  subjects had to answer separately for the 2 y (1994 and 1995) preceding the study.",1,1,1,0,1,0,0,"logistic regression, the risk for asthma (separately by both definitions) was estimated as odds ratios (ORs) and related 95% confidence intervals (CIs), adjusted for age, sex and the original presentation (bronchiolitis or pneumonia).",0,1,0,0,0,0,0,0,"""In the logistic regression, the risk for asthma (separately by both definitions) was estimated as odds ratios (ORs) and related 95% confidence intervals (CIs), adjusted for age, sex and the original presentation (bronchiolitis or pneumonia).""",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV+ LRTI hospitalization in first 2 years of life",1,0,0,0,0,2,0,1,0,"","NonRSV infection",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",51,1
"1577",51,"asthma 2 by less strict criteria:  - ""the child had needed bronchodilators for wheezing episodes at home, asthma 1 included""",1,3,1,0,1,0,0,"Logistic regression",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV- LRTI requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",51,1
"457",51,"Strict asthma diagnosis: Bronchial asthma was defined in two different ways, reflecting the certainty of the diagnosis. The strict definition (asthma 1) was: the child had needed treatment for acute wheezing either at a healthcare centre or in hospital in 1994-1995, or the child had been on continuous anti-inflammatory medication for asthma during the same years. The less strict asthma definition (asthma 2) was: the child had needed bronchodilators for wheezing episodes at home, asthma 1 included.  - The questionnaire consisted of questions on the symptoms suggestive for asthma, such as wheezing, and on asthma medication, including the use of on-demand bronchodilators and the use of continuous anti-inflammatory drugs. In addition, the subjects were asked to answer if they had needed medication for acute wheezing at home, in the healthcare centre, or in the outpatient or inpatient clinic of a hospital.  - For all the questions, the  subjects had to answer separately for the 2 y (1994 and 1995) preceding the study.",1,1,1,0,1,0,0,"logistic regression, the risk for asthma (separately by both definitions) was estimated as odds ratios (ORs) and related 95% confidence intervals (CIs), adjusted for age, sex and the original presentation (bronchiolitis or pneumonia).",0,1,0,0,0,0,0,0,"""In the logistic regression, the risk for asthma (separately by both definitions) was estimated as odds ratios (ORs) and related 95% confidence intervals (CIs), adjusted for age, sex and the original presentation (bronchiolitis or pneumonia).""",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,1,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV+ LRTI hospitalization in first 2 years of life",1,0,0,0,0,2,0,1,0,"","NonRSV infection",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",51,1
"1582",51,"asthma 2 by less strict criteria:  - ""the child had needed bronchodilators for wheezing episodes at home, asthma 1 included""",1,3,1,0,1,0,0,"Logistic regression",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV+ LRTI requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV- LRTI requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",51,1
"466",52,"Average number of wheezing days per month",2,2,1,0,0,0,1," - based on descriptives in Table 2",0,0,0,0,0,0,0,1," - included covariates in regression analysis, but no adjusted effect size reported, just a p-value on p. 1042 first paragraph;  - report unadjusted differences in Table 3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI in the first 11 months of lfie",1,0,0,0,0,0,1,0,0,"","RSV(-) LRTI in the first 11 months of lfie",2,2,1,NA,1,1,"***Not sure if this effect size is even meaningful. Basically estimating the odds of wheezing on a given day in an average month.***  Not sure that we can calculate a meaningful effect size. From Table 3, I was able to estimate something like an odds ratio of the average number of days wheezing vs. not wheezing per month, assuming 31 days. The RSV+ group wheezed on average 5.1 days per month (and didn't wheeze ~ 26 days per month). The RSV- group wheezed 1.1 days per months on average (and didn't wheeze 29.9 days per month). So an approximate odds ratio could be something like (5/26)/(1/30) = 5.77",2,5.77,1,1.13,68,5,26,1,30,"first 11 months of life",52,2
"463",52,"Average number of wheezing days per month",2,2,1,0,0,0,1," - based on descriptives in Table 2",0,0,0,0,0,0,0,1," - included covariates in regression analysis, but no adjusted effect size reported, just a p-value on p. 1042 first paragraph;  - report unadjusted differences in Table 3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI in the first 11 months of lfie",1,0,0,0,0,0,1,0,0,"","RSV(-) LRTI in the first 11 months of lfie",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",52,2
"464",52,"Average number of wheezing days per month",2,2,1,0,0,0,1," - based on descriptives in Table 2",0,0,0,0,0,0,0,1," - included covariates in regression analysis, but no adjusted effect size reported, just a p-value on p. 1042 first paragraph;  - report unadjusted differences in Table 3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI in the first 11 months of lfie",1,0,0,0,0,0,1,0,0,"","RSV(-) LRTI in the first 11 months of lfie",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",52,2
"480",54,"doctor managed asthma     - ""A clinical interview based on the structured questionnaire used when the children with bronchiolitis were admitted to hospital were performed by three of the authors in the study (H.O.F, T.F., G.R.) to give information on episodes of wheezing (defined by us as episodes of difficult breathing accompanied by a whistling noise in the chest during expiration), number of visits to a family physician, practicing paediatrician and resubmissions to any hospital for wheezing or asthma (as diagnosed by a medical doctor) during the 6-7 years that had passed since the hospitalisation in infancy.""",1,3,1,0,0,0,1,"ESs based on descriptive stats in Table 3",1,0,0,0,0,1,0,0,"RSV+ and control groups were highly comparable on sex and age at outcome",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV bronchiolitis requiring hospitalization in the 1st year of life",1,0,0,0,0,2,1,0,0,"","Non-RSV bronchiolitis requiring hospitalization in the 1st year of life",2,2,NA,NA,1,1,"unadjusted OR (Table 3)",2,1.8,1,0.55,57,21,14,10,12,"age 7 (current)",54,2
"478",54,"doctor managed asthma     - ""A clinical interview based on the structured questionnaire used when the children with bronchiolitis were admitted to hospital were performed by three of the authors in the study (H.O.F, T.F., G.R.) to give information on episodes of wheezing (defined by us as episodes of difficult breathing accompanied by a whistling noise in the chest during expiration), number of visits to a family physician, practicing paediatrician and resubmissions to any hospital for wheezing or asthma (as diagnosed by a medical doctor) during the 6-7 years that had passed since the hospitalisation in infancy.""",1,3,1,0,0,0,1,"ESs based on descriptive stats in Table 3",1,0,0,0,0,1,0,0,"RSV+ and control groups were highly comparable on sex and age at outcome",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV bronchiolitis requiring hospitalization in the 1st year of life",1,0,0,0,0,2,1,0,0,"","Non-RSV bronchiolitis requiring hospitalization in the 1st year of life",2,2,NA,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",54,2
"485",54,"doctor managed asthma     - ""A clinical interview based on the structured questionnaire used when the children with bronchiolitis were admitted to hospital were performed by three of the authors in the study (H.O.F, T.F., G.R.) to give information on episodes of wheezing (defined by us as episodes of difficult breathing accompanied by a whistling noise in the chest during expiration), number of visits to a family physician, practicing paediatrician and resubmissions to any hospital for wheezing or asthma (as diagnosed by a medical doctor) during the 6-7 years that had passed since the hospitalisation in infancy.""",1,3,1,0,0,0,1,"ESs based on descriptive stats in Table 3",1,0,0,0,0,1,0,0,"RSV+ and control groups were highly comparable on sex and age at outcome",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV bronchiolitis requiring hospitalization in the 1st year of life",1,0,0,0,0,2,1,0,0,"","Non-RSV bronchiolitis requiring hospitalization in the 1st year of life",2,2,NA,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",54,2
"1605",54,"Recurrent wheeze: 3 episodes of wheezing ever during follow-up",2,3,1,0,0,0,1,"ES based on descriptive stats in Table 3",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV bronchiolitis requiring hospitalization in the 1st year of life",1,0,0,0,0,2,1,0,0,"","Non-RSV bronchiolitis requiring hospitalization in the 1st year of life",2,2,1,NA,1,1,"Table 3 unadjusted OR",2,0.79,1,0.55,57,17,18,12,10,"ages 1-7",54,2
"1603",54,"Recurrent wheeze: 3 episodes of wheezing ever during follow-up",2,3,1,0,0,0,1,"ES based on descriptive stats in Table 3",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV bronchiolitis requiring hospitalization in the 1st year of life",1,0,0,0,0,2,1,0,0,"","Non-RSV bronchiolitis requiring hospitalization in the 1st year of life",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,54,2
"1610",54,"Recurrent wheeze: 3 episodes of wheezing ever during follow-up",2,3,1,0,0,0,1,"ES based on descriptive stats in Table 3",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV bronchiolitis requiring hospitalization in the 1st year of life",1,0,0,0,0,2,1,0,0,"","Non-RSV bronchiolitis requiring hospitalization in the 1st year of life",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,54,2
"1618",55,"Reported wheezing    - Wheezing was reported i[by mothers] n response to the question, ""In the last 12 months has he/she had any periods when there was wheezing with whistling on his/her chest when he/she breathed?""",2,3,1,0,1,0,0,"multivariable logistic",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","controls: ""Subjects with no history of admission for bronchiolitis within 12 months of birth""",2,3,2,1,1,1,"Reported wheezing 30-42 months: aOR based on Table 1",1,2.3,1,0.28,9922,27,69,1283,8543,"30-42 months",55,1
"1615",55,"Reported wheezing    - Wheezing was reported i[by mothers] n response to the question, ""In the last 12 months has he/she had any periods when there was wheezing with whistling on his/her chest when he/she breathed?""",2,3,1,0,1,0,0,"multivariable logistic",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","controls: ""Subjects with no history of admission for bronchiolitis within 12 months of birth""",2,3,2,1,2,1,"Reported wheezing 69-81 months: aOR based on Table 1",1,3.5,1,0.33,7278,14,48,694,6522,"69-81 months",55,1
"1616",55,"Reported wheezing    - Wheezing was reported i[by mothers] n response to the question, ""In the last 12 months has he/she had any periods when there was wheezing with whistling on his/her chest when he/she breathed?""",2,3,1,0,1,0,0,"multivariable logistic",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","controls: ""Subjects with no history of admission for bronchiolitis within 12 months of birth""",2,3,2,1,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",55,1
"496",56,"ASTHMA: At the follow-up visit in 2004, asthma was considered present if 1) the child was on a continuous maintenance medication for asthma, or 2) she/he had suffered from repeated (2) episodes of wheezing or prolonged (4 weeks) cough apart from infections during the  preceding 12 months as reported by parents, and the exercise challenge test was regarded as positive",1,1,1,0,1,0,0,"The statistical significance of  differences between groups was assessed with the chi-square test for proportions, supplemented by odds  ratios (OR) with 95% confidence intervals (CI). Fisher's exact test was used when the expected frequency for any cell was <5. The logistic regression was used to analyze  parental asthma and atopy, atopy in children, and markers of atopy in children, adjusted for sex and age (in months) on admission, and viral etiology during primary hospitalization, adjusted for sex, age, passive smoking, and atopic dermatitis on admission, as risk factors for asthma.",0,1,0,0,0,0,0,0,"The logistic regression was used to analyze  parental asthma and atopy, atopy in children, and markers of atopy in children, adjusted for sex and age (in months) on admission, and viral etiology during primary hospitalization, adjusted for sex, age, passive smoking during infancy (not prenatal), and atopic dermatitis on admission, as risk factors for asthma.",0,0,1,0,1,0,0,0,1,0,0,0,1,0,0,0,0,NA,NA,1,NA,2,NA,NA,NA,1,NA,NA,NA,2,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization in the first two years of life",2,2,1,NA,1,1,"Adjusted OR based on logistic regression (Table 3)",1,0.41,1,0.65,81,5,20,29,27,"~ ages 10-13",56,1
"497",56,"ASTHMA: At the follow-up visit in 2004, asthma was considered present if 1) the child was on a continuous maintenance medication for asthma, or 2) she/he had suffered from repeated (2) episodes of wheezing or prolonged (4 weeks) cough apart from infections during the  preceding 12 months as reported by parents, and the exercise challenge test was regarded as positive",1,1,1,0,1,0,0,"The statistical significance of  differences between groups was assessed with the chi-square test for proportions, supplemented by odds  ratios (OR) with 95% confidence intervals (CI). Fisher's exact test was used when the expected frequency for any cell was <5. The logistic regression was used to analyze  parental asthma and atopy, atopy in children, and markers of atopy in children, adjusted for sex and age (in months) on admission, and viral etiology during primary hospitalization, adjusted for sex, age, passive smoking, and atopic dermatitis on admission, as risk factors for asthma.",0,1,0,0,0,0,0,0,"The logistic regression was used to analyze  parental asthma and atopy, atopy in children, and markers of atopy in children, adjusted for sex and age (in months) on admission, and viral etiology during primary hospitalization, adjusted for sex, age, passive smoking during infancy (not prenatal), and atopic dermatitis on admission, as risk factors for asthma.",0,0,1,0,1,0,0,0,1,0,0,0,1,0,0,0,0,NA,NA,1,NA,2,NA,NA,NA,1,NA,NA,NA,2,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization in the first two years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",56,1
"498",56,"ASTHMA: At the follow-up visit in 2004, asthma was considered present if 1) the child was on a continuous maintenance medication for asthma, or 2) she/he had suffered from repeated (2) episodes of wheezing or prolonged (4 weeks) cough apart from infections during the  preceding 12 months as reported by parents, and the exercise challenge test was regarded as positive",1,1,1,0,1,0,0,"The statistical significance of  differences between groups was assessed with the chi-square test for proportions, supplemented by odds  ratios (OR) with 95% confidence intervals (CI). Fisher's exact test was used when the expected frequency for any cell was <5. The logistic regression was used to analyze  parental asthma and atopy, atopy in children, and markers of atopy in children, adjusted for sex and age (in months) on admission, and viral etiology during primary hospitalization, adjusted for sex, age, passive smoking, and atopic dermatitis on admission, as risk factors for asthma.",0,1,0,0,0,0,0,0,"The logistic regression was used to analyze  parental asthma and atopy, atopy in children, and markers of atopy in children, adjusted for sex and age (in months) on admission, and viral etiology during primary hospitalization, adjusted for sex, age, passive smoking during infancy (not prenatal), and atopic dermatitis on admission, as risk factors for asthma.",0,0,1,0,1,0,0,0,1,0,0,0,1,0,0,0,0,NA,NA,1,NA,2,NA,NA,NA,1,NA,NA,NA,2,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization in the first two years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",56,1
"507",57,"ASTHMA: Asthma was considered to be present if 1) the  patient was on continuous maintenance medication for asthma, or if 2) she/he had suffered from repeated (52) episodes of wheezing and/or prolonged cough (54 wk),  apart from infection, during the preceding 12 mo as reported by parents, and the exercise challenge test was regarded as positive",1,1,1,0,1,0,1,"Statistical significance of the differences between the groups was assessed  with the chi-2 test for proportions. The Fisher's exact test was used when the expected frequency for any cell was 55 in a 2r2 contingency table. The Mann-Whitney U-test was used for the statistical analyses of the continuous variables data. Logistic regression  was used for adjusted analyses of dichotomous  data.",0,0,0,0,0,0,0,1,"Analyses adjusted for early atopic sensitization, but did only provided a p value from the analysis -- not an effect size. Therefore, we relied on descriptive data provided in Table 4. .",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"100 children hospitalized for wheezing (the index episode) were recruited into this follow-up study in 1992 to 1993  - those with RSV form the exposure group",1,0,0,0,0,2,0,1,0,"","hospitalized for wheezing but RSV-",2,2,1,NA,1,1,"Based on Table 4 aggregating over different age groups (last row)",2,0.22,1,0.61,82,4,19,29,30,"approx. 4.6 to 8.8 years old",57,1
"505",57,"ASTHMA: Asthma was considered to be present if 1) the  patient was on continuous maintenance medication for asthma, or if 2) she/he had suffered from repeated (52) episodes of wheezing and/or prolonged cough (54 wk),  apart from infection, during the preceding 12 mo as reported by parents, and the exercise challenge test was regarded as positive",1,1,1,0,1,0,1,"Statistical significance of the differences between the groups was assessed  with the chi-2 test for proportions. The Fisher's exact test was used when the expected frequency for any cell was 55 in a 2r2 contingency table. The Mann-Whitney U-test was used for the statistical analyses of the continuous variables data. Logistic regression  was used for adjusted analyses of dichotomous  data.",0,0,0,0,0,0,0,1,"Analyses adjusted for early atopic sensitization, but did only provided a p value from the analysis -- not an effect size. Therefore, we relied on descriptive data provided in Table 4. .",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"100 children hospitalized for wheezing (the index episode) were recruited into this follow-up study in 1992 to 1993  - those with RSV form the exposure group",1,0,0,0,0,2,0,1,0,"","hospitalized for wheezing but RSV-",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",57,1
"512",57,"ASTHMA: Asthma was considered to be present if 1) the  patient was on continuous maintenance medication for asthma, or if 2) she/he had suffered from repeated (52) episodes of wheezing and/or prolonged cough (54 wk),  apart from infection, during the preceding 12 mo as reported by parents, and the exercise challenge test was regarded as positive",1,1,1,0,1,0,1,"Statistical significance of the differences between the groups was assessed  with the chi-2 test for proportions. The Fisher's exact test was used when the expected frequency for any cell was 55 in a 2r2 contingency table. The Mann-Whitney U-test was used for the statistical analyses of the continuous variables data. Logistic regression  was used for adjusted analyses of dichotomous  data.",0,0,0,0,0,0,0,1,"Analyses adjusted for early atopic sensitization, but did only provided a p value from the analysis -- not an effect size. Therefore, we relied on descriptive data provided in Table 4. .",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"100 children hospitalized for wheezing (the index episode) were recruited into this follow-up study in 1992 to 1993  - those with RSV form the exposure group",1,0,0,0,0,2,0,1,0,"","hospitalized for wheezing but RSV-",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",57,1
"535",60,"New recurrent obstructive episode in the year following LRTI emergency visit in the first two years of life",2,3,1,0,0,1,0,"",0,1,0,0,0,0,0,0,"Adjusted for all covariates listed in Table 6",1,0,1,0,0,0,1,1,1,1,0,0,0,1,0,1,0,1,NA,1,NA,NA,NA,1,2,2,2,NA,NA,NA,2,"RSV(+) bronchiolitis treated in the emergency unit in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis treated in the emergency unit in the first 2 years of life",2,2,1,NA,1,2,"adjusted risk ratio based on Cox proportional model (Table 6)",1,1.41,1,0.16,96,NA,NA,NA,NA,"approx. ages 0-3",60,1
"533",60,"New recurrent obstructive episode in the year following LRTI emergency visit in the first two years of life",2,3,1,0,0,1,0,"",0,1,0,0,0,0,0,0,"Adjusted for all covariates listed in Table 6",1,0,1,0,0,0,1,1,1,1,0,0,0,1,0,1,0,1,NA,1,NA,NA,NA,1,2,2,2,NA,NA,NA,2,"RSV(+) bronchiolitis treated in the emergency unit in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis treated in the emergency unit in the first 2 years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",60,1
"537",60,"New recurrent obstructive episode in the year following LRTI emergency visit in the first two years of life",2,3,1,0,0,1,0,"",0,1,0,0,0,0,0,0,"Adjusted for all covariates listed in Table 6",1,0,1,0,0,0,1,1,1,1,0,0,0,1,0,1,0,1,NA,1,NA,NA,NA,1,2,2,2,NA,NA,NA,2,"RSV(+) bronchiolitis treated in the emergency unit in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis treated in the emergency unit in the first 2 years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",60,1
"546",61,"ASTHMA: ""(1) the patient was on  a continuous maintenance medication for asthma,  or if (2) she/he had suffered from repeated ( 2) episodes of wheezing and/or prolonged cough ( 4 weeks) apart from infection during the preceding 12 months reported by parents, and the exercise challenge test was regarded as positive""",1,1,1,0,1,0,0,"""logistic regression analysis was used to calculate the adjusted ORs and related 95% CIs""",0,1,0,0,0,0,0,0,"",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV+ LRTI requiring hospitalization in the first 23 months of life",1,0,0,0,0,2,0,1,0,"","non-RSV LRTI requiring hospitalization in the first 2 years of life",2,2,1,NA,1,1,"odds ratio adjusted for child sex and age at study entry",1,0.23,1,0.7,82,3,17,30,32,"approx. ages 4-5",61,1
"541",61,"ASTHMA: ""(1) the patient was on  a continuous maintenance medication for asthma,  or if (2) she/he had suffered from repeated ( 2) episodes of wheezing and/or prolonged cough ( 4 weeks) apart from infection during the preceding 12 months reported by parents, and the exercise challenge test was regarded as positive""",1,1,1,0,1,0,0,"""logistic regression analysis was used to calculate the adjusted ORs and related 95% CIs""",0,1,0,0,0,0,0,0,"",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV+ LRTI requiring hospitalization in the first 23 months of life",1,0,0,0,0,2,0,1,0,"","non-RSV LRTI requiring hospitalization in the first 2 years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",61,1
"542",61,"ASTHMA: ""(1) the patient was on  a continuous maintenance medication for asthma,  or if (2) she/he had suffered from repeated ( 2) episodes of wheezing and/or prolonged cough ( 4 weeks) apart from infection during the preceding 12 months reported by parents, and the exercise challenge test was regarded as positive""",1,1,1,0,1,0,0,"""logistic regression analysis was used to calculate the adjusted ORs and related 95% CIs""",0,1,0,0,0,0,0,0,"",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV+ LRTI requiring hospitalization in the first 23 months of life",1,0,0,0,0,2,0,1,0,"","non-RSV LRTI requiring hospitalization in the first 2 years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",61,1
"558",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRI ages 1-24 months requiring hospitalization",1,0,0,0,0,2,0,1,0,"","non-RSV LRI requiring hospitalization",2,2,1,NA,1,1,"unadjusted OR based on Table 2",2,0.79,1,0.64,74,4,16,13,41,"approx age 5",62,1
"2808",62,"ATOPIC ASTHMA",1,1,1,0,1,0,0,"",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI WITH family history of asthma",1,0,0,0,0,0,0,1,0,"","RSV(-) LRTI WITH family history of asthma",2,2,NA,NA,1,1,"unadjusted OR",2,0.29,1,1.67,12,0,2,4,6,"approx. age 5",62,1
"553",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRI ages 1-24 months requiring hospitalization",1,0,0,0,0,2,0,1,0,"","non-RSV LRI requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,1
"2803",62,"ATOPIC ASTHMA",1,1,1,0,1,0,0,"",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI WITH family history of asthma",1,0,0,0,0,0,0,1,0,"","RSV(-) LRTI WITH family history of asthma",2,2,NA,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,1
"557",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRI ages 1-24 months requiring hospitalization",1,0,0,0,0,2,0,1,0,"","non-RSV LRI requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,1
"2807",62,"ATOPIC ASTHMA",1,1,1,0,1,0,0,"",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI WITH family history of asthma",1,0,0,0,0,0,0,1,0,"","RSV(-) LRTI WITH family history of asthma",2,2,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,62,1
"550",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization WITH family history of atopy",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization WITH family history of atopy",2,2,1,NA,1,1,"based on Table 3; unadjusted",2,0.82,1,0.91,36,2,7,7,20,"approx. age 5",62,2
"2800",62,"ATOPIC ASTHMA",1,1,1,0,1,0,0,"",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI WITHOUT family history of asthma",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI WITHOUT family history of asthma",2,2,NA,NA,1,1,"unadjusted OR",2,1.11,1,0.68,62,4,14,9,35,"approx. age 5",62,2
"551",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization WITH family history of atopy",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization WITH family history of atopy",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,2
"2801",62,"ATOPIC ASTHMA",1,1,1,0,1,0,0,"",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI WITHOUT family history of asthma",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI WITHOUT family history of asthma",2,2,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,62,2
"552",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization WITH family history of atopy",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization WITH family history of atopy",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,2
"2802",62,"ATOPIC ASTHMA",1,1,1,0,1,0,0,"",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI WITHOUT family history of asthma",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI WITHOUT family history of asthma",2,2,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,62,2
"554",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization WITHOUT family history of atopy",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization WITHOUT family history of atopy",2,2,1,NA,1,1,"descriptive stats from Table 3",2,0.78,1,0.91,38,2,9,6,21,"approx. age 5",62,3
"555",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization WITHOUT family history of atopy",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization WITHOUT family history of atopy",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,3
"556",62,"ATOPIC ASTHMA: children >5 who reported one or more of following: coughing/wheezing at night without URI, coughing & wheezing on exertion, wheezing without URI, & doctor diagnosed asthma",1,3,1,0,0,0,1,"chi-square & Fisher's exact test",0,0,0,0,0,0,0,1,"did not report attempting to minimize the influence of condounders; groups were relatively well-balanced on some potential confounders in Table 1, but not clear how much influence these variables could still have had",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization WITHOUT family history of atopy",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization WITHOUT family history of atopy",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,3
"1683",62,"Repeated wheezing (>1 episode) during the first 5 years of life",2,3,1,0,0,0,1,"chi-square/Fisher's exact",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization",2,2,1,NA,1,1,"unadjusted, based on Table 2",2,2.97,1,0.62,74,16,4,31,23,"~ages 0-5",62,1
"1678",62,"Repeated wheezing (>1 episode) during the first 5 years of life",2,3,1,0,0,0,1,"chi-square/Fisher's exact",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,1
"1682",62,"Repeated wheezing (>1 episode) during the first 5 years of life",2,3,1,0,0,0,1,"chi-square/Fisher's exact",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRI ages 1-24 months requiring hospitalization",1,0,0,0,0,2,0,1,0,"","RSV(-) LRI ages 1-24 months requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",62,1
"566",63,"RECURRENT WHEEZE:  ""parents were asked if the child had  demonstrated symptoms similar to the symptoms when  hospitalized for wheezing. Both wheezing episodes recorded by a physician or reported by parents were considered. One or more consecutive days of wheezing followed and, preceded by a healthy period of 1 wk, were counted as one wheezing episode. Further, any hospitalization of the child due to wheezing after the initial episode was noted according to the medical record. Children were considered to have recurrent wheezing if they had experienced at least three wheezing episodes including the first hospitalization, with at least one of the episodes during the past 6 mo""",2,1,1,0,1,0,0,"Logistic regression models were used to calculate the odds ratios (OR) with 95% confidence intervals (CI) for estimating the associations between potential risk factors and different outcomes.",0,1,0,0,0,0,0,0,"reported several models: (1) unadjusted model, (2) model adjusting for age, sex, and parental atopy, and (3) model adjusting for age, sex, parental atopy, and eosinophil count",1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV+ wheezing hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV- wheezing hospitalization in the first year of life",2,2,1,NA,1,1,"OR adjusted for child sex, age, and parental atopy status based on text (p. 846, first paragraph)",1,0.3,1,0.61,101,NA,NA,NA,NA,"3.5-12 months to 19-23 months",63,1
"564",63,"RECURRENT WHEEZE:  ""parents were asked if the child had  demonstrated symptoms similar to the symptoms when  hospitalized for wheezing. Both wheezing episodes recorded by a physician or reported by parents were considered. One or more consecutive days of wheezing followed and, preceded by a healthy period of 1 wk, were counted as one wheezing episode. Further, any hospitalization of the child due to wheezing after the initial episode was noted according to the medical record. Children were considered to have recurrent wheezing if they had experienced at least three wheezing episodes including the first hospitalization, with at least one of the episodes during the past 6 mo""",2,1,1,0,1,0,0,"Logistic regression models were used to calculate the odds ratios (OR) with 95% confidence intervals (CI) for estimating the associations between potential risk factors and different outcomes.",0,1,0,0,0,0,0,0,"reported several models: (1) unadjusted model, (2) model adjusting for age, sex, and parental atopy, and (3) model adjusting for age, sex, parental atopy, and eosinophil count",1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV+ wheezing hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV- wheezing hospitalization in the first year of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",63,1
"565",63,"RECURRENT WHEEZE:  ""parents were asked if the child had  demonstrated symptoms similar to the symptoms when  hospitalized for wheezing. Both wheezing episodes recorded by a physician or reported by parents were considered. One or more consecutive days of wheezing followed and, preceded by a healthy period of 1 wk, were counted as one wheezing episode. Further, any hospitalization of the child due to wheezing after the initial episode was noted according to the medical record. Children were considered to have recurrent wheezing if they had experienced at least three wheezing episodes including the first hospitalization, with at least one of the episodes during the past 6 mo""",2,1,1,0,1,0,0,"Logistic regression models were used to calculate the odds ratios (OR) with 95% confidence intervals (CI) for estimating the associations between potential risk factors and different outcomes.",0,1,0,0,0,0,0,0,"reported several models: (1) unadjusted model, (2) model adjusting for age, sex, and parental atopy, and (3) model adjusting for age, sex, parental atopy, and eosinophil count",1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV+ wheezing hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV- wheezing hospitalization in the first year of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",63,1
"570",64,"ASTHMA: ""One or more consecutive days of wheezing followed or preceded by a healthy period of at least 1 week constituted 1 wheezing episode.  - ""A recurrent wheezing episode was defined as 1 physician-diagnosed episode of bronchial obstruction after the index episode. Patients having at least 2 episodes of physician-diagnosed bronchial obstructions after the index episode of wheezing were considered as having asthma.12 If the patient with asthma had had at least 1 physician-diagnosed episode of wheezing during the year preceding the 3-year visit, or if he/she still received maintenance therapy for asthma, he/she was defined as having current asthma""",1,1,1,0,1,0,0,"""The logistic regression model was used to calculate the adjusted risk ratios (RR) with 95% confidence intervals for estimating the association between different factors and asthma.",0,1,0,0,0,0,0,0,"adjusted for potential confounders in logistic regression    effect size reported in paper adjusted only for age, but in analyses not presented, also adjusted for:    ""* The following factors were insignificant in the prediction of asthma: positive viral identification on entry, family history of atopy or asthma, male sex, passive smoking during pregnancy or early childhood, urban living area during infancy, 2 or more siblings, and elevated serum IgE on entry.""",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV(+) infants under 24 months hospitalized for infection-associated bronchial obstruction",1,0,0,0,0,2,0,1,0,"","RSV(-) infants hospitalized for bronchial obstructions",2,2,1,NA,1,2,"risk ratio from logistic regression adjusting for age",1,0.3,1,0.59,89,5,18,40,26,"ages 1-23 months (median 10) to 3.2-5.1 (median 4) years",64,1
"571",64,"ASTHMA: ""One or more consecutive days of wheezing followed or preceded by a healthy period of at least 1 week constituted 1 wheezing episode.  - ""A recurrent wheezing episode was defined as 1 physician-diagnosed episode of bronchial obstruction after the index episode. Patients having at least 2 episodes of physician-diagnosed bronchial obstructions after the index episode of wheezing were considered as having asthma.12 If the patient with asthma had had at least 1 physician-diagnosed episode of wheezing during the year preceding the 3-year visit, or if he/she still received maintenance therapy for asthma, he/she was defined as having current asthma""",1,1,1,0,1,0,0,"""The logistic regression model was used to calculate the adjusted risk ratios (RR) with 95% confidence intervals for estimating the association between different factors and asthma.",0,1,0,0,0,0,0,0,"adjusted for potential confounders in logistic regression    effect size reported in paper adjusted only for age, but in analyses not presented, also adjusted for:    ""* The following factors were insignificant in the prediction of asthma: positive viral identification on entry, family history of atopy or asthma, male sex, passive smoking during pregnancy or early childhood, urban living area during infancy, 2 or more siblings, and elevated serum IgE on entry.""",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV(+) infants under 24 months hospitalized for infection-associated bronchial obstruction",1,0,0,0,0,2,0,1,0,"","RSV(-) infants hospitalized for bronchial obstructions",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",64,1
"572",64,"ASTHMA: ""One or more consecutive days of wheezing followed or preceded by a healthy period of at least 1 week constituted 1 wheezing episode.  - ""A recurrent wheezing episode was defined as 1 physician-diagnosed episode of bronchial obstruction after the index episode. Patients having at least 2 episodes of physician-diagnosed bronchial obstructions after the index episode of wheezing were considered as having asthma.12 If the patient with asthma had had at least 1 physician-diagnosed episode of wheezing during the year preceding the 3-year visit, or if he/she still received maintenance therapy for asthma, he/she was defined as having current asthma""",1,1,1,0,1,0,0,"""The logistic regression model was used to calculate the adjusted risk ratios (RR) with 95% confidence intervals for estimating the association between different factors and asthma.",0,1,0,0,0,0,0,0,"adjusted for potential confounders in logistic regression    effect size reported in paper adjusted only for age, but in analyses not presented, also adjusted for:    ""* The following factors were insignificant in the prediction of asthma: positive viral identification on entry, family history of atopy or asthma, male sex, passive smoking during pregnancy or early childhood, urban living area during infancy, 2 or more siblings, and elevated serum IgE on entry.""",0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV(+) infants under 24 months hospitalized for infection-associated bronchial obstruction",1,0,0,0,0,2,0,1,0,"","RSV(-) infants hospitalized for bronchial obstructions",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",64,1
"577",65,"Wheezing in the first year (>= two episodes)",2,1,1,0,1,0,1,"Results from models of RSV predicting outcomes not reported, so we had to rely on descriptive stats in Table 2    Chi-square tests, log-linear analysis, Kruskall  Wallis analysis of variance (anova), and  generalized linear model analysis were used,  as appropriate, with statistica1, version 5.5,  software.",0,0,0,0,0,0,0,1,"We have to rely on descriptive stats in Table 2 -- no minimization of confounding",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) children hospitalized before age 3 (includes RSV coinfections)",1,0,0,0,0,2,0,0,1,"Birth to 36 months","RSV(-) children hospitalized before age 3 (includes Flu-A and None)",2,2,1,NA,1,1,"Based on descriptive stats in Table 2",2,1.09,1,0.26,292,129,76,53,34,"0-1; 1-2; 2-3; 3-4 depending on child's age at baseline",65,1
"1702",65,"Hospitalization for wheezing",2,2,1,0,1,0,1,"same as for Outcome 1",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) children hospitalized before age 3 (includes RSV coinfections)",1,0,0,0,0,2,0,0,1,"Birth to 36 months","RSV(-) children hospitalized before age 3 (includes Flu-A and None)",2,2,1,NA,1,1,"Based on Table 2",1,0.96,1,0.35,292,32,173,14,73,"0-1; 1-2; 2-3; 3-4 depending on child's age at baseline",65,1
"578",65,"Wheezing in the first year (>= two episodes)",2,1,1,0,1,0,1,"Results from models of RSV predicting outcomes not reported, so we had to rely on descriptive stats in Table 2    Chi-square tests, log-linear analysis, Kruskall  Wallis analysis of variance (anova), and  generalized linear model analysis were used,  as appropriate, with statistica1, version 5.5,  software.",0,0,0,0,0,0,0,1,"We have to rely on descriptive stats in Table 2 -- no minimization of confounding",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) children hospitalized before age 3 (includes RSV coinfections)",1,0,0,0,0,2,0,0,1,"Birth to 36 months","RSV(-) children hospitalized before age 3 (includes Flu-A and None)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",65,1
"1703",65,"Hospitalization for wheezing",2,2,1,0,1,0,1,"same as for Outcome 1",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) children hospitalized before age 3 (includes RSV coinfections)",1,0,0,0,0,2,0,0,1,"Birth to 36 months","RSV(-) children hospitalized before age 3 (includes Flu-A and None)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",65,1
"579",65,"Wheezing in the first year (>= two episodes)",2,1,1,0,1,0,1,"Results from models of RSV predicting outcomes not reported, so we had to rely on descriptive stats in Table 2    Chi-square tests, log-linear analysis, Kruskall  Wallis analysis of variance (anova), and  generalized linear model analysis were used,  as appropriate, with statistica1, version 5.5,  software.",0,0,0,0,0,0,0,1,"We have to rely on descriptive stats in Table 2 -- no minimization of confounding",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) children hospitalized before age 3 (includes RSV coinfections)",1,0,0,0,0,2,0,0,1,"Birth to 36 months","RSV(-) children hospitalized before age 3 (includes Flu-A and None)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",65,1
"1704",65,"Hospitalization for wheezing",2,2,1,0,1,0,1,"same as for Outcome 1",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) children hospitalized before age 3 (includes RSV coinfections)",1,0,0,0,0,2,0,0,1,"Birth to 36 months","RSV(-) children hospitalized before age 3 (includes Flu-A and None)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",65,1
"608",68,"ASTHMA: Asthma was defined as three or more episodes of wheezing with no signs of other conditions, with at least one of the episodes during the last year",1,1,1,0,0,0,1,"Wilcoxon two sample-test. P < 0.05",0,0,0,0,0,0,0,1,"no documented attempt",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization ",1,0,0,0,0,2,0,0,1,"Birth to 17 months","RSV(-) bronchiolitis requiring hospitalization",2,2,1,NA,1,1,"based on descriptive stats from p. 205 first paragraph under Results",2,0.29,1,0.97,23,2,8,6,7,"ages 1-17 (mean 6.8) months to 37-57 (mean 46) months",68,1
"609",68,"ASTHMA: Asthma was defined as three or more episodes of wheezing with no signs of other conditions, with at least one of the episodes during the last year",1,1,1,0,0,0,1,"Wilcoxon two sample-test. P < 0.05",0,0,0,0,0,0,0,1,"no documented attempt",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization ",1,0,0,0,0,2,0,0,1,"Birth to 17 months","RSV(-) bronchiolitis requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",68,1
"606",68,"ASTHMA: Asthma was defined as three or more episodes of wheezing with no signs of other conditions, with at least one of the episodes during the last year",1,1,1,0,0,0,1,"Wilcoxon two sample-test. P < 0.05",0,0,0,0,0,0,0,1,"no documented attempt",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization ",1,0,0,0,0,2,0,0,1,"Birth to 17 months","RSV(-) bronchiolitis requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",68,1
"615",69,"ASTHMA: ""all children suffering from at least one wheezing attack as late as 4 years of age or more were regarded as having asthma.""",1,3,1,0,0,0,1,"chi-square test with Yates correction and Fisher's exact probability",0,0,0,0,0,0,0,1,"No documented attempt",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization during an RSV epidemic (n=17); data were not provided for RSV-  children outside of the RSV epidemic (n=27) so no effect size could be calculated",2,2,1,NA,1,1,"based on data provided in Table 3",2,0.26,1,0.8,41,3,21,6,11,"4.5 to 6 years of age",69,1
"613",69,"ASTHMA: ""all children suffering from at least one wheezing attack as late as 4 years of age or more were regarded as having asthma.""",1,3,1,0,0,0,1,"chi-square test with Yates correction and Fisher's exact probability",0,0,0,0,0,0,0,1,"No documented attempt",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization during an RSV epidemic (n=17); data were not provided for RSV-  children outside of the RSV epidemic (n=27) so no effect size could be calculated",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",69,1
"617",69,"ASTHMA: ""all children suffering from at least one wheezing attack as late as 4 years of age or more were regarded as having asthma.""",1,3,1,0,0,0,1,"chi-square test with Yates correction and Fisher's exact probability",0,0,0,0,0,0,0,1,"No documented attempt",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization during an RSV epidemic (n=17); data were not provided for RSV-  children outside of the RSV epidemic (n=27) so no effect size could be calculated",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",69,1
"626",70,"Bronchial Asthma  - children were examined and the parents were interviewed by one of us (L. K. ) ; the histories were  obtained by means of structured questionnaires and matched  with the medical records of our hospital. Bronchial asthma  was defined as wheezing on at least three occasions after an infection or an exposure to an allergen.10 The occurrence of asthmatic attacks during the 12 months before the  follow-up examination was recorded; only attacks diagnosed and treated by a physician were included. In addition, children who were receiving continuous or intermittent preventive antiasthmatic medication, regard  less of their acute symptoms, were considered to have bronchial asthma.",1,3,1,0,0,0,1,"In statistical analysis of the data, the 2 test with a correction devised by Yates and Fisher's Exact Probability Test  were used.",0,0,0,0,0,0,0,1,"no attempt to limit confounding",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,1,1,"unadjusted OR based on Table 3",2,0.18,1,0.84,62,2,30,8,22,"ages 7-9.5",70,1
"623",70,"Bronchial Asthma  - children were examined and the parents were interviewed by one of us (L. K. ) ; the histories were  obtained by means of structured questionnaires and matched  with the medical records of our hospital. Bronchial asthma  was defined as wheezing on at least three occasions after an infection or an exposure to an allergen.10 The occurrence of asthmatic attacks during the 12 months before the  follow-up examination was recorded; only attacks diagnosed and treated by a physician were included. In addition, children who were receiving continuous or intermittent preventive antiasthmatic medication, regard  less of their acute symptoms, were considered to have bronchial asthma.",1,3,1,0,0,0,1,"In statistical analysis of the data, the 2 test with a correction devised by Yates and Fisher's Exact Probability Test  were used.",0,0,0,0,0,0,0,1,"no attempt to limit confounding",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",70,1
"622",70,"Bronchial Asthma  - children were examined and the parents were interviewed by one of us (L. K. ) ; the histories were  obtained by means of structured questionnaires and matched  with the medical records of our hospital. Bronchial asthma  was defined as wheezing on at least three occasions after an infection or an exposure to an allergen.10 The occurrence of asthmatic attacks during the 12 months before the  follow-up examination was recorded; only attacks diagnosed and treated by a physician were included. In addition, children who were receiving continuous or intermittent preventive antiasthmatic medication, regard  less of their acute symptoms, were considered to have bronchial asthma.",1,3,1,0,0,0,1,"In statistical analysis of the data, the 2 test with a correction devised by Yates and Fisher's Exact Probability Test  were used.",0,0,0,0,0,0,0,1,"no attempt to limit confounding",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",70,1
"661",74,"Established asthma  - Recurrent qr established bronchitis is defined as four or more episodes of cough necessitating medical attention, and asthma as four or more episodes of wheezing during the year before follow-up study.    -After each child's visit general practitioners were contacted and asked to confirm the history obtained from the parents. Medical records were scrutinised with the general practitioner's consent whenever there was a history of respiratory problems or apparent conflict between parental and medical information. More than two-thirds of the medical records of the children were finally reviewed and relevant information coded.",1,3,1,0,0,0,1,"Just descriptive -- based on last section of the Results",1,0,0,0,0,1,0,0,"Table 1: child sex well-matched in   - Those with and without respiratory syncytial virus were then grouped separately for each  winter period according to age (to within three months) at the time of the illness and equal numbers of ""age matched"" children with and  without respiratory syncytial virus were selected at random from each group. A total of 115 children with and 115 without respiratory syncytial virus were thus chosen as possible index cases for the study.  - Comparisons were made between those index children who had had respiratory syncytial virus (group 1) and those who had not (group 2) (100 in each group). No significant difference was found in the age at which the index illness occurred (4 3 months in both groups) or in the proportion who were breast fed (seven in group 1 and five in group 2). Social class distribution and personal or family histories of atopic disorders were similar in both subgroups.",0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,2,NA,"RSV(+) LRTI hospitalization in first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) LRTI hospitalization in first year of life",2,2,1,NA,1,1,"based on descriptive data; performed McNemar's test but not model-based effect size",2,0.52,1,0.53,200,6,94,11,89,"~ ages 6-7",74,1
"658",74,"Established asthma  - Recurrent qr established bronchitis is defined as four or more episodes of cough necessitating medical attention, and asthma as four or more episodes of wheezing during the year before follow-up study.    -After each child's visit general practitioners were contacted and asked to confirm the history obtained from the parents. Medical records were scrutinised with the general practitioner's consent whenever there was a history of respiratory problems or apparent conflict between parental and medical information. More than two-thirds of the medical records of the children were finally reviewed and relevant information coded.",1,3,1,0,0,0,1,"Just descriptive -- based on last section of the Results",1,0,0,0,0,1,0,0,"Table 1: child sex well-matched in   - Those with and without respiratory syncytial virus were then grouped separately for each  winter period according to age (to within three months) at the time of the illness and equal numbers of ""age matched"" children with and  without respiratory syncytial virus were selected at random from each group. A total of 115 children with and 115 without respiratory syncytial virus were thus chosen as possible index cases for the study.  - Comparisons were made between those index children who had had respiratory syncytial virus (group 1) and those who had not (group 2) (100 in each group). No significant difference was found in the age at which the index illness occurred (4 3 months in both groups) or in the proportion who were breast fed (seven in group 1 and five in group 2). Social class distribution and personal or family histories of atopic disorders were similar in both subgroups.",0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,2,NA,"RSV(+) LRTI hospitalization in first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) LRTI hospitalization in first year of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",74,1
"659",74,"Established asthma  - Recurrent qr established bronchitis is defined as four or more episodes of cough necessitating medical attention, and asthma as four or more episodes of wheezing during the year before follow-up study.    -After each child's visit general practitioners were contacted and asked to confirm the history obtained from the parents. Medical records were scrutinised with the general practitioner's consent whenever there was a history of respiratory problems or apparent conflict between parental and medical information. More than two-thirds of the medical records of the children were finally reviewed and relevant information coded.",1,3,1,0,0,0,1,"Just descriptive -- based on last section of the Results",1,0,0,0,0,1,0,0,"Table 1: child sex well-matched in   - Those with and without respiratory syncytial virus were then grouped separately for each  winter period according to age (to within three months) at the time of the illness and equal numbers of ""age matched"" children with and  without respiratory syncytial virus were selected at random from each group. A total of 115 children with and 115 without respiratory syncytial virus were thus chosen as possible index cases for the study.  - Comparisons were made between those index children who had had respiratory syncytial virus (group 1) and those who had not (group 2) (100 in each group). No significant difference was found in the age at which the index illness occurred (4 3 months in both groups) or in the proportion who were breast fed (seven in group 1 and five in group 2). Social class distribution and personal or family histories of atopic disorders were similar in both subgroups.",0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,2,NA,"RSV(+) LRTI hospitalization in first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) LRTI hospitalization in first year of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",74,1
"1786",74," Recurrent wheeze",2,3,1,0,0,0,1,"based on descriptive stats in last section of Results",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI hospitalization in first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) LRTI hospitalization in first year of life",2,2,1,NA,1,1,"unadjusted OR",2,1.17,1,0.28,200,49,51,45,55,"~ ages 6-7",74,1
"1783",74," Recurrent wheeze",2,3,1,0,0,0,1,"based on descriptive stats in last section of Results",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI hospitalization in first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) LRTI hospitalization in first year of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",74,1
"1784",74," Recurrent wheeze",2,3,1,0,0,0,1,"based on descriptive stats in last section of Results",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI hospitalization in first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) LRTI hospitalization in first year of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",74,1
"676",76,"Infantile asthma",1,2,1,0,0,0,1,"Britt: ""Because this was an observational study and randomization of patients to each of the study subgroups was not possible, we performed propensity score weighting to control for the confounding of the causal relationship between the subgroups and outcomes. To address this  issue, multinomial logistic regression modeling was performed to calculate a generalized propensity score, the score indicating the conditional probability of being diagnosed as RSV LRI inpatient or outpatient, UBP inpatient or outpatient, or comparison (five groups). Propensity score weighting is an expansion of the  propensity score matching technique and is appropriate when more than two groups are included in the analysis.  A propensity score weight-the inverse probability that an infant was assigned to a specific subgroup-was calculated for each infant and then normalized to reflect the sample size of the respective condition/gestational age subgroup. Propensity score weights were used to adjust the descriptive and multivariate analyses.""",0,0,0,0,0,1,0,0,"primary analysis used propensity score methods, but we used descriptive stats to calculate ESs of interest so these were unadjusted estimates  - based on Table 1, RSV-LRTI and comparison groups were well-balanced on birth weight, NICU admission, length of hospital stay, and child sex  - generalized propensity score,  the score indicating the conditional probability of being diagnosed as RSV LRI inpatient or outpatient, UBP inpatient or outpatient, or comparison (five groups).  - covariates considered in the calculation of the propensity score included pre-diagnosis factors that are likely associated with the infant's probability of having an RSV diagnosis, including gender, birth quarter, birthweight, region of residence or Medicaid state, presence of CLD or CHD, admission to the NICU during the birth hospitalization, and the cost of the birth hospitalization",0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"infants with RSV-LRTI diagnosis in medical records in the first year of life (aggregated over preterm and full-term comparisons and over inpatient and outpatient LRTIs)",0,1,0,0,0,1,1,0,0,"","infants with unspecified bronchiolitis/pneumonia (aggregated over preterm and full-term and inpatient and outpatient)",2,2,1,NA,1,1,"unadjusted based on Figure 1",2,1.37,1,0.03,24211,3178,7073,3444,10516,"~ ages 0-2",76,2
"677",76,"Infantile asthma",1,2,1,0,0,0,1,"Britt: ""Because this was an observational study and randomization of patients to each of the study subgroups was not possible, we performed propensity score weighting to control for the confounding of the causal relationship between the subgroups and outcomes. To address this  issue, multinomial logistic regression modeling was performed to calculate a generalized propensity score, the score indicating the conditional probability of being diagnosed as RSV LRI inpatient or outpatient, UBP inpatient or outpatient, or comparison (five groups). Propensity score weighting is an expansion of the  propensity score matching technique and is appropriate when more than two groups are included in the analysis.  A propensity score weight-the inverse probability that an infant was assigned to a specific subgroup-was calculated for each infant and then normalized to reflect the sample size of the respective condition/gestational age subgroup. Propensity score weights were used to adjust the descriptive and multivariate analyses.""",0,0,0,0,0,1,0,0,"primary analysis used propensity score methods, but we used descriptive stats to calculate ESs of interest so these were unadjusted estimates  - based on Table 1, RSV-LRTI and comparison groups were well-balanced on birth weight, NICU admission, length of hospital stay, and child sex  - generalized propensity score,  the score indicating the conditional probability of being diagnosed as RSV LRI inpatient or outpatient, UBP inpatient or outpatient, or comparison (five groups).  - covariates considered in the calculation of the propensity score included pre-diagnosis factors that are likely associated with the infant's probability of having an RSV diagnosis, including gender, birth quarter, birthweight, region of residence or Medicaid state, presence of CLD or CHD, admission to the NICU during the birth hospitalization, and the cost of the birth hospitalization",0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"infants with RSV-LRTI diagnosis in medical records in the first year of life (aggregated over preterm and full-term comparisons and over inpatient and outpatient LRTIs)",0,1,0,0,0,1,1,0,0,"","infants with unspecified bronchiolitis/pneumonia (aggregated over preterm and full-term and inpatient and outpatient)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",76,2
"679",76,"Infantile asthma",1,2,1,0,0,0,1,"Britt: ""Because this was an observational study and randomization of patients to each of the study subgroups was not possible, we performed propensity score weighting to control for the confounding of the causal relationship between the subgroups and outcomes. To address this  issue, multinomial logistic regression modeling was performed to calculate a generalized propensity score, the score indicating the conditional probability of being diagnosed as RSV LRI inpatient or outpatient, UBP inpatient or outpatient, or comparison (five groups). Propensity score weighting is an expansion of the  propensity score matching technique and is appropriate when more than two groups are included in the analysis.  A propensity score weight-the inverse probability that an infant was assigned to a specific subgroup-was calculated for each infant and then normalized to reflect the sample size of the respective condition/gestational age subgroup. Propensity score weights were used to adjust the descriptive and multivariate analyses.""",0,0,0,0,0,1,0,0,"primary analysis used propensity score methods, but we used descriptive stats to calculate ESs of interest so these were unadjusted estimates  - based on Table 1, RSV-LRTI and comparison groups were well-balanced on birth weight, NICU admission, length of hospital stay, and child sex  - generalized propensity score,  the score indicating the conditional probability of being diagnosed as RSV LRI inpatient or outpatient, UBP inpatient or outpatient, or comparison (five groups).  - covariates considered in the calculation of the propensity score included pre-diagnosis factors that are likely associated with the infant's probability of having an RSV diagnosis, including gender, birth quarter, birthweight, region of residence or Medicaid state, presence of CLD or CHD, admission to the NICU during the birth hospitalization, and the cost of the birth hospitalization",0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"infants with RSV-LRTI diagnosis in medical records in the first year of life (aggregated over preterm and full-term comparisons and over inpatient and outpatient LRTIs)",0,1,0,0,0,1,1,0,0,"","infants with unspecified bronchiolitis/pneumonia (aggregated over preterm and full-term and inpatient and outpatient)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",76,2
"1801",76,"Recurrent wheeze",2,3,1,0,0,0,1,"based on descriptive stats",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants with RSV-LRTI diagnosis in medical records in the first year of life (aggregated over preterm and full-term comparisons and over inpatient and outpatient LRTIs)",0,1,0,0,0,1,1,0,0,"","infants with unspecified bronchiolitis/pneumonia (aggregated over preterm and full-term and inpatient and outpatient)",2,2,1,NA,1,1,"unadjusted OR based on descriptive stats (Figure 1)",2,1.51,1,0.04,24211,1955,8296,1880,12080,"~ ages 0-2",76,2
"1802",76,"Recurrent wheeze",2,3,1,0,0,0,1,"based on descriptive stats",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants with RSV-LRTI diagnosis in medical records in the first year of life (aggregated over preterm and full-term comparisons and over inpatient and outpatient LRTIs)",0,1,0,0,0,1,1,0,0,"","infants with unspecified bronchiolitis/pneumonia (aggregated over preterm and full-term and inpatient and outpatient)",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,76,2
"1804",76,"Recurrent wheeze",2,3,1,0,0,0,1,"based on descriptive stats",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants with RSV-LRTI diagnosis in medical records in the first year of life (aggregated over preterm and full-term comparisons and over inpatient and outpatient LRTIs)",0,1,0,0,0,1,1,0,0,"","infants with unspecified bronchiolitis/pneumonia (aggregated over preterm and full-term and inpatient and outpatient)",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,76,2
"694",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"RSV only bronchiolitis requiring hospitalization in first 12 months (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",2,2,1,NA,1,1,"adjusted OR from online supplement 1",1,0.07,1,1.02,191,16,106,43,26,"~ ages 0-2",78,1
"697",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"RSV only bronchiolitis requiring hospitalization in first 12 months (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",78,1
"698",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"RSV only bronchiolitis requiring hospitalization in first 12 months (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",78,1
"696",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","bronchiolitis hospitalization caused by non-RSV and non-HRV virus (no co-infection) among kids hospitalized in first 12 months with no prior wheezing",2,2,1,NA,1,1,"adjusted odds based on online supplement table 1 (inverse of the odds ratios reported)",1,0.15,1,0.71,169,16,106,17,30,"~ ages 0-2",78,2
"701",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","bronchiolitis hospitalization caused by non-RSV and non-HRV virus (no co-infection) among kids hospitalized in first 12 months with no prior wheezing",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",78,2
"702",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","bronchiolitis hospitalization caused by non-RSV and non-HRV virus (no co-infection) among kids hospitalized in first 12 months with no prior wheezing",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",78,2
"695",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","bronchiolitis hospitalization caused by a non-viral agent among kids hospitalized in first 12 months with no prior wheezing",2,2,1,NA,1,1,"adjusted OR from supplement 1: adjusted for age at index hospitalization, sex, gestational age, atopic eczema, older siblings, parental asthma,  oral intake on admission and use systemic corticosteroids during index hospitalization.",1,0.97,1,0.97,166,16,106,16,28,"~ ages 0-2",78,3
"699",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","bronchiolitis hospitalization caused by a non-viral agent among kids hospitalized in first 12 months with no prior wheezing",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",78,3
"700",78,"use of long-term asthma controller medication (inhaled corticosteroid and/or leukotriene receptor antagonist) for recurrent wheezing, prolonged cough or asthma during the 12-month follow-up",3,1,1,0,1,1,0,"Binary logistic or Cox regression was used for multivariable analyses",0,1,0,0,0,0,0,0,"adjustments for age (<2, 2-11.9 vs. 12-23.9 months), sex (male vs. female), gestational age (<=31, 32-36 vs. >=37 weeks), atopic eczema ever (no vs. yes), presence of older siblings (no vs. yes), parental asthma (no vs. yes, if either of the parents had ever been diagnosed with asthma), oral intake on index hospital admission (adequate vs. inadequate) and use of systemic corticosteroids during index hospitalization (no vs. yes). ",1,1,1,1,1,0,0,1,0,0,0,0,1,0,0,1,0,1,1,1,1,2,NA,NA,2,NA,NA,NA,NA,2,NA,"Rhinovirus only bronchiolitis requiring hospitalization in the first year (no prior wheezing)",1,0,0,0,0,2,1,0,0,"","bronchiolitis hospitalization caused by a non-viral agent among kids hospitalized in first 12 months with no prior wheezing",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",78,3
"739",83,"Asthma (any grade): ""Asthma was ranked according to a system used in the department (8), i.e. grade 1 asthma= 1-5 obstructive periods of less than 2 weeks' duration during the last year; grade 2=6-10 obstructive periods of less than 2 weeks' duration during the last year, and occasional symptoms during the intervening intervals; and grades 3-4= > 10 obstructive periods of less than 2 weeks' duration, or repeated lengthy periods during the last year, requiring constant bronchodilator and antiinflammatory treatment.""",1,1,1,0,0,0,1,"""Factors predicting the presence of  asthma at reinvestigation were analysed using Fisher's permutation test and Fisher's exact test for dichotomous variables."" ",0,0,0,0,0,0,0,1,"none documented; ",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI in the first two years of life requiring hospitalization -- first wheezing episode",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI in the first two years of life requiring hospitalization -- first wheezing episode",2,2,1,NA,1,1,"reported that RSV was not a significant predictor of asthma but no coefficient, so I estimated the unadjusted OR by piecing together the 2x2 table (see excel sheet)",2,1.08,1,0.46,94,13,14,31,36,"approx. ages 2-6 (sx in last year when kids were 3-6 years old)",83,1
"742",83,"Asthma (any grade): ""Asthma was ranked according to a system used in the department (8), i.e. grade 1 asthma= 1-5 obstructive periods of less than 2 weeks' duration during the last year; grade 2=6-10 obstructive periods of less than 2 weeks' duration during the last year, and occasional symptoms during the intervening intervals; and grades 3-4= > 10 obstructive periods of less than 2 weeks' duration, or repeated lengthy periods during the last year, requiring constant bronchodilator and antiinflammatory treatment.""",1,1,1,0,0,0,1,"""Factors predicting the presence of  asthma at reinvestigation were analysed using Fisher's permutation test and Fisher's exact test for dichotomous variables."" ",0,0,0,0,0,0,0,1,"none documented; ",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI in the first two years of life requiring hospitalization -- first wheezing episode",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI in the first two years of life requiring hospitalization -- first wheezing episode",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",83,1
"740",83,"Asthma (any grade): ""Asthma was ranked according to a system used in the department (8), i.e. grade 1 asthma= 1-5 obstructive periods of less than 2 weeks' duration during the last year; grade 2=6-10 obstructive periods of less than 2 weeks' duration during the last year, and occasional symptoms during the intervening intervals; and grades 3-4= > 10 obstructive periods of less than 2 weeks' duration, or repeated lengthy periods during the last year, requiring constant bronchodilator and antiinflammatory treatment.""",1,1,1,0,0,0,1,"""Factors predicting the presence of  asthma at reinvestigation were analysed using Fisher's permutation test and Fisher's exact test for dichotomous variables."" ",0,0,0,0,0,0,0,1,"none documented; ",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI in the first two years of life requiring hospitalization -- first wheezing episode",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI in the first two years of life requiring hospitalization -- first wheezing episode",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",83,1
"748",84,"Asthma: ' Asthma was classified as mild, moderate or severe, as  estimated by the frequency of symptoms and the need for  treatment to remain symptom-free, according to a modification of the International Paediatric Asthma Consensus (6). Mild asthma was defined as mild and infrequent asthma symptoms, symptom control with a &-agonist p.r.n alone and need of a P2-agonist not exceeding 3 doseslweek. The children with moderate asthma had more frequent asthma  symptoms and required more than 3 dosesJweek of a P2-  agonist. These children were symptom-free when they received maintenance treatment with sodium cromoglycate or inhaled steroids at doses of 200-400 hg/day. With such maintenance treatment they had little need of extra P2-agonists (not exceeding 3 dosedweek). Children with severe asthma had acute exacerbations in spite of treatment with low to moderate doses of inhaled steroids. They needed high doses of inhaled steroids or inhaled steroids in combination with a long-acting inhaled P2-agonist to be symptom-free""",1,1,1,0,0,0,1,"""Factors predicting the presence of asthma at reinvestigation were analysed using Pitman's non-parametric permutation test """,0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI with wheezing severe enough to warrant hospitalization in first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI with wheezing severe enough to warrant hospitalization in first 2 years of life",2,2,1,NA,1,1," - report NS effect without providing estimate using Pitman's permutation test; effect size based on recreation of 2x2 table using data provided in Table 1 and results (see excel sheet)",2,0.92,1,0.52,92,7,17,21,47,"approx. ages 9-10 (symptoms in last year at age 10)",84,1
"749",84,"Asthma: ' Asthma was classified as mild, moderate or severe, as  estimated by the frequency of symptoms and the need for  treatment to remain symptom-free, according to a modification of the International Paediatric Asthma Consensus (6). Mild asthma was defined as mild and infrequent asthma symptoms, symptom control with a &-agonist p.r.n alone and need of a P2-agonist not exceeding 3 doseslweek. The children with moderate asthma had more frequent asthma  symptoms and required more than 3 dosesJweek of a P2-  agonist. These children were symptom-free when they received maintenance treatment with sodium cromoglycate or inhaled steroids at doses of 200-400 hg/day. With such maintenance treatment they had little need of extra P2-agonists (not exceeding 3 dosedweek). Children with severe asthma had acute exacerbations in spite of treatment with low to moderate doses of inhaled steroids. They needed high doses of inhaled steroids or inhaled steroids in combination with a long-acting inhaled P2-agonist to be symptom-free""",1,1,1,0,0,0,1,"""Factors predicting the presence of asthma at reinvestigation were analysed using Pitman's non-parametric permutation test """,0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI with wheezing severe enough to warrant hospitalization in first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI with wheezing severe enough to warrant hospitalization in first 2 years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",84,1
"755",84,"Asthma: ' Asthma was classified as mild, moderate or severe, as  estimated by the frequency of symptoms and the need for  treatment to remain symptom-free, according to a modification of the International Paediatric Asthma Consensus (6). Mild asthma was defined as mild and infrequent asthma symptoms, symptom control with a &-agonist p.r.n alone and need of a P2-agonist not exceeding 3 doseslweek. The children with moderate asthma had more frequent asthma  symptoms and required more than 3 dosesJweek of a P2-  agonist. These children were symptom-free when they received maintenance treatment with sodium cromoglycate or inhaled steroids at doses of 200-400 hg/day. With such maintenance treatment they had little need of extra P2-agonists (not exceeding 3 dosedweek). Children with severe asthma had acute exacerbations in spite of treatment with low to moderate doses of inhaled steroids. They needed high doses of inhaled steroids or inhaled steroids in combination with a long-acting inhaled P2-agonist to be symptom-free""",1,1,1,0,0,0,1,"""Factors predicting the presence of asthma at reinvestigation were analysed using Pitman's non-parametric permutation test """,0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI with wheezing severe enough to warrant hospitalization in first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI with wheezing severe enough to warrant hospitalization in first 2 years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",84,1
"763",85,"Asthma: ""Current asthma was defined as wheezing or asthma and/or the need for antiasthmatic treatment (2agonists or inhaled corticosteroids) during the preceding 12 months. Asthma was classified as mild, moderate or severe, according to the classification system of the Swedish Society of Paediatric Allergology""",1,1,1,1,0,0,1,"""chisquare test, independent samples ttest and binary logistic regression. Unavailable data were coded as missing""",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life ",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization in the first two years of life ",2,2,1,NA,1,1,"unadjusted OR based on descriptive stats in Table 1",2,1.35,1,0.47,89,12,13,26,38,"ages 16-20 (past year symptoms assessed at ages 17-20)",85,1
"764",85,"Asthma: ""Current asthma was defined as wheezing or asthma and/or the need for antiasthmatic treatment (2agonists or inhaled corticosteroids) during the preceding 12 months. Asthma was classified as mild, moderate or severe, according to the classification system of the Swedish Society of Paediatric Allergology""",1,1,1,1,0,0,1,"""chisquare test, independent samples ttest and binary logistic regression. Unavailable data were coded as missing""",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life ",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization in the first two years of life ",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",85,1
"765",85,"Asthma: ""Current asthma was defined as wheezing or asthma and/or the need for antiasthmatic treatment (2agonists or inhaled corticosteroids) during the preceding 12 months. Asthma was classified as mild, moderate or severe, according to the classification system of the Swedish Society of Paediatric Allergology""",1,1,1,1,0,0,1,"""chisquare test, independent samples ttest and binary logistic regression. Unavailable data were coded as missing""",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) LRTI requiring hospitalization in the first two years of life ",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization in the first two years of life ",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",85,1
"770",86,"Time to recurrent wheezing: ""time to recurrent wheezing-that is, time to the third physician-confirmed episode of wheezing within 12 months of the first episode at study entry""",2,1,1,0,0,1,0,"""Cox proportional hazards regression to identify any risk factors of prognostic significance. In this study, the Cox hazard ratio (HR) indicated the probability of recurrent wheezing. First, we analyzed in separate models the interactions between treatment grouping and each risk factor. Then, we used stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05. """,0,1,0,0,0,0,0,0,"'stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05""",1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) LRTI induced wheezing requiring hospitalization in the placebo condition of the RCT  (no Prednisolone Tx)",1,0,0,0,0,2,0,0,1,"3-35 months","RSV(-) LRTI induced wheezing requiring hospitalization in the placebo condition of the RCT  (no Prednisolone Tx)",2,2,1,NA,1,4,"hazard ratio based on Cox multivariable regression model (Table 2)",1,5.05,1,0.83,NA,NA,NA,NA,NA,"~ ages 3mos to 47 months; exposure: 3-35 months and followed for 1 year",86,1
"771",86,"Time to recurrent wheezing: ""time to recurrent wheezing-that is, time to the third physician-confirmed episode of wheezing within 12 months of the first episode at study entry""",2,1,1,0,0,1,0,"""Cox proportional hazards regression to identify any risk factors of prognostic significance. In this study, the Cox hazard ratio (HR) indicated the probability of recurrent wheezing. First, we analyzed in separate models the interactions between treatment grouping and each risk factor. Then, we used stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05. """,0,1,0,0,0,0,0,0,"'stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05""",1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) LRTI induced wheezing requiring hospitalization in the placebo condition of the RCT  (no Prednisolone Tx)",1,0,0,0,0,2,0,0,1,"3-35 months","RSV(-) LRTI induced wheezing requiring hospitalization in the placebo condition of the RCT  (no Prednisolone Tx)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",86,1
"772",86,"Time to recurrent wheezing: ""time to recurrent wheezing-that is, time to the third physician-confirmed episode of wheezing within 12 months of the first episode at study entry""",2,1,1,0,0,1,0,"""Cox proportional hazards regression to identify any risk factors of prognostic significance. In this study, the Cox hazard ratio (HR) indicated the probability of recurrent wheezing. First, we analyzed in separate models the interactions between treatment grouping and each risk factor. Then, we used stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05. """,0,1,0,0,0,0,0,0,"'stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05""",1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) LRTI induced wheezing requiring hospitalization in the placebo condition of the RCT  (no Prednisolone Tx)",1,0,0,0,0,2,0,0,1,"3-35 months","RSV(-) LRTI induced wheezing requiring hospitalization in the placebo condition of the RCT  (no Prednisolone Tx)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",86,1
"774",86,"Time to recurrent wheezing: ""time to recurrent wheezing-that is, time to the third physician-confirmed episode of wheezing within 12 months of the first episode at study entry""",2,1,1,0,0,1,0,"""Cox proportional hazards regression to identify any risk factors of prognostic significance. In this study, the Cox hazard ratio (HR) indicated the probability of recurrent wheezing. First, we analyzed in separate models the interactions between treatment grouping and each risk factor. Then, we used stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05. """,0,1,0,0,0,0,0,0,"'stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05""",1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) LRTI induced wheezing requiring hospitalization in the Prednisolone treatment condition of the RCT",1,0,0,0,0,2,0,0,1,"3-35 months","RSV(-) LRTI induced wheezing requiring hospitalization in the Prednisolone treatment condition of the RCT",2,2,1,NA,1,4,"Cox multivariable regression model",1,0.93,1,0.67,NA,NA,NA,NA,NA,"~ ages 3mos to 47 months; exposure: 3-35 months and followed for 1 year",86,2
"769",86,"Time to recurrent wheezing: ""time to recurrent wheezing-that is, time to the third physician-confirmed episode of wheezing within 12 months of the first episode at study entry""",2,1,1,0,0,1,0,"""Cox proportional hazards regression to identify any risk factors of prognostic significance. In this study, the Cox hazard ratio (HR) indicated the probability of recurrent wheezing. First, we analyzed in separate models the interactions between treatment grouping and each risk factor. Then, we used stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05. """,0,1,0,0,0,0,0,0,"'stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05""",1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) LRTI induced wheezing requiring hospitalization in the Prednisolone treatment condition of the RCT",1,0,0,0,0,2,0,0,1,"3-35 months","RSV(-) LRTI induced wheezing requiring hospitalization in the Prednisolone treatment condition of the RCT",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",86,2
"773",86,"Time to recurrent wheezing: ""time to recurrent wheezing-that is, time to the third physician-confirmed episode of wheezing within 12 months of the first episode at study entry""",2,1,1,0,0,1,0,"""Cox proportional hazards regression to identify any risk factors of prognostic significance. In this study, the Cox hazard ratio (HR) indicated the probability of recurrent wheezing. First, we analyzed in separate models the interactions between treatment grouping and each risk factor. Then, we used stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05. """,0,1,0,0,0,0,0,0,"'stepwise multivariable model to identify independent risk factors for recurrent wheezing. We included all risk factors, and those interaction terms were included that showed a potential effect on outcome. We used a backward stepwise procedure in which we eliminated factors or interaction terms one by one according to the highest P value >.05""",1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) LRTI induced wheezing requiring hospitalization in the Prednisolone treatment condition of the RCT",1,0,0,0,0,2,0,0,1,"3-35 months","RSV(-) LRTI induced wheezing requiring hospitalization in the Prednisolone treatment condition of the RCT",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",86,2
"777",87,"Current asthma (atopic or non-atopic) at age 8 years  - ""Children were given a diagnosis of current asthma at age 8 years if they met 1 or more of the subsequent criteria during the preceding 12 months: reports from patient charts of doctor-diagnosed asthma and need for regular use of doctor-prescribed asthma therapy with ICSs for more than a month, use of OCSs for asthma exacerbations, acute asthma attack relieved by repeated use of bronchodilator, and/or hyperreactivity in spirometry defined as reversible airflow obstruction with an increase of 12% or greater in FEV1 in the bronchodilatation test or a decrease of 15% or greater in the exercise challenge test.""  - ""Current atopic asthma at age 8 years was defined as asthma with laboratory-verified sensitization (95% [18/19]) or patient chart- and parent-reported allergy symptoms """,1,1,1,0,1,0,0,"univariable and multivariable logistic regression",0,0,0,0,0,0,0,1,"adjusted for potential confounders in multivariable regression, but the effect of RSV group was only evaluated in unadjusted analyses.  - ""Multivariable analyses were adjusted with age 3 to 11 months, eczema, any sensitization, parental smoking, and rhinovirus positivity or negativity""",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) and HRV(-) wheezing episode requiring emergency care and/or hospitalization in chidlren 3-23 months -- ""RSV alone or with other viruses, rhinovirus excluded""",1,0,0,0,0,2,0,1,0,"","children with severe wheezing episodes ages 3-23 months without RSV infection",2,2,1,NA,1,1,"adjusted OR based on multivariable logistic regression (Table 3)",1,0.31,1,0.53,127,NA,NA,NA,NA,"approximately ages 7-8",87,1
"1902",87,"Atopic asthma at age 7-8: ""Current atopic asthma at age 8 years was defined as asthma with laboratory-verified sensitization (95% [18/19]) or patient chart- and parent-reported allergy symptoms """,1,2,1,0,1,0,0,"used multivariable regression but effect of RSV only evaluated in unadjusted model",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) and HRV(-) children ages 3-23 months with first severe wheezing episodes and had RSV alone or with other viruses, rhinovirus excluded",1,0,0,0,0,2,0,1,0,"","RSV(-) children ages 3-23 months with first severe wheezing episodes ",2,2,1,NA,1,1,"unadjusted based on Table 3",1,0.27,1,0.76,127,NA,NA,NA,NA,"approx. ages 7-8",87,1
"3027",87,"Non-atopic asthma at age 7-8:",1,2,1,0,1,0,0,"unadjusted logistic regression",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV alone or with other viruses, rhinovirus excluded, causing severe wheezing at ages 3-23 months",1,0,0,0,0,2,0,1,0,"","RSV(-) illness causing severe wheezing at ages 3-23 months",2,2,1,NA,1,1,"unadjusted OR based on logistic regression",1,0.48,1,0.66,127,NA,NA,NA,NA,"approx. ages 7-8",87,1
"778",87,"Current asthma (atopic or non-atopic) at age 8 years  - ""Children were given a diagnosis of current asthma at age 8 years if they met 1 or more of the subsequent criteria during the preceding 12 months: reports from patient charts of doctor-diagnosed asthma and need for regular use of doctor-prescribed asthma therapy with ICSs for more than a month, use of OCSs for asthma exacerbations, acute asthma attack relieved by repeated use of bronchodilator, and/or hyperreactivity in spirometry defined as reversible airflow obstruction with an increase of 12% or greater in FEV1 in the bronchodilatation test or a decrease of 15% or greater in the exercise challenge test.""  - ""Current atopic asthma at age 8 years was defined as asthma with laboratory-verified sensitization (95% [18/19]) or patient chart- and parent-reported allergy symptoms """,1,1,1,0,1,0,0,"univariable and multivariable logistic regression",0,0,0,0,0,0,0,1,"adjusted for potential confounders in multivariable regression, but the effect of RSV group was only evaluated in unadjusted analyses.  - ""Multivariable analyses were adjusted with age 3 to 11 months, eczema, any sensitization, parental smoking, and rhinovirus positivity or negativity""",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) and HRV(-) wheezing episode requiring emergency care and/or hospitalization in chidlren 3-23 months -- ""RSV alone or with other viruses, rhinovirus excluded""",1,0,0,0,0,2,0,1,0,"","children with severe wheezing episodes ages 3-23 months without RSV infection",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",87,1
"1903",87,"Atopic asthma at age 7-8: ""Current atopic asthma at age 8 years was defined as asthma with laboratory-verified sensitization (95% [18/19]) or patient chart- and parent-reported allergy symptoms """,1,2,1,0,1,0,0,"used multivariable regression but effect of RSV only evaluated in unadjusted model",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) and HRV(-) children ages 3-23 months with first severe wheezing episodes and had RSV alone or with other viruses, rhinovirus excluded",1,0,0,0,0,2,0,1,0,"","RSV(-) children ages 3-23 months with first severe wheezing episodes ",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",87,1
"3028",87,"Non-atopic asthma at age 7-8:",1,2,1,0,1,0,0,"unadjusted logistic regression",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV alone or with other viruses, rhinovirus excluded, causing severe wheezing at ages 3-23 months",1,0,0,0,0,2,0,1,0,"","RSV(-) illness causing severe wheezing at ages 3-23 months",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",87,1
"776",87,"Current asthma (atopic or non-atopic) at age 8 years  - ""Children were given a diagnosis of current asthma at age 8 years if they met 1 or more of the subsequent criteria during the preceding 12 months: reports from patient charts of doctor-diagnosed asthma and need for regular use of doctor-prescribed asthma therapy with ICSs for more than a month, use of OCSs for asthma exacerbations, acute asthma attack relieved by repeated use of bronchodilator, and/or hyperreactivity in spirometry defined as reversible airflow obstruction with an increase of 12% or greater in FEV1 in the bronchodilatation test or a decrease of 15% or greater in the exercise challenge test.""  - ""Current atopic asthma at age 8 years was defined as asthma with laboratory-verified sensitization (95% [18/19]) or patient chart- and parent-reported allergy symptoms """,1,1,1,0,1,0,0,"univariable and multivariable logistic regression",0,0,0,0,0,0,0,1,"adjusted for potential confounders in multivariable regression, but the effect of RSV group was only evaluated in unadjusted analyses.  - ""Multivariable analyses were adjusted with age 3 to 11 months, eczema, any sensitization, parental smoking, and rhinovirus positivity or negativity""",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) and HRV(-) wheezing episode requiring emergency care and/or hospitalization in chidlren 3-23 months -- ""RSV alone or with other viruses, rhinovirus excluded""",1,0,0,0,0,2,0,1,0,"","children with severe wheezing episodes ages 3-23 months without RSV infection",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",87,1
"1901",87,"Atopic asthma at age 7-8: ""Current atopic asthma at age 8 years was defined as asthma with laboratory-verified sensitization (95% [18/19]) or patient chart- and parent-reported allergy symptoms """,1,2,1,0,1,0,0,"used multivariable regression but effect of RSV only evaluated in unadjusted model",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) and HRV(-) children ages 3-23 months with first severe wheezing episodes and had RSV alone or with other viruses, rhinovirus excluded",1,0,0,0,0,2,0,1,0,"","RSV(-) children ages 3-23 months with first severe wheezing episodes ",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",87,1
"3026",87,"Non-atopic asthma at age 7-8:",1,2,1,0,1,0,0,"unadjusted logistic regression",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV alone or with other viruses, rhinovirus excluded, causing severe wheezing at ages 3-23 months",1,0,0,0,0,2,0,1,0,"","RSV(-) illness causing severe wheezing at ages 3-23 months",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,87,1
"793",89,"Current asthma  - ""a combination of a history of 'asthma ever' and a positive answer to at least one of the two questions on wheezing/whistling/chest tightness during the preceding 12months or use of asthma medication during the preceding 12months""",1,1,1,0,1,0,0,"""or subjects with a history of bronchiolitis, logistic regression models were constructed to assess a set of potential risk factors for current asthma and atopy. Each variable was entered separately into univariate models, and odds ratios (OR) with 95% CI were calculated. Explanatory factors with pvalues<0.1 in univariate analysis were further analysed in a multiple regression model. pvalue of <0.05 was regarded as statistically significant.""",0,0,0,0,0,0,0,1,"control group age-matched, but doesn't appear as though they were fully matched in the RSV+ group compared to either RSV- or controls  - did multivariable logistic regression but didn't report findings",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"All children with RSV(+) hospitalized for bronchiolitis during first year of life",1,0,0,0,0,2,1,0,0,"","All children with RSV(-) hospitalized for bronchiolitis during first year of life",2,2,1,NA,1,1,"unadjusted OR because adjusted estimate (not significant) was not reported",2,0.33,1,0.47,121,14,76,11,20,"past year asthma: ages 10-13",89,2
"794",89,"Current asthma  - ""a combination of a history of 'asthma ever' and a positive answer to at least one of the two questions on wheezing/whistling/chest tightness during the preceding 12months or use of asthma medication during the preceding 12months""",1,1,1,0,1,0,0,"""or subjects with a history of bronchiolitis, logistic regression models were constructed to assess a set of potential risk factors for current asthma and atopy. Each variable was entered separately into univariate models, and odds ratios (OR) with 95% CI were calculated. Explanatory factors with pvalues<0.1 in univariate analysis were further analysed in a multiple regression model. pvalue of <0.05 was regarded as statistically significant.""",0,0,0,0,0,0,0,1,"control group age-matched, but doesn't appear as though they were fully matched in the RSV+ group compared to either RSV- or controls  - did multivariable logistic regression but didn't report findings",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"All children with RSV(+) hospitalized for bronchiolitis during first year of life",1,0,0,0,0,2,1,0,0,"","All children with RSV(-) hospitalized for bronchiolitis during first year of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",89,2
"795",89,"Current asthma  - ""a combination of a history of 'asthma ever' and a positive answer to at least one of the two questions on wheezing/whistling/chest tightness during the preceding 12months or use of asthma medication during the preceding 12months""",1,1,1,0,1,0,0,"""or subjects with a history of bronchiolitis, logistic regression models were constructed to assess a set of potential risk factors for current asthma and atopy. Each variable was entered separately into univariate models, and odds ratios (OR) with 95% CI were calculated. Explanatory factors with pvalues<0.1 in univariate analysis were further analysed in a multiple regression model. pvalue of <0.05 was regarded as statistically significant.""",0,0,0,0,0,0,0,1,"control group age-matched, but doesn't appear as though they were fully matched in the RSV+ group compared to either RSV- or controls  - did multivariable logistic regression but didn't report findings",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"All children with RSV(+) hospitalized for bronchiolitis during first year of life",1,0,0,0,0,2,1,0,0,"","All children with RSV(-) hospitalized for bronchiolitis during first year of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",89,2
"859",96,"Current doctordiagnosed asthma  - "" either asthma diagnosed by a doctor during the preceding 24 months, or the use of maintenance medication for asthma during the preceding 12 months""",1,1,1,0,1,0,0,"logistic regression adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",1,1,0,0,0,0,0,0,"controls were sex and birth month matched  - adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,NA,NA,NA,2,NA,NA,NA,1,NA,NA,NA,NA,2,"RSV(+) bronchiolitis (no co-infections) requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first 2 years of life",2,2,1,NA,1,1,"unadjusted OR based on descriptive stats from Table 4; adjusted OR was not significant but data not shown",2,0.67,1,0.66,61,4,12,15,30,"ages 14-18",96,2
"1984",96,"Selfreported asthma  - ""either a weekly use of ondemand bronchodilating drugs, or asthma diagnosed by a doctor previously and the presence of wheezing symptoms, prolonged cough in the absence of infection or repeated night cough during the preceding 12 months""",1,1,1,0,1,0,0,"logistic regression adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis (no co-infections) requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","SV(-) bronchiolitis requiring hospitalization in the first 2 years of life",2,2,1,NA,1,1,"unadjusted OR based on Table 4",2,0.36,1,0.6,61,8,8,33,12,"ages 14-18",96,2
"863",96,"Current doctordiagnosed asthma  - "" either asthma diagnosed by a doctor during the preceding 24 months, or the use of maintenance medication for asthma during the preceding 12 months""",1,1,1,0,1,0,0,"logistic regression adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",1,1,0,0,0,0,0,0,"controls were sex and birth month matched  - adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,NA,NA,NA,2,NA,NA,NA,1,NA,NA,NA,NA,2,"RSV(+) bronchiolitis (no co-infections) requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first 2 years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",96,2
"1988",96,"Selfreported asthma  - ""either a weekly use of ondemand bronchodilating drugs, or asthma diagnosed by a doctor previously and the presence of wheezing symptoms, prolonged cough in the absence of infection or repeated night cough during the preceding 12 months""",1,1,1,0,1,0,0,"logistic regression adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis (no co-infections) requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","SV(-) bronchiolitis requiring hospitalization in the first 2 years of life",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,96,2
"861",96,"Current doctordiagnosed asthma  - "" either asthma diagnosed by a doctor during the preceding 24 months, or the use of maintenance medication for asthma during the preceding 12 months""",1,1,1,0,1,0,0,"logistic regression adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",1,1,0,0,0,0,0,0,"controls were sex and birth month matched  - adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,NA,NA,NA,2,NA,NA,NA,1,NA,NA,NA,NA,2,"RSV(+) bronchiolitis (no co-infections) requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first 2 years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",96,2
"1986",96,"Selfreported asthma  - ""either a weekly use of ondemand bronchodilating drugs, or asthma diagnosed by a doctor previously and the presence of wheezing symptoms, prolonged cough in the absence of infection or repeated night cough during the preceding 12 months""",1,1,1,0,1,0,0,"logistic regression adjusted for age, sex, smoking, allergic rhinitis, asthma in parents, and asthma in siblings",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis (no co-infections) requiring hospitalization in the first 2 years of life",1,0,0,0,0,2,0,1,0,"","SV(-) bronchiolitis requiring hospitalization in the first 2 years of life",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,96,2
"869",97,"Asthma  - ""the child (1) had ongoing continuous maintenance medication for asthma at the study visit or (2) had had asthma-suggestive symptoms (repeated parent-reported episodes of wheezing [2 episodes] and/or prolonged cough [4 weeks] apart from infection during the preceding 12 months), and the exercise challenge test was positive""  - 'medical records of our university hospital were available, and the cards of regional hospitals and public health care centers were checked in case the child had been treated in one of them""",1,1,1,0,1,0,0,"Logistic regression analysis was used to calculate the adjusted ORs and related 95% CIs",0,1,0,0,0,0,0,0,"",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV(+) LRTI requiring hospitalization at ages 1-23 months",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization at ages 1-23 months",2,2,1,NA,1,1,"adjusted OR based on logistic regression adjusting for child sex and age",1,0.23,1,0.7,82,NA,NA,NA,NA,"ages 5-6",97,1
"866",97,"Asthma  - ""the child (1) had ongoing continuous maintenance medication for asthma at the study visit or (2) had had asthma-suggestive symptoms (repeated parent-reported episodes of wheezing [2 episodes] and/or prolonged cough [4 weeks] apart from infection during the preceding 12 months), and the exercise challenge test was positive""  - 'medical records of our university hospital were available, and the cards of regional hospitals and public health care centers were checked in case the child had been treated in one of them""",1,1,1,0,1,0,0,"Logistic regression analysis was used to calculate the adjusted ORs and related 95% CIs",0,1,0,0,0,0,0,0,"",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV(+) LRTI requiring hospitalization at ages 1-23 months",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization at ages 1-23 months",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",97,1
"865",97,"Asthma  - ""the child (1) had ongoing continuous maintenance medication for asthma at the study visit or (2) had had asthma-suggestive symptoms (repeated parent-reported episodes of wheezing [2 episodes] and/or prolonged cough [4 weeks] apart from infection during the preceding 12 months), and the exercise challenge test was positive""  - 'medical records of our university hospital were available, and the cards of regional hospitals and public health care centers were checked in case the child had been treated in one of them""",1,1,1,0,1,0,0,"Logistic regression analysis was used to calculate the adjusted ORs and related 95% CIs",0,1,0,0,0,0,0,0,"",0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"RSV(+) LRTI requiring hospitalization at ages 1-23 months",1,0,0,0,0,2,0,1,0,"","RSV(-) LRTI requiring hospitalization at ages 1-23 months",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",97,1
"963",107,"Subsequent wheeze",2,3,1,0,0,0,1,"based on descriptive stats in results section",0,0,0,0,0,0,0,1,"had a matched control group but not clear whether the RSV(+) and RSV(-) groups were equivalent on confounders or not",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) hospitalization in the first year of life",2,2,1,NA,1,2,"unadjusted and based on text from the results: ""In the index group, 39*5% of those who had been RSV positive reported subsequent wheezing, compared with 36-8% of those who were RSV negative""  - I could not get the numbers to add up in a 2x2 table, but I did my best based on the fact that 42/62 with viral results were RSV(+) and thus 20/62 were RSV(-); 39.5% of RSV(+) had subsequent wheeze whereas 36.8% among those who were RSV(-)  - I competed the risk ratio based on the percentages provided and I approximated the SE based on my approximate recreation of the 2x2 table",2,1.07,1,0.56,62,17,25,7,13,"exposure (ages 0-1) to age 5.5",107,1
"960",107,"Subsequent wheeze",2,3,1,0,0,0,1,"based on descriptive stats in results section",0,0,0,0,0,0,0,1,"had a matched control group but not clear whether the RSV(+) and RSV(-) groups were equivalent on confounders or not",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) hospitalization in the first year of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",107,1
"961",107,"Subsequent wheeze",2,3,1,0,0,0,1,"based on descriptive stats in results section",0,0,0,0,0,0,0,1,"had a matched control group but not clear whether the RSV(+) and RSV(-) groups were equivalent on confounders or not",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) hospitalization in the first year of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",107,1
"978",109,"Pneumonia with wheeze",2,2,1,0,1,0,0,"""A multivariable Poisson regression model was developed by using a forward stepwise procedure, rejecting variables with a p value >0.05 in likelihood ratio tests. Risk factors were introduced in descending order of strength of association determined from the univariate analysis. We used a robust variance estimator (Huber-White sandwich estimator) to account for within-person correlation of outcomes. We also performed time-to-event analysis with multiple-failure per person and single failure per person (censoring at first readmission with pneumonia), treating death as a competing risk.""    ""Incidence rates were calculated as the number of outcome events among cohort members divided by the sum of child-years at risk within the cohort.""",0,1,0,0,0,0,0,0,"multivariable Poisson regression adjusting for covariates; adjusted for age at exposure (>3 months  or not), age at outcome ascertainment (0-11, 12-23-24-36-48-59 months). admission for non-LRTI, quality of access to hospital",0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,1,"infants hospitalized in the first year of life with LRTI who were RSV+ on the basis of RSV immuno-fluorescence antibody test results.",1,0,0,0,0,2,1,0,0,"","infants hospitalized in the first year of life with LRTI who were CONFIRMED non-RSV- on the basis of RSV immuno-fluorescence antibody test results. (we only considered the effect size in which kids not tested for RSV were excluded)",2,2,1,NA,1,10,"Adjusted incidence rate ratio based on poisson regression",1,1.32,1,0.27,2472,NA,NA,NA,NA,"exposure (0-12 months) through age 5",109,2
"979",109,"Pneumonia with wheeze",2,2,1,0,1,0,0,"""A multivariable Poisson regression model was developed by using a forward stepwise procedure, rejecting variables with a p value >0.05 in likelihood ratio tests. Risk factors were introduced in descending order of strength of association determined from the univariate analysis. We used a robust variance estimator (Huber-White sandwich estimator) to account for within-person correlation of outcomes. We also performed time-to-event analysis with multiple-failure per person and single failure per person (censoring at first readmission with pneumonia), treating death as a competing risk.""    ""Incidence rates were calculated as the number of outcome events among cohort members divided by the sum of child-years at risk within the cohort.""",0,1,0,0,0,0,0,0,"multivariable Poisson regression adjusting for covariates; adjusted for age at exposure (>3 months  or not), age at outcome ascertainment (0-11, 12-23-24-36-48-59 months). admission for non-LRTI, quality of access to hospital",0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,1,"infants hospitalized in the first year of life with LRTI who were RSV+ on the basis of RSV immuno-fluorescence antibody test results.",1,0,0,0,0,2,1,0,0,"","infants hospitalized in the first year of life with LRTI who were CONFIRMED non-RSV- on the basis of RSV immuno-fluorescence antibody test results. (we only considered the effect size in which kids not tested for RSV were excluded)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",109,2
"980",109,"Pneumonia with wheeze",2,2,1,0,1,0,0,"""A multivariable Poisson regression model was developed by using a forward stepwise procedure, rejecting variables with a p value >0.05 in likelihood ratio tests. Risk factors were introduced in descending order of strength of association determined from the univariate analysis. We used a robust variance estimator (Huber-White sandwich estimator) to account for within-person correlation of outcomes. We also performed time-to-event analysis with multiple-failure per person and single failure per person (censoring at first readmission with pneumonia), treating death as a competing risk.""    ""Incidence rates were calculated as the number of outcome events among cohort members divided by the sum of child-years at risk within the cohort.""",0,1,0,0,0,0,0,0,"multivariable Poisson regression adjusting for covariates; adjusted for age at exposure (>3 months  or not), age at outcome ascertainment (0-11, 12-23-24-36-48-59 months). admission for non-LRTI, quality of access to hospital",0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,1,0,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,1,"infants hospitalized in the first year of life with LRTI who were RSV+ on the basis of RSV immuno-fluorescence antibody test results.",1,0,0,0,0,2,1,0,0,"","infants hospitalized in the first year of life with LRTI who were CONFIRMED non-RSV- on the basis of RSV immuno-fluorescence antibody test results. (we only considered the effect size in which kids not tested for RSV were excluded)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",109,2
"991",111,"Current physician-diagnosed asthma",1,1,1,0,1,0,0,"multivariable logistic",0,1,0,0,0,0,0,0,"adjusted for gender, age on admission and current smoking and current atopy",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,1,1,"adjusted OR based on Table 3 and inverted so that RSV(-) is the reference group",1,0.12,1,1,44,4,18,9,13,"ages 17-20, median = 19 years old",111,1
"2116",111,"Previous asthma and current wheezing or prolonged cough",1,2,1,0,1,0,0,"multivariable logistic",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,1,1,"adjusted OR (inverted) based on Table 3",1,0.13,1,0.99,44,6,16,11,11,"ages 17-20, median = 19 years old",111,1
"999",111,"Current physician-diagnosed asthma",1,1,1,0,1,0,0,"multivariable logistic",0,1,0,0,0,0,0,0,"adjusted for gender, age on admission and current smoking and current atopy",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",111,1
"2124",111,"Previous asthma and current wheezing or prolonged cough",1,2,1,0,1,0,0,"multivariable logistic",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",111,1
"996",111,"Current physician-diagnosed asthma",1,1,1,0,1,0,0,"multivariable logistic",0,1,0,0,0,0,0,0,"adjusted for gender, age on admission and current smoking and current atopy",0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",111,1
"2121",111,"Previous asthma and current wheezing or prolonged cough",1,2,1,0,1,0,0,"multivariable logistic",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) bronchiolitis requiring hospitalization in the first two years of life",1,0,0,0,0,2,0,1,0,"","RSV(-) bronchiolitis requiring hospitalization in the first two years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",111,1
"1005",112,"Persistent wheezing:    ""considered to have persistent wheezing if they had experienced at least three wheezing episodes including the first hospitalization, with at least one of the episodes during the last 6 months which was during the winter season""",2,1,1,0,1,0,0,"unadjusted logistic regression",0,0,0,0,0,0,0,1,"no attempt -- unadjusted analysis; matched on age with control group but that is not relevant to this comparison",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing illness requiring hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) wheezing illness requiring hospitalization in the first year of life",2,2,1,NA,1,1,"unadjusted OR inverted to make RSV(-) the reference group.",1,0.18,1,0.44,103,NA,NA,NA,NA,"exposure (ages 0-12 months) to 22-31 months",112,1
"1006",112,"Persistent wheezing:    ""considered to have persistent wheezing if they had experienced at least three wheezing episodes including the first hospitalization, with at least one of the episodes during the last 6 months which was during the winter season""",2,1,1,0,1,0,0,"unadjusted logistic regression",0,0,0,0,0,0,0,1,"no attempt -- unadjusted analysis; matched on age with control group but that is not relevant to this comparison",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing illness requiring hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) wheezing illness requiring hospitalization in the first year of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",112,1
"1007",112,"Persistent wheezing:    ""considered to have persistent wheezing if they had experienced at least three wheezing episodes including the first hospitalization, with at least one of the episodes during the last 6 months which was during the winter season""",2,1,1,0,1,0,0,"unadjusted logistic regression",0,0,0,0,0,0,0,1,"no attempt -- unadjusted analysis; matched on age with control group but that is not relevant to this comparison",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV(+) wheezing illness requiring hospitalization in the first year of life",1,0,0,0,0,2,1,0,0,"","RSV(-) wheezing illness requiring hospitalization in the first year of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",112,1
"1016",113,"Asthma symptoms were recorded by a questionnaire based on the International Study of Asthma and Allergies in Childhood. Asthma ever was defined as a positive answer to have you ever been diagnosed with asthma by a  doctor?",1,1,1,0,1,0,0,"Mixed effects logistic regression was used to assess the association between bronchiolitis in infancy and  later-life asthma diagnosis. Potential correlations between matched individuals were allowed by including a random intercept term in the models. All effect estimates were adjusted for age and potential confounders. The RSV group and non-RSV group were directly compared (i.e., authors compared prevalences).",0,1,0,0,0,0,0,0,"The authors adjusted for sex, age, birth weight, gestational age at birth, household smoking ever, atopic dermatitis, and family history of atopy (see Table 2 footnote). Table 1 implies that age was at outcome ascertainment.",1,0,1,1,1,0,0,0,1,0,0,0,0,1,0,0,0,1,NA,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"Bronchiolitis was defined as an acute viral respiratory tract infection during the first year of life with fever, tachypnoea, dyspnoea, prolonged expiration and wheeze on auscultation. During hospitalisation for bronchiolitis, nasopharyngeal mucus was examined for RSV by direct immunofluorescence (BioMrieux, Marcy-l'toile,  France). Other viruses were not systematically tested for. Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",1,0,0,0,0,2,1,0,0,"","Other viruses were not systematically tested for.  Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",2,2,1,NA,1,1,"Asthma ever:   OR 0.74 (95% CI 0.40-1.39)  aOR 0.86 (95% CI 0.42-1.77)",1,0.86,1,0.37,162,NA,NA,NA,NA,"ever asthma diagnosis (0-20 years)",113,1
"2141",113," Current asthma was defined as asthma ever and a positive answer to at least one of the two questions: (1) Have you during the last 12 months had heavy breathing or wheezing/chest-tightness (2) Have you during the last 12 months used any asthma medications (inhaled corticosteroids (ICS), long-acting or short-acting  beta-2- agonists, montelukast, ipratropium bromide; any combination).",1,1,1,0,1,0,0,"Mixed effects logistic regression was used to assess the association between bronchiolitis in infancy and  later-life asthma diagnosis. Potential correlations between matched individuals were allowed by including a random intercept term in the models. All effect estimates were adjusted for age and potential confounders. The RSV group and non-RSV group were directly compared (i.e., authors compared prevalences).",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Bronchiolitis was defined as an acute viral respiratory tract infection during the first year of life with fever, tachypnoea, dyspnoea, prolonged expiration and wheeze on auscultation. During hospitalisation for bronchiolitis, nasopharyngeal mucus was examined for RSV by direct immunofluorescence (BioMrieux, Marcy-l'toile,  France). Other viruses were not systematically tested for. Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",1,0,0,0,0,2,1,0,0,"","Other viruses were not systematically tested for.  Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",2,2,1,NA,1,1,"Current asthma:   OR 0.88 (95% CI 0.44-1.76)  aOR 1.02 (95% CI 0.45-2.29)",1,1.02,1,0.37,NA,NA,NA,NA,NA,"current asthma (18-20 years)",113,1
"1013",113,"Asthma symptoms were recorded by a questionnaire based on the International Study of Asthma and Allergies in Childhood. Asthma ever was defined as a positive answer to have you ever been diagnosed with asthma by a  doctor?",1,1,1,0,1,0,0,"Mixed effects logistic regression was used to assess the association between bronchiolitis in infancy and  later-life asthma diagnosis. Potential correlations between matched individuals were allowed by including a random intercept term in the models. All effect estimates were adjusted for age and potential confounders. The RSV group and non-RSV group were directly compared (i.e., authors compared prevalences).",0,1,0,0,0,0,0,0,"The authors adjusted for sex, age, birth weight, gestational age at birth, household smoking ever, atopic dermatitis, and family history of atopy (see Table 2 footnote). Table 1 implies that age was at outcome ascertainment.",1,0,1,1,1,0,0,0,1,0,0,0,0,1,0,0,0,1,NA,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"Bronchiolitis was defined as an acute viral respiratory tract infection during the first year of life with fever, tachypnoea, dyspnoea, prolonged expiration and wheeze on auscultation. During hospitalisation for bronchiolitis, nasopharyngeal mucus was examined for RSV by direct immunofluorescence (BioMrieux, Marcy-l'toile,  France). Other viruses were not systematically tested for. Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",1,0,0,0,0,2,1,0,0,"","Other viruses were not systematically tested for.  Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",113,1
"2138",113," Current asthma was defined as asthma ever and a positive answer to at least one of the two questions: (1) Have you during the last 12 months had heavy breathing or wheezing/chest-tightness (2) Have you during the last 12 months used any asthma medications (inhaled corticosteroids (ICS), long-acting or short-acting  beta-2- agonists, montelukast, ipratropium bromide; any combination).",1,1,1,0,1,0,0,"Mixed effects logistic regression was used to assess the association between bronchiolitis in infancy and  later-life asthma diagnosis. Potential correlations between matched individuals were allowed by including a random intercept term in the models. All effect estimates were adjusted for age and potential confounders. The RSV group and non-RSV group were directly compared (i.e., authors compared prevalences).",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Bronchiolitis was defined as an acute viral respiratory tract infection during the first year of life with fever, tachypnoea, dyspnoea, prolonged expiration and wheeze on auscultation. During hospitalisation for bronchiolitis, nasopharyngeal mucus was examined for RSV by direct immunofluorescence (BioMrieux, Marcy-l'toile,  France). Other viruses were not systematically tested for. Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",1,0,0,0,0,2,1,0,0,"","Other viruses were not systematically tested for.  Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",113,1
"1010",113,"Asthma symptoms were recorded by a questionnaire based on the International Study of Asthma and Allergies in Childhood. Asthma ever was defined as a positive answer to have you ever been diagnosed with asthma by a  doctor?",1,1,1,0,1,0,0,"Mixed effects logistic regression was used to assess the association between bronchiolitis in infancy and  later-life asthma diagnosis. Potential correlations between matched individuals were allowed by including a random intercept term in the models. All effect estimates were adjusted for age and potential confounders. The RSV group and non-RSV group were directly compared (i.e., authors compared prevalences).",0,1,0,0,0,0,0,0,"The authors adjusted for sex, age, birth weight, gestational age at birth, household smoking ever, atopic dermatitis, and family history of atopy (see Table 2 footnote). Table 1 implies that age was at outcome ascertainment.",1,0,1,1,1,0,0,0,1,0,0,0,0,1,0,0,0,1,NA,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,2,"Bronchiolitis was defined as an acute viral respiratory tract infection during the first year of life with fever, tachypnoea, dyspnoea, prolonged expiration and wheeze on auscultation. During hospitalisation for bronchiolitis, nasopharyngeal mucus was examined for RSV by direct immunofluorescence (BioMrieux, Marcy-l'toile,  France). Other viruses were not systematically tested for. Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",1,0,0,0,0,2,1,0,0,"","Other viruses were not systematically tested for.  Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",113,1
"2135",113," Current asthma was defined as asthma ever and a positive answer to at least one of the two questions: (1) Have you during the last 12 months had heavy breathing or wheezing/chest-tightness (2) Have you during the last 12 months used any asthma medications (inhaled corticosteroids (ICS), long-acting or short-acting  beta-2- agonists, montelukast, ipratropium bromide; any combination).",1,1,1,0,1,0,0,"Mixed effects logistic regression was used to assess the association between bronchiolitis in infancy and  later-life asthma diagnosis. Potential correlations between matched individuals were allowed by including a random intercept term in the models. All effect estimates were adjusted for age and potential confounders. The RSV group and non-RSV group were directly compared (i.e., authors compared prevalences).",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Bronchiolitis was defined as an acute viral respiratory tract infection during the first year of life with fever, tachypnoea, dyspnoea, prolonged expiration and wheeze on auscultation. During hospitalisation for bronchiolitis, nasopharyngeal mucus was examined for RSV by direct immunofluorescence (BioMrieux, Marcy-l'toile,  France). Other viruses were not systematically tested for. Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",1,0,0,0,0,2,1,0,0,"","Other viruses were not systematically tested for.  Infants testing positive for RSV were defined as having RSV bronchiolitis and infants testing negative as having non-RSV bronchiolitis.",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",113,1
"1019",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV A",2,2,2,1,1,4,"Unadjusted: HR 1.37 (95% CI 0.93-2.02)  Adjusted: aHR 1.27 (95% CI 0.86-1.88)  Number of outcome events can be inferred from Figure 1 (541-337=204 with recurrent wheeze in RSV group; 85-44=41 with recurrent wheeze in RV A group)",1,1.27,1,0.2,716,204,337,41,44,"recurrent wheeze by age 3 (ages 0-3)",114,1
"1020",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV A",2,2,2,1,2,4,"Sensitivity analyses presented in eTable 3 removing 101 infants with coinfection.  HR 2.02 (95% CI 1.22-3.34)  aHR 1.86 (95% CI 1.11-3.11)",1,1.86,1,NA,613,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,1
"1021",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV A",2,2,2,1,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",114,1
"1023",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV B",2,2,1,NA,1,4,"Unadjusted: HR 1.43 (95% CI 0.53-3.87)  Adjusted: aHR 1.39 (95% CI 0.51-3.77)  Number of outcome events can be inferred from Figure 1 (541-337=204 with recurrent wheeze in RSV group; 12-5=7 with recurrent wheeze in RV B group)",1,1.39,1,NA,716,204,337,7,12,"recurrent wheeze by age 3 (ages 0-3)",114,2
"1024",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV B",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",114,2
"1022",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV B",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",114,2
"1018",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV C",2,2,2,1,1,4,"Unadjusted: HR 1.69 (95% CI 1.16-2.47)  Adjusted: aHR 1.58 (95% CI 1.08-2.32)  Number of outcome events can be inferred from Figure 1 (541-337=204 with recurrent wheeze in RSV group; 78-37=41 with recurrent wheeze in RV C group)",1,1.58,1,NA,716,204,337,41,37,"recurrent wheeze by age 3 (ages 0-3)",114,3
"1026",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV C",2,2,2,1,2,4,"Sensitivity analyses presented in eTable 3 removing 101 infants with coinfection.  HR 3.90 (95% CI 2.53-6.02)  aHR 3.76 (95% CI 2.40-5.90)",1,3.76,1,NA,613,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,3
"1025",114,"The outcome measure of interest was development of recurrent wheeze by age 3 years. Recurrent wheeze was defined in the 2007 National Institutes of Health (NIH) asthma  guidelines as having at least 2 corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep.",2,1,1,0,0,1,0,"First, we categorized patients into 4 groups: RSV-only (reference) and 3 rhinovirus species (A, B, and C) infection groups, excluding 5 infants with coinfection of multiple rhinovirus species. We examined the between-group differences in the patient characteristics and clinical presentation  by using Kruskal-Wallis, 2, and Fisher exact tests as appropriate. Next, to examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional  hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.    We conducted several sensitivity analyses. First, we performed a subgroup analysis that excluded 101 infants with RSV/rhinovirus coinfection. ",0,1,0,0,0,0,0,0,"In the multivariable model, we adjusted for 7  patient-level potential confounders (age, sex, race/ethnicity, parental history of asthma, household siblings, IgE sensitization, and bronchiolitis severity defined by the use of  mechanical ventilation [continuous positive airway pressure and/or intubation] during the index hospitalization) and accounted for between-hospital differences by including  the sites as random effects. We chose these covariates on the basis of a priori knowledge and clinical plausibility. By using age strata, the evaluation of scaled Schoenfeld residuals was not statistically significant in the model. ",1,0,1,0,1,0,0,1,0,0,0,0,0,0,0,1,0,1,NA,2,NA,2,NA,NA,2,NA,NA,NA,NA,NA,NA,"Table 2: RSV-only",1,0,0,0,0,2,1,0,0,"","Table 2: RV C",2,2,2,1,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",114,3
"2144",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV A",2,2,1,NA,1,4,"Unadjusted: HR 1.60 (95% CI 0.91-2.81)  Adjusted: aHR 1.40 (95% CI 0.79-2.49)",1,1.4,1,NA,590,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,1
"3269",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV A",2,2,1,NA,1,4,"Unadjusted: HR 1.25 (95% CI 0.72-2.16)  Adjusted: aHR 1.21 (95% CI 0.69-2.10)",1,1.21,1,NA,604,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,1
"2145",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV A",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",114,1
"3270",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV A",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",114,1
"2146",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV A",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",114,1
"3271",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV A",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,1
"2148",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV B",2,2,1,NA,1,4,"Unadjusted: HR 2.63 (95% CI 0.82-8.41)  Adjusted: aHR 2.41 (95% CI 0.75-7.78)",1,2.41,1,NA,590,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,2
"3273",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV B",2,2,1,NA,1,4,"Unadjusted: HR 0.63 (95% CI 0.09-4.50)  Adjusted: aHR 0.60 (95% CI 0.08-4.34)",1,0.6,1,NA,604,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,2
"2149",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV B",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,2
"3274",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV B",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,2
"2147",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV B",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,2
"3272",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV B",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,2
"2143",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV C",2,2,1,NA,1,4,"Unadjusted: HR 2.23(95% CI 1.33-3.76)  Adjusted: aHR 2.04 (95% CI 1.19-3.49)",1,2.41,1,NA,590,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,3
"3268",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV C",2,2,1,NA,1,4,"Unadjusted: HR 1.38 (95% CI 0.80-2.39)  Adjusted: aHR 1.31 (95% CI 0.75-2.30)",1,1.31,1,NA,604,NA,NA,NA,NA,"recurrent wheeze by age 3 (ages 0-3)",114,3
"2151",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV C",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,3
"3276",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV C",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,3
"2150",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,0,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze with subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze with subsequent development of asthma, RV C",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,3
"3275",114,"To address the potential heterogeneity  of recurrent wheeze, we also fit the models with stratifying the recurrent wheeze outcome (by age 3 years) by asthma status at age 4 years. Asthma was defined using a commonly used epidemiologic definition: physician-diagnosis  of asthma, with either asthma medication use (eg, albuterol inhaler or inhaled corticosteroids) or asthma-associated symptoms (eg, wheezing or nocturnal cough) in the preceding year.",3,2,1,0,0,1,0,"To examine the association of viruses with the risk of outcome, we modeled the time to event (ie, the development of recurrent wheeze) by fitting Cox proportional hazards models. Patients who did not have an outcome were censored at their last follow-up interview or at the time of withdrawal during the 36-month follow-up period.",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Table 3: Recurrent wheeze without subsequent development of asthma, RSV-only",1,0,0,0,0,2,1,0,0,"","Table 3: Recurrent wheeze without subsequent development of asthma, RV C",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,3
"1030",115,"",2,1,1,0,1,0,0,"a backward stepwise binomial logistic regression model was built. All the variables with P-value < 0.1 were introduced in the multivariate analysis.",0,1,0,0,0,0,0,0,"It's not entirely clear, but I think the only comparison of interest for the secondary meta-analysis compared those with RSV+ bronchiolitis hospitalization to RSV- bronchiolitis (p. 347, 2nd complete paragraph). I believe the comparison is unadjusted because RSV status is not reported in Table 4 as a predictor in the multivariate model; however, I am not sure about this.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA," -Recurrent wheezing: two or more wheezing episodes in the first 3 years of life, excluding bronchiolitis (measured by parent report on the ISAAC questionnaire).",1,1,0,0,0,2,0,1,0,"","Preterm and term children with RSV- bronchiolitis hospitalization in the first two years of life",2,2,1,NA,1,1,"In contrast, children with respiratory syncytial virus (RSV) detection had lower risk of hospitalization for RW than those RSVnegative [18 (29%) vs 92 (53%), (p=0.01)]. (p. 347)",2,0.37,1,0.32,236,18,44,92,82,"ages 6-9",115,1
"1027",115,"",2,1,1,0,1,0,0,"a backward stepwise binomial logistic regression model was built. All the variables with P-value < 0.1 were introduced in the multivariate analysis.",0,1,0,0,0,0,0,0,"It's not entirely clear, but I think the only comparison of interest for the secondary meta-analysis compared those with RSV+ bronchiolitis hospitalization to RSV- bronchiolitis (p. 347, 2nd complete paragraph). I believe the comparison is unadjusted because RSV status is not reported in Table 4 as a predictor in the multivariate model; however, I am not sure about this.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA," -Recurrent wheezing: two or more wheezing episodes in the first 3 years of life, excluding bronchiolitis (measured by parent report on the ISAAC questionnaire).",1,1,0,0,0,2,0,1,0,"","Preterm and term children with RSV- bronchiolitis hospitalization in the first two years of life",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",115,1
"1034",115,"",2,1,1,0,1,0,0,"a backward stepwise binomial logistic regression model was built. All the variables with P-value < 0.1 were introduced in the multivariate analysis.",0,1,0,0,0,0,0,0,"It's not entirely clear, but I think the only comparison of interest for the secondary meta-analysis compared those with RSV+ bronchiolitis hospitalization to RSV- bronchiolitis (p. 347, 2nd complete paragraph). I believe the comparison is unadjusted because RSV status is not reported in Table 4 as a predictor in the multivariate model; however, I am not sure about this.",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA," -Recurrent wheezing: two or more wheezing episodes in the first 3 years of life, excluding bronchiolitis (measured by parent report on the ISAAC questionnaire).",1,1,0,0,0,2,0,1,0,"","Preterm and term children with RSV- bronchiolitis hospitalization in the first two years of life",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",115,1
"1044",116,"At age seven, a clinical questionnaire was administered to assess data on respiratory  symptoms (day or night cough, discomfort during exercise, use of salbutamol), respiratory  treatments (corticosteroid p.o. or inhaled, long-acting bronchodilator), hospitalisation for  asthma, wheezing outside viral episodes, personal atopy (presence of atopic dermatitis,  eczema, rhinoconjunctivitis, food anaphylaxis from birth), environmental exposure to  tobacco smoke (currently or during pregnancy), pets, type of housing, day-care attendance  and number of siblings. Asthma was defined according to the frequency of the following symptoms: asthma  symptoms (tachypnea, wheezing, expiratory stridor, respiratory chest retraction), and  doctor-diagnosed wheezes or use of anti-asthmatic medication with a medical prescription. If >=3 respiratory symptoms were documented >=2 times or if any such episode lasted >=4 weeks, then the subject was classified as having asthma.",1,1,1,0,0,0,1,"Univariate analysis of asthma was conducted using the chi-squared test.",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV only",1,0,0,0,0,1,1,0,0,"","HRV only",2,2,1,NA,1,10,"The authors only report the p-value from the chi-squared, univariate test (Table 3).  The numbers listed in the table can be used to calculate an odds ratio for RSV vs. HRV. RSV asthma: 11/15, RSV no asthma: 41/53, HRV asthma: 7/15, HRV no asthma 9/53. OR (from excel spreadsheet) 0.34.",2,0.34,1,0.61,68,11,41,7,9,"ever asthma diagnosis by age 7 (ages 0-7)",116,1
"1041",116,"At age seven, a clinical questionnaire was administered to assess data on respiratory  symptoms (day or night cough, discomfort during exercise, use of salbutamol), respiratory  treatments (corticosteroid p.o. or inhaled, long-acting bronchodilator), hospitalisation for  asthma, wheezing outside viral episodes, personal atopy (presence of atopic dermatitis,  eczema, rhinoconjunctivitis, food anaphylaxis from birth), environmental exposure to  tobacco smoke (currently or during pregnancy), pets, type of housing, day-care attendance  and number of siblings. Asthma was defined according to the frequency of the following symptoms: asthma  symptoms (tachypnea, wheezing, expiratory stridor, respiratory chest retraction), and  doctor-diagnosed wheezes or use of anti-asthmatic medication with a medical prescription. If >=3 respiratory symptoms were documented >=2 times or if any such episode lasted >=4 weeks, then the subject was classified as having asthma.",1,1,1,0,0,0,1,"Univariate analysis of asthma was conducted using the chi-squared test.",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV only",1,0,0,0,0,1,1,0,0,"","HRV only",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",116,1
"1042",116,"At age seven, a clinical questionnaire was administered to assess data on respiratory  symptoms (day or night cough, discomfort during exercise, use of salbutamol), respiratory  treatments (corticosteroid p.o. or inhaled, long-acting bronchodilator), hospitalisation for  asthma, wheezing outside viral episodes, personal atopy (presence of atopic dermatitis,  eczema, rhinoconjunctivitis, food anaphylaxis from birth), environmental exposure to  tobacco smoke (currently or during pregnancy), pets, type of housing, day-care attendance  and number of siblings. Asthma was defined according to the frequency of the following symptoms: asthma  symptoms (tachypnea, wheezing, expiratory stridor, respiratory chest retraction), and  doctor-diagnosed wheezes or use of anti-asthmatic medication with a medical prescription. If >=3 respiratory symptoms were documented >=2 times or if any such episode lasted >=4 weeks, then the subject was classified as having asthma.",1,1,1,0,0,0,1,"Univariate analysis of asthma was conducted using the chi-squared test.",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV only",1,0,0,0,0,1,1,0,0,"","HRV only",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",116,1
"1051",117,"Recurrent wheezing was defined as two or more episodes following initial bronchiolitis for two years.",2,1,1,0,0,0,1,"Descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV",1,0,0,0,0,2,0,1,0,"","HRV (could have RSV co-infection?)",2,2,1,NA,1,10,"Descriptive statistics- can calculate odds ratio from Table 2- RSV and recurrent wheeze: 7/18; RSV and no recurrent wheeze: 29/63; HRV and recurrent wheeze: 1/18; HRV and no recurrent wheeze: 2/63",2,0.48,1,1.3,81,7,29,1,2,"recurrent wheeze (ages 1-4 years)",117,1
"1048",117,"Recurrent wheezing was defined as two or more episodes following initial bronchiolitis for two years.",2,1,1,0,0,0,1,"Descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV",1,0,0,0,0,2,0,1,0,"","HRV (could have RSV co-infection?)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",117,1
"1049",117,"Recurrent wheezing was defined as two or more episodes following initial bronchiolitis for two years.",2,1,1,0,0,0,1,"Descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV",1,0,0,0,0,2,0,1,0,"","HRV (could have RSV co-infection?)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",117,1
"1050",117,"Recurrent wheezing was defined as two or more episodes following initial bronchiolitis for two years.",2,1,1,0,0,0,1,"Descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV",1,0,0,0,0,2,0,1,0,"","HBoV (could have RSV co-infection?)",2,2,1,NA,1,10,"Descriptive statistics- can calculate odds ratio from Table 2- RSV and recurrent wheeze: 7/18; RSV and no recurrent wheeze: 29/63; HBoV and recurrent wheeze: 1/18; HBoV and no recurrent wheeze: 1/63",2,0.24,1,1.48,81,7,29,1,1,"recurrent wheeze (ages 1-4 years)",117,2
"1052",117,"Recurrent wheezing was defined as two or more episodes following initial bronchiolitis for two years.",2,1,1,0,0,0,1,"Descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV",1,0,0,0,0,2,0,1,0,"","HBoV (could have RSV co-infection?)",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",117,2
"1053",117,"Recurrent wheezing was defined as two or more episodes following initial bronchiolitis for two years.",2,1,1,0,0,0,1,"Descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV",1,0,0,0,0,2,0,1,0,"","HBoV (could have RSV co-infection?)",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",117,2
"1054",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV",2,2,1,NA,1,10,"Descriptive statistics- used Table 1 to calculate odds ratio for RSV vs. non-RSV comparisons",2,1.02,1,0.25,294,107,112,45,48,"recurrent wheeze by age 2 years (ages 0-2)",118,1
"1055",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",118,1
"1060",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",118,1
"1058",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV A or B",2,2,1,NA,1,10,"Descriptive statistics- used Table 1 to calculate odds ratio for RSV vs. non-RSV comparisons",2,1.27,1,0.41,294,107,112,12,16,"recurrent wheeze by age 2 years (ages 0-2)",118,2
"1059",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV A or B",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",118,2
"1062",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV A or B",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",118,2
"1056",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV C",2,2,1,NA,1,10,"Descriptive statistics- used Table 1 to calculate odds ratio for RSV vs. non-RSV comparisons",2,0.93,1,0.28,294,107,112,33,32,"recurrent wheeze by age 2 years (ages 0-2)",118,3
"1057",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV C",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",118,3
"1061",118,"Wheezing episodes were reported based upon the questions, ""Has the child had episodes of wheezing and/or chest tightness? If yes: specify the total number of episodes from birth to enrolment (first assessment) and from enrolment to the two-year assessment."" Additionally, parents were asked if the child had  doctor-diagnosed asthma. The primary outcome was early asthma by use of the proxy recurrent wheeze at 2 years, defined as at least  three episodes of wheeze, including the acute bronchiolitis at enrolment. We also used the total number of wheezing episodes by 2 years of age.",2,1,1,0,1,0,0,"The analyses focused on the total number of wheezing episodes experienced by 2 years of age, including the acute bronchiolitis at enrolment. A dichotomisation with at least three events was used as a proxy for early asthma and served as our primary outcome. It was analysed by a logistic regression.",0,1,0,0,0,0,0,0,"Footnote in Table 2 states that the authors adjusted for sex, age at inclusion, and parental atopy.",1,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2,NA,"RSV",1,0,0,0,0,2,1,0,0,"","HRV C",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",118,3
"1063",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,1,2,"Incidence risk ratio for ANY WHEEZING SINCE BIRTH (birth to 2 years)",1,2.68,1,0.11,1131,NA,NA,NA,NA,"any wheezing in past 2 years (birth to 2 years)",119,1
"2188",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,1,10,"Incidence risk ratio for RECURRENT WHEEZING (2 OR MORE EVENTS) SINCE BIRTH (birth to 2 years)",1,1.41,1,0.06,1131,NA,NA,NA,NA,"recurrent wheezing (2 or more events) from birth to 2 years",119,1
"3313",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Non-RSV LRTI",2,2,1,NA,1,10,"Incidence risk ratio for RECURRENT WHEEZING (3 OR MORE EVENTS) SINCE BIRTH (birth to 2 years)",1,1.42,1,0.1,1131,NA,NA,NA,NA,"recurrent wheezing (3 or more events) from birth to 2 years",119,1
"1064",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,1
"2189",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,1
"3314",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Non-RSV LRTI",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,1
"1067",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,1
"2192",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,1
"3317",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Non-RSV LRTI",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,1
"1065",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,1,10,"Incidence risk ratio for ANY WHEEZING SINCE BIRTH (birth to 2 years)",1,2.72,1,0.15,1131,NA,NA,NA,NA,"any wheezing in past 2 years (birth to 2 years)",119,2
"2190",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,1,10,"Incidence risk ratio for RECURRENT WHEEZING (2 OR MORE EVENTS) SINCE BIRTH (birth to 2 years)",1,1.32,1,0.09,1131,NA,NA,NA,NA,"recurrent wheezing (2 or more events) from birth to 2 years",119,2
"3315",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,NA,0,1,0,"","Non-RSV LRTI",2,2,1,NA,1,10,"Incidence risk ratio for RECURRENT WHEEZING (3 OR MORE EVENTS) SINCE BIRTH (birth to 2 years)",1,1.51,1,0.15,1131,NA,NA,NA,NA,"recurrent wheezing (3 or more events) from birth to 2 years",119,2
"1066",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,2
"2191",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,2
"3316",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,NA,0,1,0,"","Non-RSV LRTI",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,2
"1071",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,2
"2196",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","non-RSV LRTI",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,2
"3321",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Hospitalized RSV LRTI (Table 4)",1,0,0,0,0,NA,0,1,0,"","Non-RSV LRTI",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,2
"1068",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,NA,NA,1,10,"Incidence risk ratio for ANY WHEEZING SINCE BIRTH (birth to 2 years)",1,0.92,1,0.14,1131,NA,NA,NA,NA,"any wheezing in past 2 years (birth to 2 years)",119,3
"2193",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,1,NA,1,10,"Incidence risk ratio for RECURRENT WHEEZING (2 OR MORE EVENTS) SINCE BIRTH (birth to 2 years)",1,1.11,1,0.13,1131,NA,NA,NA,NA,"recurrent wheezing (2 or more events) from birth to 2 years",119,3
"3318",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,1,NA,1,10,"Incidence risk ratio for RECURRENT WHEEZING (3 OR MORE EVENTS) SINCE BIRTH (birth to 2 years)",1,1.12,1,0.28,1131,NA,NA,NA,NA,"recurrent wheezing (3 or more events) from birth to 2 years",119,3
"1069",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,NA,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,3
"2194",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,3
"3319",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,1,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,3
"1070",119,"We followed up children from birth until age 2 years for LRTI or wheezing using active surveillance systems. Episodes of wheezing were reported by a caregiver using questions adapted from the international Study of Asthma and Allergies in Childhood or were diagnosed on auscultation by trained study staff at a study visit or during an intercurrent illness. Outcome 1: any wheezing birth to two years",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,1,0,0,0,0,0,0,"Adjusted for sex, socioeconomic status quartile, season at birth, other children in the household, HIV exposure, maternal smoking, prematurity, low birthweight, and age at time of reported or assessed wheeze or mid-interval of no wheeze recorded.",0,0,0,1,1,0,1,1,1,0,0,0,0,1,0,1,0,NA,NA,NA,2,2,NA,2,2,2,NA,NA,NA,NA,2,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,NA,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",119,3
"2195",119,"Outcome 2: recurrent wheezing (two or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,3
"3320",119,"Outcome 2: recurrent wheezing (three or more events); Recurrent wheezing was defined a-priori as two or more observations of wheezing after the LRTI event in individuals experiencing LRTI and two or more observations of wheezing in those who did not experience an LRTI.",2,2,1,0,1,0,0,"generalised estimating equations with a negative  binomial family and link function (GEE used to acocunt for intraindividual clustering of intervals) ",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 4)",1,0,0,0,0,0,0,1,0,"","Rhinovirus LRTI",2,2,1,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,3
"1077",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Mycoplasma infection",2,2,1,NA,1,10,"descriptive statistics- I calculated OR",2,1.82,1,0.74,145,20,11,5,5,"wheezing in past year (1 year post hospital admission)",120,1
"1078",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Mycoplasma infection",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",120,1
"1079",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Mycoplasma infection",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",120,1
"1072",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Hib infection",2,2,1,NA,1,10,"descriptive statistics",2,3.64,1,1.28,145,20,11,1,2,"wheezing in past year (1 year post hospital admission)",120,2
"1073",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Hib infection",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",120,2
"1074",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Hib infection",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",120,2
"1075",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Influenza B infection",2,2,1,NA,1,10,"descriptive statistics",2,0.45,1,1.18,145,20,11,4,1,"wheezing in past year (1 year post hospital admission)",120,3
"1076",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Influenza B infection",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",120,3
"1080",120,"Recurrent wheezing in the year of follow up was defined as having at least 4 wheezing episodes. The authors did not describe how wheezing was ascertained.",2,1,1,0,0,0,1,"descriptive statistics (Table 2)",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI (Table 2)",1,0,0,0,0,2,0,0,1,"Birth to 3 years","Influenza B infection",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",120,3
"1085",121,"Based on biannual parent telephone interviews, the primary outcome for the present analysis was recurrent wheezing by age 3 years, as defined by the 2007 National Institutes of Health's Expert Panel Report 3: having at least 2  corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep. There is no required or specified time frame between episodes of wheezing. Because wheezing in early childhood can be transient, we extended this outcome to children who had recurrent wheezing by age 3 years and also had asthma at age 4 years. We defined asthma at age 4 years using an epidemiologic definition:  having both a physician's diagnosis of asthma and either asthma medication use (eg, albuterol inhaler, and inhaled corticosteroids) or asthma-related symptoms (eg, wheezing and nocturnal cough) between the ages of 3 and 4 years.",2,1,1,0,0,0,1,"descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI during hospitalization (Table 1)",1,0,0,0,0,2,1,0,0,"","Rhinovirus",2,2,1,NA,1,10,"descriptive statistics- I used information in Table 1 to calculate the odds ratio",2,0.71,1,0.18,842,196,494,62,111,"recurrent wheezing by 3 years (ages 0-3)",121,1
"1089",121,"Based on biannual parent telephone interviews, the primary outcome for the present analysis was recurrent wheezing by age 3 years, as defined by the 2007 National Institutes of Health's Expert Panel Report 3: having at least 2  corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep. There is no required or specified time frame between episodes of wheezing. Because wheezing in early childhood can be transient, we extended this outcome to children who had recurrent wheezing by age 3 years and also had asthma at age 4 years. We defined asthma at age 4 years using an epidemiologic definition:  having both a physician's diagnosis of asthma and either asthma medication use (eg, albuterol inhaler, and inhaled corticosteroids) or asthma-related symptoms (eg, wheezing and nocturnal cough) between the ages of 3 and 4 years.",2,1,1,0,0,0,1,"descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI during hospitalization (Table 1)",1,0,0,0,0,2,1,0,0,"","Rhinovirus",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",121,1
"1087",121,"Based on biannual parent telephone interviews, the primary outcome for the present analysis was recurrent wheezing by age 3 years, as defined by the 2007 National Institutes of Health's Expert Panel Report 3: having at least 2  corticosteroid-requiring exacerbations in 6 months or having at least 4 wheezing episodes in 1 year that last at least 1 day and affect sleep. There is no required or specified time frame between episodes of wheezing. Because wheezing in early childhood can be transient, we extended this outcome to children who had recurrent wheezing by age 3 years and also had asthma at age 4 years. We defined asthma at age 4 years using an epidemiologic definition:  having both a physician's diagnosis of asthma and either asthma medication use (eg, albuterol inhaler, and inhaled corticosteroids) or asthma-related symptoms (eg, wheezing and nocturnal cough) between the ages of 3 and 4 years.",2,1,1,0,0,0,1,"descriptive statistics",0,0,0,0,0,0,0,1,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV LRTI during hospitalization (Table 1)",1,0,0,0,0,2,1,0,0,"","Rhinovirus",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",121,1
"1092",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Children with LRTI with only RSV detected",1,0,0,0,0,2,0,0,1,"birth to 36 months","Children with LRTI with only HRV detected",2,2,NA,NA,1,1,"LOG ODDS for ALL participants computed from raw data below (from Table 3 of the manuscript):     for those with family history of RSV, 28/42 had recurrent wheezing compared to 3/11 with HRV    For those without family history of RSV, 16/101 had recurrent wheezing vs 3/16 with HRV",2,0.89,1,0.5,134,44,63,6,21,"reccurrent wheeze or asthma after hospitalization at age 0-3 years",122,1
"1093",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Children with LRTI with only RSV detected",1,0,0,0,0,2,0,0,1,"birth to 36 months","Children with LRTI with only HRV detected",2,2,NA,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",122,1
"1094",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Children with LRTI with only RSV detected",1,0,0,0,0,2,0,0,1,"birth to 36 months","Children with LRTI with only HRV detected",2,2,NA,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",122,1
"1091",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-LRTI hospitalization, 0-36 months",1,0,0,0,0,2,0,0,1,"0-36 months","HRV-LRTI hospitalization, 0-36 months",2,2,1,NA,1,1,"LOG ODDS for participants WITH FAMILY HISTORY OF WHEEZE computed from raw data below (from Table 3 of the manuscript):     for those with family history of RSV, 28/42 had recurrent wheezing compared to 3/11 with HRV    For those without family history of RSV, 16/101 had recurrent wheezing vs 3/16 with HRV",2,1.67,1,0.75,53,28,14,3,8,"reccurrent wheeze or asthma after hospitalization at age 0-3 years",122,2
"1096",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-LRTI hospitalization, 0-36 months",1,0,0,0,0,2,0,0,1,"0-36 months","HRV-LRTI hospitalization, 0-36 months",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",122,2
"1097",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-LRTI hospitalization, 0-36 months",1,0,0,0,0,2,0,0,1,"0-36 months","HRV-LRTI hospitalization, 0-36 months",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",122,2
"1090",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-LRTI hospitalization, 0-36 months",1,0,0,0,0,2,0,0,1,"0-36 months","HRV-LRTI hospitalization, 0-36 months",2,2,1,NA,1,1,"LOG ODDS for participants WITHOUT FAMILY HISTORY OF WHEEZE computed from raw data below (from Table 3 of the manuscript):       For those without family history of RSV, 16/101 had recurrent wheezing vs 3/16 with HRV",2,0.35,1,0.7,81,16,49,3,13,"reccurrent wheeze or asthma after hospitalization at age 0-3 years",122,3
"1098",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-LRTI hospitalization, 0-36 months",1,0,0,0,0,2,0,0,1,"0-36 months","HRV-LRTI hospitalization, 0-36 months",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",122,3
"1095",122,"*combined wheezing/asthma outcome was used*     Outcome was assessed in June 2017 by phone call, after hospitalization any time between March 2007 and December 2016.    Outcome was parent-reported wheezing or physician diagnosed Asthma 'after child was discharged from the hospital' - no washout period specified. Also asked how many wheezing episodes per year <3 or >=3, but ascertainment period could have covered multiple years depending on the child.     ",3,1,1,0,1,0,0,"Proportion with recurrent wheezing compared for single RSV infection vs. single HRV infection vs. mixed HRV/RSV infection, stratified by whether or not there was a family history of wheezing",0,0,1,0,0,0,0,0,"Stratified by family history of wheeze, otherwise, there was no attempt to reduce the influence of confounders",1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-LRTI hospitalization, 0-36 months",1,0,0,0,0,2,0,0,1,"0-36 months","HRV-LRTI hospitalization, 0-36 months",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",122,3
"1110",124,"All cause wheeze admissions from 12mo-8 years,   No clear washout period",2,1,1,0,1,0,0,"log-binomial regression adjusted for gender to calculate relative risks comparing RSV bronchiolitis to non-RSV bronchiolitis groups",0,1,0,0,0,0,0,0," -To test for confounding between our  cohorts, we compared the rates of head injury (a  common non-infective reason for paediatric admission) as a negative control, with the hypothesis that if unbiased that this should not differ between cohorts.    Adjusted for gender    Excluded those admitted to NICU",0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants hospitalized with RSV bronchiolitis in the first year of life ",0,1,0,0,0,1,1,0,0,"","Infants hospitalized with non-RSV bronchiolitis in the first year of life ",2,2,1,NA,1,2,"RR was calculated for non-rsv LRTI vs UTI  =3.1 (95% CI 2.4-3.9); separately rsv LRTI vs UTI was calculated = 2.3 (95% CI 2.0-2.6)    ",1,0.74,2,NA,7908,NA,NA,NA,NA,NA,124,1
"1111",124,"All cause wheeze admissions from 12mo-8 years,   No clear washout period",2,1,1,0,1,0,0,"log-binomial regression adjusted for gender to calculate relative risks comparing RSV bronchiolitis to non-RSV bronchiolitis groups",0,1,0,0,0,0,0,0," -To test for confounding between our  cohorts, we compared the rates of head injury (a  common non-infective reason for paediatric admission) as a negative control, with the hypothesis that if unbiased that this should not differ between cohorts.    Adjusted for gender    Excluded those admitted to NICU",0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants hospitalized with RSV bronchiolitis in the first year of life ",0,1,0,0,0,1,1,0,0,"","Infants hospitalized with non-RSV bronchiolitis in the first year of life ",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",124,1
"1108",124,"All cause wheeze admissions from 12mo-8 years,   No clear washout period",2,1,1,0,1,0,0,"log-binomial regression adjusted for gender to calculate relative risks comparing RSV bronchiolitis to non-RSV bronchiolitis groups",0,1,0,0,0,0,0,0," -To test for confounding between our  cohorts, we compared the rates of head injury (a  common non-infective reason for paediatric admission) as a negative control, with the hypothesis that if unbiased that this should not differ between cohorts.    Adjusted for gender    Excluded those admitted to NICU",0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Infants hospitalized with RSV bronchiolitis in the first year of life ",0,1,0,0,0,1,1,0,0,"","Infants hospitalized with non-RSV bronchiolitis in the first year of life ",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",124,1
"1118",125,"Recurrent wheezing:  3 episodes of wheezing diagnosed by a pediatrician during the 2-year follow-up after the acute episode of bronchiolitis",2,1,1,0,0,0,1,"Descriptive statistics only -- the RSV vs non-RSV comparison was not of interest in the paper; however, Table 1 presents data on the percentage of those with RSV LRTI had recurrent wheeze and wheeze outcomes which can be used to calculate effect sizes. ",0,0,0,0,0,0,0,1,"None. This was not of interest in the study. They simply reported descriptive stats that could allow for an effect size calculation",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-positive bronchiolitis requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV-negative bronchiolitis requiring hospitalization",2,2,1,NA,1,1,"OR based on descriptive stats -- 2-year follow-up after bronchiolitis hospitalization",2,0.96,1,0.7,52,13,27,4,8,"0-3",125,1
"2243",125,"Any wheeze: recurrent wheeze as defined above (3+ episodes diagnosed by physician) or wheezing falling short of this criterion (1-2 episodes diagnosed by physician) ",2,2,1,0,0,0,1,"Not of interest in the paper -- OR determined from Table 1 descriptives",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-positive bronchiolitis requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV-negative bronchiolitis requiring hospitalization",2,2,1,NA,1,1,"Based on data in Table 1",2,1.22,1,0.66,52,22,18,6,6,"0-3",125,1
"1119",125,"Recurrent wheezing:  3 episodes of wheezing diagnosed by a pediatrician during the 2-year follow-up after the acute episode of bronchiolitis",2,1,1,0,0,0,1,"Descriptive statistics only -- the RSV vs non-RSV comparison was not of interest in the paper; however, Table 1 presents data on the percentage of those with RSV LRTI had recurrent wheeze and wheeze outcomes which can be used to calculate effect sizes. ",0,0,0,0,0,0,0,1,"None. This was not of interest in the study. They simply reported descriptive stats that could allow for an effect size calculation",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-positive bronchiolitis requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV-negative bronchiolitis requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",125,1
"2244",125,"Any wheeze: recurrent wheeze as defined above (3+ episodes diagnosed by physician) or wheezing falling short of this criterion (1-2 episodes diagnosed by physician) ",2,2,1,0,0,0,1,"Not of interest in the paper -- OR determined from Table 1 descriptives",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-positive bronchiolitis requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV-negative bronchiolitis requiring hospitalization",2,2,1,NA,2,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",125,1
"1120",125,"Recurrent wheezing:  3 episodes of wheezing diagnosed by a pediatrician during the 2-year follow-up after the acute episode of bronchiolitis",2,1,1,0,0,0,1,"Descriptive statistics only -- the RSV vs non-RSV comparison was not of interest in the paper; however, Table 1 presents data on the percentage of those with RSV LRTI had recurrent wheeze and wheeze outcomes which can be used to calculate effect sizes. ",0,0,0,0,0,0,0,1,"None. This was not of interest in the study. They simply reported descriptive stats that could allow for an effect size calculation",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-positive bronchiolitis requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV-negative bronchiolitis requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",125,1
"2245",125,"Any wheeze: recurrent wheeze as defined above (3+ episodes diagnosed by physician) or wheezing falling short of this criterion (1-2 episodes diagnosed by physician) ",2,2,1,0,0,0,1,"Not of interest in the paper -- OR determined from Table 1 descriptives",0,0,0,0,0,0,0,0,"",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"RSV-positive bronchiolitis requiring hospitalization",1,0,0,0,0,2,1,0,0,"","RSV-negative bronchiolitis requiring hospitalization",2,2,1,NA,3,NA,"",NA,NA,NA,NA,NA,NA,NA,NA,NA,"",125,1
